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ABSTRACT 
 
Oligodendrocyte precursor cells (OPCs) are the main actors involved in developmental 
myelination and adult myelination dynamic, including remyelination after myelin injury. The 
recapitualtion hypothesis states that remyelination in adulthood is a complete recapitulation of 
developmental myelination. However, the different nature of foetal and adult OPCs could 
reflect a different myelination mechanism and different response to demyelinating insults. 
The main objective of the present study is the investigation of foetal and adult OPCs 
vulnerability to the two main components of the demyelinating diseases: inflammation and 
hypoxia/ischemia (HI). In order to develop the main objective, robust and efficient in vitro 
models and readouts were set up. In particular, a cell-based high content screening approach 
was used as the elective technique in order to obtain robust and reproducible data. 
Moreover, since the differential response of foetal and adult OPCs could come from a 
different physiological differentiation process, driven by thyroid hormone (TH) and exerted 
by nuclear receptors (NRs) activity, we first focused on the role of NRs and co-regulator in 
foetal and adult OPCs differentiation. We found a different expression of NRs in early 
precursors, a different response to T3-mediated differentiation, the selective importance of 
PARP activity for foetal OPCs and the fundamental role of RXRγ in both systems. 
Differences in physiological differentiation can reflect different responses to noxious stimuli. 
Thus, we exposed OPCs to inflammatory cytokines mix, in order to mimic the inflammation 
environment, or to oxygen-glucose deprivation (OGD), in order to mimic HI. OGD was first 
characterized in primary neuronal cultures and tested for its reliability in disease model 
studies and pharmacological analysis. 
Foetal and adult OPCs show both a cytokines-mediated differentiation block, reflecting what 
the in vivo pathological condition. We thus tested a pharmacological tool in adult cultures, in 
order to study the mechanism. In particular, we found that the differentiation block was linked 
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to an increase of deiodinase 3 (D3), the enzyme inactivating T3, the active form of TH and, 
blocking its activity, it was possible to restore the OPC differentiation process. 
On the other hand, only foetal OPCs are sensitive to OGD, showing OPCs/OLs-specific cell 
death. Since we found an increase in D3 expression after OGD in foetal OPCs, further studies 
will elucidate the mechanism underlying the foetal-selective OPCs cell death, analysing the 
role of D3 in the process and glutamate-mediated excitotxicity, the major triggerer of HI-
induced cell death. 
The better understanding of OPCs biology and mechanisms underlying physiological and 
pathological conditions, bound to information about differences in foetal and adult OPCs, will 
open the way to new therapies development, based on differential strategies for demyelinating 
diseases affecting foetal or adult life. 
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1 INTRODUCTION 
 
1.1 The oligodendrocyte precursor cell in development and myelin turnover 
 
Oligodendrocytes (OLs) are the glial-subtype myelinating cells of the central nervous system 
(CNS), generated from oligodendrocytes precursor cells (OPCs), discovered by Robertson in 
1899 (Robertson, 1899) and named and classified by Rio Hortega in 1921 (Rio Hortega et al., 
1921). During embryonic development, the life of an OL is defined by four distinct phases: i) 
birth, migration, and proliferation of OPCs; ii) morphological differentiation; iii) axonal 
contact, and generation of compact myelin and iv) long-term trophic and metabolic support of 
the encased axon (Michalski et al., 2015). During the adult life, a substantial number of OPCs 
persist in the CNS. Here, they comprise the largest population of dividing cells, involved in 
myelin turnover, repair and replacement (Dawson et al., 2003; Hughes et al., 2013). 
 
1.1.1 Development 
 
The development of the oligodendrocyte lineage begins with specification of OPCs from 
neural stem cells (NSCs) during late embryonic gestation. NSCs initially expand within the 
ventricular lining of the CNS generated by the neuroepithelial cells along the neuroaxsis. 
These multipotent stem cells give rise to neurons, radial glia, astrocytes and bipotential 
astrocyte-oligodendrocyte progenitor cells that colonize the CNS. Neurons and their radial 
glial guides are the first cell types to be specified while only late in neurogenesis significant 
gliogenesis and glial progenitor cell production begin (Goldman and Kuypers, 2015). 
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OPCs are recognized because of the expression of membrane protein, e.g. NG2, a type I 
membrane glycoprotein expressed by a subpopulation of glial cells and, in the developing 
brain, also by pericytes. NG2 is a marker for early OPCs overlapping CNPase (2’, 3’-cyclic 
nucleotide 3’-phosphodiesterase), a marker for mature OLs, but absent in myelinating OLs 
expressing MOG (myelin oligodendrocyte glycoprotein) (Karram et al., 2005; Polito and 
Reynolds, 2005). NG2-expressing cells are recognized as progenitors of glia, given rise to 
both OPCs and astrocytes and they are also referred as NG2-glia, in order to distinguish these 
progenitors from other NG2-expressing cells, like pericytes or macrophages (Dimou and 
Gallo, 2015). Thus, OPCs are recognized as NG2/PDGFRα (platelet-derived growth factor 
alpha receptor)-expressing cells with high proliferative and migrating capability. They 
differentiate through premyelinating stage to become mature and myelinating 
oligodendrocytes, interacting with neuronal axons in order to organize the nodal, paranodal 
nad juxtaparanodal regions of myelinated axons (Bercury et al., 2015). 
NG2-progenitors are not an homogeneous population and they give rise to different progenies 
in different brain regions and in different stages of the development (Dimou and Gallo, 2015; 
Viganò and Dimou, 2016; Figure 1). In the CNS three separate waves (starting at E12.5 in 
mice and during the second trimester of gestation in humans), define the OLs population. 
OPCs are first produced ventrally, along the neural tube in the ventral ganglionic eminence, in 
a process driven by Sonic Hedgehog (Shh). After this first wave, they are completely replaced 
by a dorsal derived population (from the dorsal cortical subventricular zone) and, at last, 
within the cortex (Kessaris et al., 2006; Jakovcevski et al., 2009).  
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Figure 1. Oligodendrocyte precursor cells generation during development. 
(A) Patterning of the embryonic neural tube by organizing signals (Shh, Wnt, BMP) is 
reflected in the expression of Olig2 and homeodomain (Nkx2.2, Nkx6.1, Pax6) transcription 
factors in restricted progenitor domains (pMN, p0-p3, dP1-dP6). (B) Embryonic OPCs arise 
from the ventral domain under control of Shh, replaced by OPC-generating in the dorsal 
region in foetal stage and within the cortex in postnatal age (Fancy et al., 2011 modified). 
 
 
The progression of OPCs along the myelination process is tightly regulated in all the stages, 
by signals including growth factors, protein kinases and extracellular matrix molecules, all of 
which influence epigenetic modifications, transcriptional and translational regulation, and the 
actin cytoskeleton (Bercury et al., 2015). 
In the mouse forebrain, several transcription factors, such as Znf488 and Znf536, are involved 
in the early phase of oligodendroglial lineage restriction, a process also mediated by 
downregulation of Sox2, and upregulation of Sox8 and Sox9. Upregulation of these genes, is 
correlated to the upregulation of Nkx2.2, Olig1, Olig2 and Sox10, the main mediators of 
OPCs differentiation, leading to the upregulation of PDGFRα. Moreover, OPCs maturation, 
can proceed only after cell cycle arrest, repressing E2F1 and c-myc genes, a process requiring 
p27kip1. At the transition between proliferating to differentiating OPCs, other transcription 
factors are upregulated. In particular Sox17 repress the Wnt signaling, triggering the cell cycle 
exit. After OL specification, myelination is triggered by the myelin regulatory factor (MYRF), 
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activating the expression of myelin basic protein (MBO), proteolipid protein 1 (PLP), myelin-
associated glycoprotein (MAG), CNPase and MOG. The retained transcription of Olig2 and 
Sox10 is necessary for the mantainence of MYRF expression (Goldman and Kuypers, 2015; 
Figure 2). Thus, gene expression regulation through chromatin remodelling is a key process 
that regulates OL development, involving histone acetylation/deacetylation and ATP-
dependent remodeling by SWI/SNF enzymes (Zuchero and Barres, 2015).  
 
 
 
Figure 2. Transcription factors in OPCs differentiation and associated markers. 
At the cellular level, pluripotent stem cells progress through serial developmental stages: 
neuroepithelial stem cell, OPC, premyelinating and ultimately myelinating oligodendroglia. 
Figure shows all the factors involved in this differentiation process (Goldman and Kuypers, 
2015, modified). 
 
 
The most important factors regulating the differentiation process are thyroid hormones (THs; 
Calzà et al., 2017). Triiodothyronine (T3), the active form of TH, acts via genomic, epigenetic 
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and non-genomic mechanisms (Lee and Petratos, 2016), inducing OPCs cell cycle exit and 
terminal differentiation (Durand and Raff, 2000; Raff, 2006). In particular, after a definite 
number of cell division, proliferating OPCs start expressing thyroid hormone receptors (TRs) 
and became sensitive to T3 (Maruvada et al., 2004). T3 mediates its action binding TRs (TRα 
and TRβ), a class of nuclear receptors (NRs) that migrate into the nucleus and regulate the 
expression of specific genes controlling OPCs cell cycle exit and regulating the expression of 
premyelinating genes (Baxi et al., 2014; Casaccia-Bonnefil and Liu, 2003; Dugas et al., 
2012). 
 
1.1.2 Adult life 
 
OPCs generated during the development are distributed in the adult brain and spinal cord, in 
the grey and the white matter. They comprise the largest population of dividing cells in the 
mature CNS and, each OPC, exists within unique spatial pockets established through inter-
repulsive cues with other progenitors (Michalski et al., 2015). These cells are highly 
exploratory, sampling in search of unoccupied space and are responsible for the myelin 
turnover and repair in adult life. In response to specific stimuli, they can proliferate, migrate 
to axons and differentiate in mature oligodendrocytes (Fukushima et al., 2015). New OPCs 
are also generated from NSCs in the subventricular zone (SVZ) of the lateral ventricle (Urbán 
and Guillemot, 2014). This neurogenic area of the adult CNS contains the niche of 
multipotent stem cells, composed by three different kind of cells: type B (neural stem 
precursor cells), type C (transit-amplifying cells) and type A (neuroblasts) (Alvarez-Builla 
and Garcia-Verdugo, 2002; Figure 3). New OPCs can be generated from type C cells 
differentiating into NG2-positive glia, migrating and starting the maturation process to 
became myelinating OLs (Gonzalez-Perez and Alvarez-Buylla, 2011; Menn et al., 2006). 
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Figure 3. Subventricular zone niche and neural stem cells multipotency. 
In the upper panel is showed the cross section of the mouse brain, highlighting the lateral 
ventricle (V) and the subventricular zone (SVZ). 
The lower panel shows cellular composition of the adult SVZ niche: B1 cells are surrounded 
by multiciliated ependymal cells (E) and contact the lateral ventricle with an apical region (I) 
containing a primary cilium and, on the opposite side, contacting blood vessels with a long 
distal process (III). These cells give rise to C cells (transit-amplifying cells) that divide to 
generate neuroblasts (type A cells). B1 cells domain II (intermediate) is in close proximity to 
C cells, neuroblasts, neuronal terminals, and other supporting cells (Fuentealba et al., 2012). 
 
 
In the healthy adult brain, new myelin is continually generated, showing a persisting 
remodelling (Yeung et al., 2014). Myelin volume in humans is activity-dependent, and can 
increase producing	  new	  cells	  or	  new	  membrane	  from	  the	  already	  existing	  cells	  (Bercury	  et	   al.,	   2015)	  when	   practicing new skills (Bengtsson	   et	   al.,	   2005), in learning a language 
(Schlegel	  et	  al.,	  2012),	  etc.	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Myelination	  is	  a	  conserved	  process	  during	  adult	  life,	  showing	  high	  plasticity.	  An	  effective	  remyelination	   can	   occurs	   after	   demyelination	   insults,	   also	   leading	   to	   a	   complete	  anatomical	   and	   functional	   myelin	   sheath	   restoration,	   thus	   representing	   the	   only	   true	  regenerative	   capability	  of	   the	  CNS	   (Crawford	  et	   al.,	   2013). Remyelination process is not 
performed by pre-existing mature OLs, but involves the generation of new mature cells from 
the quiescent OPC pool distributed throughout the CNS or from the subventricular zone. 
Factors derived from activated microglia activate local OPCs switch from quiescent state to a 
regenerative phenotype, migrate to demyelinated areas and generate mature OLs 
remyelinating axons (Bradl and Lassmann, 2010), in a process that is believed to be similar to 
the developmental myelination (Franklin and Hinks 1999; Franklin and Ffrench-Constant, 
2008). 
Different factors are involved in the activation of OPCs cell cycle and their migration, two 
fundamental processes for an efficient remyelination. Inflammation plays a critical role in the 
activation of OPCs, through inflammation–associated factors (e.g. IL-1b, TNFa, LIF; see 
chapter 1.2.1 Inflammation). Than chemotactic factors induce OPCs proliferation, and attract 
OPCs to the demyelinated site (e.g. by PDGF, bFGF, CXCL1), than remyelination starts by 
an upregulation of Olig2 and Nkx2.2 (Miron et al., 2011).  It has been shown that Bmp (Bone 
morphogenic protein) signalling regulates migration of neural crest cells and osteoblasts, but 
also OPCs into cortical areas, both in development and in adult life (Choe et al., 2014).  As	   already	   described	   for	   foetal	   OPCs,	   T3	   is	   a	   key	   player	   in	   OPC	   maturation.	   The	  biological	   activity	   of	   TH	   versus	   target	   cells	   is	   determined	   by	   the	   intracellular	  concentration	  of	  T4	  and	  T3,	  which	  depends	  on:	  i)	  circulating	  T4	  and	  T3,	  ii)	  the	  presence	  and	  activity	  of	  transporters	  on	  the	  plasma	  membrane,	  and	  iii)	  the	  presence	  and	  activity	  of	   tissue	   specific	   deiodinases.	   TH	   cellular	   action	   implies	   that	   T4,	   as	   produced	   by	   the	  thyroid	  gland,	  is	  converted	  into	  the	  active	  form	  T3	  by	  deiodinases	  enzymes	  in	  the	  target	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organs.	  T4	  is	  in	  fact	  considered	  the	  “prohormone”	  (the	  most	  abundant	  in	  the	  blood)	  and	  T3	  is	  the	  active	  form	  (Calzà	  et	  al.,	  2015).	  A	   correct	   tissue	   THs	   metabolism	   is	   fundamental	   for	   an	   appropriate	   adult	   OPCs	  maturation.	   	   The	   circulating	   prohormone	   T4	   is	   converted	   in	   T3	   in	   loco,	   by	   astrocytes	  throught	  deiodinase	  2	   (D2)	   enzyme	   (Bianco	  et	   al.,	   2002;	  Calzà	   et	   al.,	   2015;	  Morte	   and	  Bernal,	   2014).	   Deiodinase	   3	   (D3)	   guarantees	   the	   THs	   homeostasis	   inactivating	   T4	   in	  reverse-­‐T3	  (rT3)	  and	  T3	  in	  3,5-­‐diiodo-­‐l-­‐thyronine	  (T2).	  THs	   cross	   the	   Blood	   Brain	   Barrier	   (BBB)	   by	   specific	   transporters,	   leading	   to	   a	  concentration	   of	   TH	   in	   the	   brain	   20%	   higher	   than	   in	   the	   blood.	   The	   process	   is	   also	  regulated	  by	  the	  highest	  affinity	  of	  TH	  transporters	  to	  T4	  than	  T3.	  Moreover,	  T4	  in	  the	  blood	   is	  mostly	  segregated	  by	   its	   transporter,	   transthyretin.	  THs	  are	   transported	   from	  blood	   to	   CNS	   mainly	   by	   monocarboxylate	   transporter	   8	   (MCT8)	   and	   organic	   anion	  transporter	  protein	  1C1	  (OATP1C1).	  This	  last	  transporter	  mediates	  also	  the	  transport	  of	  T4	  inside	  astrocytes,	  where	  is	  converted	  in	  T3	  by	  D2.	  Also	  integrin	  aVb3	  has	  high	  affinity	  to	  T4,	  and	   it	   is	   the	  mediator	  of	   the	  non-­‐genomic	  effects	  of	  TH	  (Calzà	  et	  al.,	  2015).	  The	  importance	   of	   TH	   transporters	   and,	   thus	   of	   the	   intracellular	   T3	   concentration,	   is	   also	  demonstrated	   in	   humans	  with	  MCT8	  mutations,	   leading	   to	   the	   Allan-­‐Herndon-­‐Dudley	  syndrome,	   characterized	   by	   severe	   neurodevelopmental	   defects	   (Dumitrescu	   and	  Refetoff,	  2013).	  THs	  metabolism	  and	  transport	  guarantees	  the	  appropritate	  intracellular	  content	  of	  THs	  mediating	   the	   downstream	  genomic	   and	  non-­‐genomic	   processes	   (Dentice	   et	   al.,	   2013;	  Bernal	  et	  al.,	  2015;	  Lee	  et	  al.,	  2015). 
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1.1.3 Is remyelination a recapitulation of developmental myelination? 
 
Myelination and remyelination share a common objective: wrap non-myelinating axons, to 
create the correct cellular and molecular structure for an efficient saltatory axonal conduction. 
The recapitulation hypothesis of myelin regeneration holds that mechanisms that underlie 
remyelination after injury are essentially a rerunning of a developmental myelination program 
(Franklin and Hinks 1999). For example, two of the best studied pathways, identified as 
crucial players in regulating developmental myelination, have been subsequently found to be 
also limiting factors for remyelination: Notch signaling pathway and the leucine-rich repeat 
and Ig-containing Nogo receptor interacting protein-1 (LINGO-1), two strong inhibitors of 
OPCs differentiation and myelination. Both factors are expressed during development and 
contribute to the control of differentiation timing and, in different demyelinating conditions, 
they are highly expressed, contributing to the pathogenesis (Bhatt et al., 2014).  
However, in spite of the evidences remarking the recapitulation hypothesis, morphological 
differences between the two processes lead to the view that these two mechanisms are 
differentially regulated (Miron, 2011). The OPCs generated by the three different waves 
during development, produce the adult OPCs pool. Thus, these cells are different spatio-
temporally defined OPCs classes, differing from their perinatal forebears for antigenic 
markers, growth factor responsiveness, basal motility rates and cell cycle (Fancy et al., 2011). 
Moreover, compared to foetal OPCs, adult progenitors show a longer cell cycle time and a 
slower rate of migration. 
Little is known about transcription factors roles during remyelination, but Olig1 and Olig2 
seem to play different roles in the two processes. According to some authors, Olig1 is 
essential for myelination but not for remyelination (Bradl and Lassmann, 2008), but other 
authors believe that is essential also for remyelination (Fancy et al., 2011). It is well known, 
instead, that Olig2 is fundamental for remyelination (Bradl and Lassmann, 2008). 
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Moreover, even Notch signalling is a limiting factor for remyelination, it seems not to be 
essential for the process, in a opposite way compared to the developmental myelination. The 
myelin morphology is also different from the one formed during development or after 
remyelination, showing thinner and shorter sheath segments in remyelinated axons (Bradl and 
Lassmann, 2008). 
All these morphological and molecular differences could reflect a different response to 
demyelinating stimuli in foetal and adult OPCs. 
 
1.1.4 The role of Nuclear Receptors in oligodendrocyte precursor cells. 
 
NRs represent a superfamily of intracellular receptors, which upon binding of specific 
ligands, change conformation to facilitate recruitment to DNA and regulation of gene 
expression. The NRs superfamily comprises 48 members in human and 49 in mouse.  
NRs response elements contain two or more closely spaced core recognition motifs, each of 
which comes into contact with a single DNA binging domain (DBD). Some responsive 
elements are bound by NRs homodimer, like the steroid-hormone receptors, while a subset of 
NRs bind to DNA as heterodimers. These heterodimers act also independently from ligands 
(Glass et al., 2006). The ligand binding domain (LBD) is connected to the DBD by flexible 
hinge domain and contains three-layered, antiparallel, helical sandwich in which a central 
core layer of three helices packed between two additional layers of helices forms the ligand-
binding cavity. At C-terminus of LBD is also present an additional helix required for the 
ligand-dependent transcriptional activation. The LBD is the region conferring the specific 
ligand-binding properties, but it also contributes to dimerization (Saijo et al., 2010). 
Many NRs have the ability to bind to DNA even in the absence of their ligand, but often act 
as transcriptional repressors in this form rather than activators (Gonzales and Ng, 2013). NRs 
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harbour a C-terminal ligand-binding and transactivation domain (LBD), a central DNA-
binding domain (DBD) and a variable N-terminal disordered transactivation domain. These 
receptors transduce signals regulating gene expression by recruiting co-regulator proteins that 
modify chromatin (Kojetin et al., 2015).  
NRs play fundamental roles in all the OLs differentiation stages, from NSCs self-renewal and 
lineage specification, to OLs maturation. Relatively to NSCs biology, key members include 
the thyroid hormone receptors (TRs), the retinoic acid receptors (RARs), the retinoid X 
receptors (RXRs), the peroxisome proliferator-activated receptors (PPARs), the liver X 
receptors (LXRs), the estrogen receptors (ERs), the mineralocorticoid receptor (MR), the 
glucocorticoid receptor (GR), as well as orphan nuclear receptors, for which no known 
cognate endogenous ligands have yet been identified (Stergiopoulos, 2013).  
As described above, T3, one of the key player in oligodendrocyte differentiation, act through 
binding TRs. The two TR isoforms, α and β, are NRs acting as ligand-regulated transcription 
factor trasducing the hormonal signal, physiologically exerting their action within a limited 
time windows, in a spatially and timely controlled way (Mohácsik et al., 2011). 
The biological effect of T3 in a given tissue depends on a number of factors: i) the amount of 
bioavailable hormone, ii) the levels of different TR isoforms, and post-transcriptional 
modifications of TRs, iii) the type of their heterodimerization partners, iv) the interaction with 
co-repressors and co-activators, and v) on the structure of thyroid hormone response elements 
(TREs) in the promoters of target genes (Puzianowska-Kuznicka et al., 2006). 
It is well known that TH regulates the cell cycle of different cells, including OPCs during 
developmental myelination. In particular, OPCs start showing TH sensitivity at E14 in mice, 
due to the expression of TRs, giving to them the role of the timer controller of the 
differentiation  (Gao et al., 1998; Billon et al., 2001).  T3 directly regulates different proteins 
involved in cell cycle control. It has been shown that T3-mediated action of TRs decreases the 
expression of E2F1 and c-myc, molecules involved in the transcriptional activation of 
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different positive regulators of cell cycle (e.g. cyclin E, cyclin A and cdk2) and reduces the 
expression of cyclin D1 (Puzianowska-Kuznicka et al., 2006). It has also been demonstrated 
that T3 is the mediator of Sertoli cells cell cycle exit, during development, by acting to the 
transcriptional control of the Kip/Cip family member p27 (Holsberger et al., 2003), an 
important factor also in OPCs proliferation (Gao et al., 1998). Moreover, Runt-related 
transcription factor 1 (Ranx1), a well known factor controlling the hematopoietic stem cells 
development, is proven to be directly involved in the T3-mediated cell cycle control of OPCs, 
regulating the expression of p15/INK4b, the major effector molecule for the TH-dependent 
cell cycle deceleration in OPCs (Tokumoto et al., 2017).  
The regulation of TH sensitivity is also dependent on the cell cycle phase. In vitro data 
suggest that TRs expression varies according to cell cycle. In particular there is no expression 
in early S phase, but progressive increase during late S and G2 until maximal level at G2/M, 
showing also an increase in TH binding capability (Maruvada et al., 2004). 
The critical role of TH in OPC development and myelination is well supported by the dozens 
of publication describing the effect of hypothyroidism in experimental and clinical studies 
(Calzà et al., 2015). For example, TH depletion results in the reduction of OLs in the white 
matter (Schoonover et al., 2004) and hypothyroidism delays the expression of genes involving 
in the myelination process (myelin basic protein, MBP; proteolipid protein, PLP; myelin-
associated glycoprotein, MAG) and the number of myelinating axons (Ibarrola and 
Rodríguez-Pe˜na, 1997). TRα1 mediates the differentiating effect of TH on OPCs, in fact 
TRα1-/- P7 OPCs in mice are unable to exit cell cycle and differentiate, while overexpression 
of TRα1 accelerate OPCs differentiation in vitro (Billon et al., 2002).  
Apart of TRs, other NRs are involved in the gene expression regulation in OPCs and OLs and, 
moreover, TRs can act as homodimer or as heterodimer producing different effects on gene 
expression regulation (Zhuang S et al., 2013).  For example, PPARγ agonists promote OL 
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differentiation of mouse NSCs by modulating the expression of different genes involved in 
stemness and differentiation (Kanakasabai et al., 2012). 
Other fundamental NRs are retinoic acid receptors and, in particular RXRs (Retinoid X 
Receptors). RXRγ has been described as upregulated during the regenerative phase of 
remyelination, in fact its expression was detected in OLs in remyelinating lesions in rat CNS 
and in tissue from individuals with multiple sclerosis (MS), a disease characterized by 
extensive demyelination and remyelination attempts. The activation of RXR by pharmaco-
logical and genetic manipulation, stimulates oligodendrocyte differentiation, enhancing 
remyelination (Huang et al., 2011). Moreover, TR/RXR heterodimer, is proposed to be the 
primary mediators of the target gene regulation by T3 (Lee and Privalsky, 2005; Figure 4). 
NRs action is also mediated by binding coactivator (e.g. steroid receptor coactivator, SRC) or 
corepressor (e.g. nucler receptor corepressor, NCoR; silencing mediator of retinoic acid and 
thyroid hormone receptor, SMRT) molecules. The ligand-dependent transcriptional activation 
involves an allosteric change in the LBD that decreases its affinity for corepressors, 
increasing affinity for coactivators (Saijo et al., 2010). TRs and RARs (Retinoic Acid 
Receptors) heterodimers typically recruit corepressors and repress gene expression in the 
absence of hormone. When the lingand binds the heterodimer, the conformational changes 
allow it to interact with coactivators, thus activating gene expression. In the presence of T3, 
corepressor complexes are released from TRs, and coactivator complexes are recruited, 
leading to increased local histone acetylation and transcriptional activation (Maruvada et al., 
2004).   
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Figure 4. Structure of the TR/RXR heterodimer. 
The figure shows the structure of the TRβ (green)/RXRα (light blue) heterodimer and the 
ligand position of T3 and SRC-2 peptide (Steroid Receptor co-activator 2) (Kojetin et al., 
2015 - modified). 
 
Molecules involved in the regulation of NRs expression and activity are also key players in 
the transcription regulation process. Poly (ADP-ribose) polymerase 1 (PARP-1) is a well 
known factor involved in DNA repair and cell death induction. It also acts as a transcription 
regulator, probably interacting with NRs (Ko and Ren, 2012), regulating Olig2 gene 
expression. PARP-1 inhibition results in decreased myelination in specific areas (corpus 
callosum, SVZ; Plane et al., 2012).  
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1.2 The oligodendrocyte precursor cell in acute lesions of foetal and adult brain 
 
Myelin damages can be efficiently and correctly repaired and functions restored (Crawford et 
al., 2013) thanks to OPCs, which proliferate, migrate to the unmyelinated axons and 
differentiate in mature OLs after lesion (Trotter et al., 2010). Two main pathological 
mechanisms are involved in myelin injury and demyelination, both in foetal (e.g. neonatal 
hypoxia/ischemia) and adult lesions (e.g. MS, spinal cord and brain trauma, stroke): 
inflammation and hypoxia/ischemia (Calzà et al., 2017; Figure 5). 
 
1.2.1 Inflammation 
 
Inflammation has a dual role on myelin and OPC pathobiology, being a promoter of myelin 
repair in some conditions, and a severe inhibitor in other conditions (Tognatta and Miller, 
2016). The establishment of an inflammation environment is essential to activate quiescent 
OPCs and for a successful proliferation, migration and remyelination, and cytokines and 
chemokines promote OPCs proliferation. In particular, cytokines mediate inflammatory 
response promoting pathogen clearance and preventing excessive tissue damage, playing a 
critical role in repair mechanisms in CNS. Some cytokines seem also to be involved in the 
physiological OLs maturation process, as through the activation of TNFR2. Chemokines, also, 
induce direct chemotaxis of immune cells and migration and maturation of NSCs, playing a 
fundamental role in CNS repair process. On the other hand, depending on the severity of the 
inflammation, an overproduction of cytokines/chemokines may lead to excessive 
inflammation and cell death, thus interfering with the repair process  (Patel and Klein, 2011). 
In fact, for unknown reasons, the remyelination process fails in several conditions, usually 
characterized by the establishment of severe (and chronic) inflammatory environment. This 
remyelination failure is a pathological landmark in different neurological conditions 
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characterized by intense inflammation, and it is a major cause in related chronic sensory, 
motor, and cognitive disabilities. For example, acute demyelination after spinal cord injury is 
caused by an oligodendrocyte loss (Myers et al., 2016) and impaired OPC differentiation 
(Franklin & Ffrench-Constant, 2008; Mekhail et al., 2012) both in experimental animals and 
humans. Also in stroke models local OPCs in the white matter proliferate and part of them 
differentiates into astrocytes, while the remaining cells are mainly blocked in a progenitor 
phenotype (Sozmen et al., 2016).  
The most important example of the strong implication of inflammation in remyelination 
failure is MS, the most diffuse inflammatory/demyelinating disease in humans (Goodin, 
2014). In the acute focal phase of the disease, remyelination is efficient (Rodgers et al., 2013), 
however this process progressively fails (Boyd et al., 2013; Lassmann et al., 2012), and the 
most accredited hypothesis for remyelination failure is the block of OPCs maturation 
(Kuhlmann et al., 2008; Miller and Mi, 2007). In fact, the blocking of this process does not 
guarantee anymore the OPCs differentiation in mature OLs, leading to an inefficient myelin 
repair (Zhang et al., 2015). 
Numerous in vitro and in vivo studies have indicated that inflammatory cytokines are involved 
in OPCs differentiation block, affecting cell cycle exit and the expression of genes encoding 
for proteins regulating and determining remyelination (Chew et al., 2005; Falahati et al., 
2013; Kang et al., 2013; Su et al., 2011; Tanner et al.,  2011; Fernandez et al., 2016).  
In vivo experiments in our lab have demonstrated that a complex dysregulation of the TH 
tissue signalling is present in acute phase of EAE (experimental allergic encephalomyelitis), 
the rodents and primate animal model of MS (Dell’Acqua et al., 2012; D’Intino et al., 2011; 
Fernandez et al., 2016), which correlates with the rise of inflammatory cytokines released by 
peripheral cells and resident microglia (Borjini et al., 2016). Cytokines and chemokines play a 
key role in the MS pathogenesis, by regulating cell migration, proliferation, and activation of 
resident and infiltrating cells (Dendrou et al., 2015). In EAE model, it has been demonstrated 
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that a strong modulation of cytokines/chemokines expression occurs during all the phases of 
the disease progression, from the very early stages (Borjini et al., 2016). Moreover, a direct 
correlation between the onset of the inflammatory microenvironment and an increase of D3 
enzyme expression has been described in vivo and in vitro (Dell’Acqua et al., 2012; 
Fernandez et al., 2016), possibly resulting in a local disregulation of TH metabolism leading 
to a depletion of T3 and down-regulation of TRs, supporting the view that a local 
hypothyroidism induced by inflammatory cytokines is a co-factor in remyelination failure 
(Calzà et al., 2015). An increase in D3 activity and mRNA expression level has been 
described in other neurological conditions characterized by inflammation and demyelination, 
e.g., ischemia-induced hypoxic brain damage (Jo et al., 2012) and nerve lesion (Li et al., 
2001). This hypothesis has been confirmed by in vitro studies in our lab, where we 
demonstrated that the inhibition of the T3 inactivating enzyme D3 restores the OPC 
differentiation during exposure to an inflammatory cytokine cocktail (Fernandez et al., 2016). 
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Figure 5. Injury mechanisms in Oligodendrocytes. 
Schematic representation of the principal mechanisms involved in oligodendrocytes 
vulnerability: glutamate excitotoxicity, hypoxia/ischemia, oxidative stress and cytokines (Liao 
and Mani, 2011). 
 
 
Thus, an altered TH tissue metabolism induced by inflammatory cytokines could be one of the 
most relevant factors involved in the OPCs differentiation block, extending to the CNS the 
evidence described in peripheral tissues on the relationship between inflammatory cytokines 
and TH tissue metabolism (Boelen et al., 2011; de Vries et al., 2015). In fact, in peripheral 
tissues, T3 level drops during starvation and illness, without affecting the thyroid function, as 
indicated by TSH and THs serum levels (De Groot, 2015). This condition has been defined 
“nonthyroidal illness syndrome (NTIS)” because it does not involve alteration in thyroid 
function but a tissue dysregulation of TH metabolism, played mostly by tissue-specific 
deyodinases enzymes, transporters and TH receptors (Warner and Beckett, 2010). 
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Since the role of TH in developmental myelination and the OPC differentiation block in the 
presence of inflammatory cytokines, our lab proposed the TH supplementation as a possible 
therapeutic strategy to overcome OPC differentiation block in MS (Calzà et al, 2002; 
Fernandez et al., 2004; D’Intino et al., 2011; Dell’Acqua et al., 2012). Afterwards, several 
other laboratories indicated that TH supplementation favours myelin protection/repair in 
different demyelination models characterized by intense tissue inflammation (reviewed in 
Calzà et al., 2005, Calzà et al. 2010, Calzà et al. 2015, Calzà et al., 2017), thus suggesting the 
possibility of including TH as adjuvant therapy during the acute inflammatory phase  of 
disease and injuries characterized by demyelination. TH may be the ideal compound that can 
promote remyelination and impede MS progression. TH treatment activate OPCs, probably by 
stimulating KLF9 transcription, a key factor in the maturation process, related with 
CXCL12/CXCR4 signal axis (Zhang et al., 2016).  
 
1.2.2 Hypoxia/ischemia 
 
As described above, demyelination and white matter lesion also occurs in acute injuries, like 
trauma and stroke. Most of white matter infarcts are believed to be secondary to vascular 
occlusion and endothelial cell dysfunction (El Waly et al., 2014). In fact, three hours after 
hypoxia/ischemia (HI), OLs show swelling and vacuolization, followed by retraction and cell 
death after 24 hours (Pantoni et al., 2006; McIver et al., 2010). 
Oxygen deprivation in perinatal period often results in HI-induced brain damage, which 
remains a common cause of neonatal brain injury and affects 1 to 3 per 1000 live births in 
developed countries and up to 26 per 1000 live births in the developing world. The pattern of 
injury depends on the level of the development of the brain and on the severity of the insult 
(Rocha-Ferreira and Hristoya, 2016). In particular, demyelination following brain damage is a 
typical event at neonatal stages, correlating with susceptibility of late OPCs (Back et al., 
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2002), and leading to apoptosis, delayed maturation of OLs and activation of the Cdk2 
pathway, inducing proliferation of OPCs (Jablonska et al., 2012). 
The mechanism and mode of HI-induced cell death depends on: severity of the insult, 
glutamate receptor stimulation, degree of calcium overload, cellular energy depletion and 
mitochondrial dysfunction (Rocha-Ferreira and Hristoya, 2016). Moreover, OLs vulnerability 
to HI is maturation-dependent: the most susceptible stage is PreOLs (late OPCs), followed by 
early OPCs and mature OLs, which implies death of PreOLs and subsequent failure of 
myelination (Back et al., 2002). In vitro experiments demonstrated that oxygen-glucose 
deprivation (OGD) in primary OPCs, induces intracellular Ca2+ overload, mitochondrial 
damage and ROS generation (via ERK1/2 pathway), resulting in PreOLs death (Cai et al., 
2016). Calcium overload leads also to lipases, endonucleases and proteases activation, leading 
to the cytoskeleton disaggregation (Rocha-Ferreira and Hristoya, 2016). 
HI injury is also characterized by an early excitotoxic-oxidative cascade, caused by the 
reduction of the high-energy phosphate metabolism, the consequent increase in lactic acid, 
and cell membrane ionic transport failure. This, combined with cytoskeleton destruction, 
causes depolarization and excessive presynaptic release of glutamate, worsen by the depleted 
glutamate reuptake caused by the reduced glucose availability (Rocha-Ferreira and Hristoya, 
2016). 
The excitatory neurotransmitter glutamate is a major player in CNS cell death. Excessive 
glutamate release causes excitotoxicity and can trigger OLs apoptosis, depending on the 
developmental stage (Butts et al., 2008). HI-mediated glutamate excitotoxicity have been also 
demonstrated in in vitro models in which OGD causes a local glutamate accumulation leading 
to cell death, enhanced by mitochondrial dysfunction (Deng et al., 2006). 
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Figure 6 – Glutamate excitotoxicity in oligodendrocyte. 
AMPA and kainite receptors activation leads to Na+ and Ca2+ influx and consequent 
depolarization, contributing to the Ca2+ concentration increasing by the activation of VGCC 
channels. Calcium influx in mitochondria results in depolarization, increase in ROS 
production and finally in Cyt-c release, which interacts with Apaf-1 and activate caspases. 
AIF also contribute to apoptosis induction by activating PARP-1. Moreover, AMPA-R 
activates CdP, which dephosphorylates Bad and facilitates apoptosis. Abbreviations: AIF, 
apoptosis-inducing factor; Apaf-1, apoptotic protease-activating factor 1; Cdp, calcineurin; 
Cyt-c, cytochrome c; FADD, Fas-associated death domain; 14-3-3, phosphoserine-binding 
protein 14-3-3; PARP-1, poly(ADP-ribose)polymerase-1; ROS, reactive oxygen species; 
VGCC, voltage-gated Ca2+ channels (Matute et al., 2007; based on Sánchez-Gómez et al., 
2003).   
 
 
For many years, AMPA/kainite, but not NMDA receptors, have been considered the mediator 
of glutamate excitotoxicity in glial cells (Tekkök and Goldberg, 2001) and, in particular, the 
HI-induced cell death glutamate-mediated in pre OLs (Deng et al., 2003). These data are 
supported by the in vitro demonstration that OLs glutamate-induced cell death is prevented by 
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AMPA/KA receptors block. However, more recently it has been demonstrated that NMDA 
receptors play a role during development myelination (Káradóttir and Attwell, 2007; Figure 7) 
and are partners in the OL myelinating processes. Moreover, neurodegenerative disorders and 
MS, usually involve a small, but prolonged rise in extracellular glutamate concentration. 
Thus, the higher glutamate affinity of NMDA receptors, compared to AMPA receptors, makes 
them more likely to be activated (Káradóttir et al., 2005). A different expression of these 
receptors during the differentiation process, could also explain the different sensitivity to 
glutamate in different stages. In particular OPCs show higher expression of AMPA/kainite 
receptor, mGluR while, postmitotic OLs have higher NMDA receptor expression (Butts et al., 
2008). 
Excitotoxic cell death in OLs can be mediated in different ways (Matute et al., 2007). For 
instance, a calcium influx and accumulation in mitochondria is generated by AMPA/kainite 
receptor, leading to mitochondria depolarization, cytochrome c release into the cytosol and 
production of reactive oxygen species (ROS). Cytochrome c release into the cytosol triggers 
the intrinsic caspase activation pathway, thus causing apoptosis, while the maximal AMPA 
receptor stimulation can trigger necrosis. Moreover, in pro-OLs, glutamate mediates also the 
pro-apoptotic Bax translocation into mitochondria. Additionally, OPC vulnerability to 
excitotoxicity mediated by calcium influx is also influenced by the fact that i) the particular 
GluR subunits expressed in OPCs are those that confer high calcium permeability; and ii) 
OPCs, unlike neurons, do not express calcium-binding proteins for maintenance of 
intracellular calcium homeostasis (Butts et al., 2008). 
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Figure 7. Role of Glutamate receptors in OPCs differentiation 
OPCs, immature OLs and mature OLs express glutamate receptors. Glutamatergic stimulation 
of OPCs regulates their differentiation while, in conditions of energy deprivation (e.g. stroke 
or ischemia following spinal cord injury) axonal and OLs glutamate transporters cause a non-
vesicular glutamate release (Kolodziejczyk et al., 2010). 
 
 
HI also induces an inflammatory response that has the positive role to remove damaged cells, 
debris and lipids, followed by a switch from pro- to anti-inflammatory profile that stimulates 
repair processes (Rocha-Ferreira et al., 2016). Several cell types are involved in these 
complex events, which is quite different in neonatal and adult life. After HI in adult CNS, 
leukocytes are activated and migrate into the brain/spinal cord injured site, where cytokines 
are produced in large amounts. This process takes place within hours in adult. On the 
contrary, HI induces an immediate (minutes) innate immune response in new-borns. Age 
differences in HI-response mechanisms include also the cross-talk between excitotoxic, 
oxidative and inflammatory injury, creating “windows of susceptibility” to HI-injury during 
embryonic and early postnatal brain in development (Liu et al., 2013). 
 
Different responses to THs treatments have been described in neonatal inflammatory-
demyelinating lesions and diseases. TH treatment has been suggested to overcome myelin 
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damages of neonatal encephalopathy, a combined insult of infection/inflammation and HI, 
leading to OPCs injury and death and also to failure of proper OLs maturation (La Gamma 
and Paneth, 2012; Schang et al., 2014). However, conflicting results have been obtained by 
TH treatment in experimental perinatal inflammation-induced white matter injury and HI, 
probably because of substantial differences in the models tested (Calzà et al., 2017). 
 
1.2.3 Nuclear Receptors and neuroinflammation 
 
It is well known the role of some NRs in inflammation, including glucocorticoid receptor 
(GR), PPARs, LXRs and NR4A (Huang and Glass, 2010). It has been widely investigated the 
action of different NRs to inhibit inflammation by different mechanisms, including ligand-
dependent inhibition of inflammatory gene expression and enhancing expression of genes that 
encode inhibitory proteins. In this context, the most extensively studied receptor is the GR, 
exerting its action throughout glucocorticoids binding activation and subsequent DNA 
binding and expression regulation of target genes involved in inflammatory response. 
However, the main interaction between NRs action and inflammation, called transrepression, 
is a mechanism in which NRs interfere with activation of inflammatory response through 
protein-protein interactions with coregulatory proteins and transcription factors, rather than 
directly interacting with DNA (Pascual and Glass, 2006). Moreover, receptor-specific 
mechanisms for repression indicate that each nuclear receptor has a distinct impact on the 
development of the inflammatory response (Glass et and Ogawa, 2006).  
The different mechanisms involved in NRs-mediated inflammatory response include i) 
ligand-dependent inhibition of inflammatory gene expression by sequence-specific binding of 
NRs to negative regulatory elements, ii) positive regulation of genes that encode inhibitory 
proteins, and iii) ligand-dependent transrepression. NRs require an overlapping set of 
coactivator proteins, some of which already present in cells at functionally limiting levels. 
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Moreover, evidence for a coactivator competition model of transrepression involving cAMP 
response element-binding protein (CREB)-binding protein (CBP) was first provided for RXR 
and GR transrepression of AP-1 target genes. In addition, many NRs have been suggested to 
exert inhibitory effects on inflammatory response genes through direct interactions with NF-
kB and AP-1 factors (Pascual and Glass, 2006).  
Interestingly, several NRs positively and negatively regulate T cells and myeloid-mediated 
immune responses in MS, including RORs, oestrogen receptors, GR, VDR, RAR, and 
PPARγ. T cell receptor stimulation in the presence of IL-6 and TGFβ skews na ̈ıve T cell 
differentiation and all-trans retinoic acid (at-RA), a ligand for RAR, strongly inhibits this 
process (Mucida et al., 2007). Moreover, in in vivo model of demyelination RXRs-ligand 
mediated activation accelerates CNS remyelination, also modulating the inflammatory 
response (Huang and Glass, 2010).  
NRs and cytokines influence each other by a complex crosstalk.  Inflammation mediators are 
substantially regulated by AP-1, C/EBP and NF-kB transcriptional factors and their 
expression can be repressed by NRs. Glucocorticoids and oestrogens are immunosuppressive 
NRs, suppressing proinflammatory cytokines expression, while RA induces IFN-α synthesis. 
PPARγ also shows anti-inflammatory properties, inhibiting the secretion of IL-6, TNFα and 
IL-1b (Wang et al., 2004). 
The role of NRs in regulation of inflammation response in macrophages and T cells is widely 
described (reviewed in Glass and Saijo, 2010) however, little is known about their interaction 
in demyelinating diseases. 
Proinflammatory cytokines have been associated with non-thyroidal illness syndrome in view 
of their capability to decrease D1 and TRβ mRNA expression in the liver. In particular, Il1b is 
able to decrease TRβ1 expression in the liver and TRα1 and TRα2 mRNA level in hepatoma 
cells, in an NFkB-dependent way (Kwakkel et al., 2007). IL1b and IL6 also downregulate 
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TRβ1 and TR cofactor DOR/TP53INP2, in cultured hepatocytes and, moreover, the TRα1, 
TRα2 and TRβ1 T3-mediated upregulation is blocked by IL-6 exposure (Malik et al., 2010). 
 
1.3 In vitro models for OPC: methodological remarks 
 
In vitro models are simple and widely applicable systems that provide information about OLs 
development and their vulnerability at different noxious stimuli, also for drug discovery 
purposes. These models are useful to study physiologic and pathological conditions at cellular 
and molecular level, recreating some cellular interactions and microenvironment complexity. 
Obviously, in vitro models lack the in vivo complexity, being also difficult to recreate the 
spatial and temporal signalling of OLs development and the complexity of multifactorial 
diseases (Barateiro and Fernandes, 2014).  
However, several key aspects of in vitro modelling should be carefully considered in order to 
compare published data, and to try to address specific experimental question using the most 
appropriate approach, i.e. cell source and experiment readout. 
 
1.3.1 Cell sources  
 
In vitro OPCs models include cell lines, stem cells-derived OPCs (from embryonic stem cells 
or foetal/adult neurospheres) and primary OPCs isolated from both developing and adult 
CNS.  
Few cell lines are available for OLs. Oligodendrocyte-type 2 astrocyte (O-2A) precursors 
were spontaneously generated from cultures of neonatal rat cerebral cortex and give rise to 
bipotential cell line (CG4) able to generate both oligodendrocytes and astrocytes (Franklin et 
al., 1995). Also the OLN93 line, derived from primary rat brain cultures, resembles the O2A-
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progenitor cells and can be differentiated into immature OLs when cultured in the presence of 
serum (Richter-Landsberg and Heinrich, 1996). 
Mice immortalized cell lines were also produced. In 1993 (Jensen et al., 1993) 6E12 line were 
derived from MBP-SV40 large T-antigen transgenic mouse spinal cord. These cells express 
O4 and GalC lightly and they need activation with forskolin or dibutyryl cyclic AMP to 
increase the expression of these markers and turn on PLP mRNA expression. However, this 
cell line is unable to express MBP (Merrill, 2009). Oli-neu is a mouse OPC line containing 
replication-defective retroviruses expressing the t-neu oncogene. These cells are useful in co-
culture studies, because of their ability to interact with neurons, in order to analyse neuron-
glia interactions (Kipp et al., 2012). 
Human OLs cell lines were also generated, to overcome the difficulty to obtain human culture 
of OLs. HOG, MO3.13 and KG-1C lines express immature OL markers, (CNPase and GalC), 
and do not express GFAP. HOG and MO3.13 can be differentiated to express MBP and 
MOG, while KG-1C remains mostly undifferentiated (Buntnix et al., 2003).  
Cell lines show considerable variability, largely depending on the origin, isolation method and 
growth conditions. They usually maintain proliferative status, due to their tumorigenic 
potential, and differentiation is difficult and often incomplete (Lin et al., 2006; Pringproa et 
al., 2008).  
 
The most widely used OLs cultures are primary OPCs, isolated from P1-P2 rodents brain, and 
purified by the shake-off technique, that prifits by the different cell adhesion capability of the 
different cell types (Chen et al., 2007). Cells can be purified also by using the magnetic 
activated cell sorting (MACS), just after the brain dissociation, using magnetic beads linked to 
specific antibodies. These cultures usually show 4.3% of early nestin-expressing precursors, 
84.5% of NG2-positive OPCs and 10.6% of pre-OLs A2B5-positive, with only 0.6% of 
GFAP-positive cells (Barateiro and Fernandes, 2014). 
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Human foetal OPCs can also be obtained from post-mortem foetal spinal cord and brain (18-
23 weeks of gestation), reaching 90% of purity by using immunomagnetic microbeads 
separation (Merrill, 2009). These cells show less variability and are more genetically stable 
compared to OPCs derived from stem cells, and they are as similar as possible to the in vivo 
counterparts. However, in comparison with cell lines and NSCs-derived OPCs, there are 
limitations of this in vitro model. Passages and freezing/thawing of these cells cause their 
differentiation in astrocytes, due to the capability of O4-positive OPCs to retain the capacity 
to differentiate in GFAP-positive cells. Moreover, additional factors are necessary to 
accompany T3 for high yield of differentiation (Dincman et al., 2012). 
 
OPCs can be differentiated from NSCs isolated from foetal or adult brain. As described 
above, NSCs are a mixed population of uni- and multipotent cells that, driven by specific 
signals, which can differentiate in OPCs. 
NSCs can be isolated from foetal forebrain and from adult hippocampal sub-granular zone 
(SGZ) and SVZ, and maintained in vitro as spheroids called neurospheres (Alhenius and 
Kokaia, 2010). SVZ-derived neurospheres are widely used as a NSCs in vitro model and, 
even if physiological in vivo differences of the two neurogenic niches are widely explored 
(Fuentealba et al., 2012), little is known about differences in their in vitro derivatives. 
Moreover, even regional differences in the same niche are emerging. For example it has been 
demonstrated that the rostral side of the SVZ shows the major activity in generating OPCs 
after demyelinating stimuli (Brousse et al., 2015). 
Spheroids can be passed several times under the exposure to two specific growth factors, i.e. 
basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF). In order to drive 
the OPC differentiation, after the first splitting, bFGF/EGF mix should be replaced by 
bFGF/PDGF growth factors, generating the so-called oligospheres. Once splitted and seeded 
as single cell culture they can differentiate in mature OLs, removing growth factors and 
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adding T3 (Chen et al., 2007). OPCs can be generated also from foetal human neurospheres 
expressing O4, NG2 and Sox10 markers and very low expression of GFAP and Tuj1, showing 
capability to respond to OLs differentiation induction (Lu et al., 2015). 
OPC cultures derived from neurospheres show phenotypic variability (Chen et al., 2007) and, 
subtle cellular changes can occur with culture passages, often resulting in a cell type having 
molecular properties different from the original cells (Lin et al., 2006). However, NSCs-based 
in vitro differentiation model allows the study of the whole process, from early progenitors to 
mature OLs. Moreover, these cells are highly sensitive to T3-mediated differentiation 
induction, a necessary condition to induce mature OLs. This allows the analysis of the whole 
mechanism of T3 action and the pathological interferences on the molecular machinery 
involved in the process (Castelo-Branco et al., 2014; Baldassarro et al., unpublished-a). 
 
In particular, NSCs derived from foetal or adult rodent brain show phenotypic and genotypic 
differences, such as OPCs derived at different developmental stages, but properties of these 
two cell systems are not yet fully characterized. For example, foetal NSCs need bFGF for 
self-renewal and are less sensitive to PDGF, while adult cells could generate neurospheres 
driven by PDGF and NT-3 but they do not need bFGF, even if they need more time to 
generate spheroids. Moreover, the capacity of foetal NSCs-derived OPCs to generate OLs 
decreases through passages and with the increase of the foetal brain tissue age (Chojnacki et 
al., 2008). 
  
In order to mimic in vivo myelination process, the co-culture is the most suitable and 
informative technique. This model preserves the physiological relevance of the neurons-OLs 
interaction maintaining the accessibility of in vitro cultures, without the interference of other 
glial cells. However, although in vitro cultures and co-cultures are very useful and accessible 
models, their main disadvantage resides in the loss of the three-dimensional structure. To 
	   38	  
overcome this issue, it is possible to study diverse neurobiological processes using ex vivo 
brain slice cultures, which preserve the three-dimensional architectural organization that 
supports all tissue circuits and interactions. Slices are thick brain sections (250–400 µm) 
grown on semi-porous membranes and kept at an air–liquid interface, which causes less tissue 
thinning and allow much simple maintenance and processing (Barateiro and Fernandes, 
2014). 
Another 3D model is the isolation of CNS spheroids from telencephalon or embryonic whole 
brain, both from rodents or humans fetus. When cultured under continual rotation, cells 
gradually reassemble into clusters. In these 3D structures, myelin is multilayered, resembling 
myelin in CNS and responds to demyelination stimuli, as antibody anti-MOG or IFNg (Kipp 
et al., 2012). 
 
As described above, foetal and adult OPCs share common myelination mechanisms, but also 
show quite different cellular and molecular aspects, not yet well characterized. Several in vivo 
and in vitro studies indicate that OPCs have substantially different properties according to 
their chronological age. For example, human foetal OPCs from different gestational stages 
exhibit differences in the myelination profile (Cui et al., 2012), such as human OPCs derived 
from foetal brain during the period of maximum oligoneogenesis or from adult subcortical 
white matter (Windrem et al., 2004). Even if the mechanisms behind the different age-related 
OPC biological properties are not known, these could reflect differences in OPCs in vitro 
models when isolated at different stages of the development. 
Three different subsets of OPCs were identified in adult human CNS, expressing different 
miRNAs compared to foetal OPCs and mature OLs. Moreover, two subsets of OPCs were 
isolated from early and mid second trimester foetal brains. Both in adult and foetal brains, the 
different OPCs subsets, have been identified by the different O4 expression level, leading to 
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different expression of the different genes involved in OLs maturation (Olig2, Nkx2.2 and 
PDGFαR; Leong et al., 2014). 
Adult OPCs isolated from grey and white matter shows also differences. Transplanted OPCs 
isolated from white matter are able to differentiate into mature myelinating OLs both in white 
and gray matter, while gray matter-OPCs are less efficient. This difference could derive from 
the surrounding environment where cells reside from the CNS development (Viganò et al., 
2013). This variability is also proven in cuprizone-induced demyelination mouse model, 
where the remyelination in the corpus callosum is faster than in the cerebral cortex (Gudi et 
al., 2009), as also confirmed in humans MS patients (Albert et al., 2007). 
As discussed above, it is well known that O-2A-expressing OPCs isolated from animals at 
different ages have different properties (Gao and Raff, 1997; Wolswijk and Noble, 1989; 
Wolswijk et al., 1990; 1991). Moreover, in rats at P7, when myelination is ongoing in 
different brain regions, different O-2A-expressing OPCs population where identified, 
characterized by cell-intrinsic differences in self-renewing, maturation-induction responses 
and intracellular redox state (Power et al., 2002). 
 
1.3.2 Robust readouts for OPC/OL in vitro models 
 
Depending on the experimental question, different in vitro models have been set up in order to 
study proliferation, differentiation, maturation, myelination and vulnerability of the 
OPCs/OLs cell systems. 
 
While proliferation in cultured OPCs is usually analysed by standard in vitro assays (e.g. 
MTT, cell counting and Ki67 staining), differentiation and maturation analysis need specific 
OPCs/OLs lineage markers. 
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As described above, in absence of axons, neurospheres-derived or primary OPCs are able to 
proliferate and, under specific stimuli, to differentiate in mature OLs. Using these models, it is 
possible to evaluate if any compound added during proliferation or differentiation stages is 
able to delay or reduce OLs differentiation, analysing the number of OPCs (e.g. NG2- or 
PDGFαR-positive cells) and OLs (e.g. MBP-positive cells) in the culture. 
Different challenges could also affect OLs maturation, by affecting cell morphology. This is 
possible to analyse by dividing mature OLs in different categories by the complexity of the 
cell structure: i) poorly branched OLs, ii) complex branched OLs, and iii) complex branched 
OLs forming membrane (Barateiro and Fernandes, 2014). 
 
Although cultured MBP-positive OLs are considered myelinating OLs, the lack of axons do 
not preserves the OL-neuron interaction. A co-culture model comprising dorsal root ganglion 
neurons, growing on 3D Matrigel and primary OLs, allows the study of axon myelination in 
vitro (Wang et al., 2007). However, new methods involving engineered artificial fibers 
mimicking axonos, has been developed in order to co-cultures limitations on time, costs and 
reproducibility (Lee et al., 2013). 
 
Using the described above models to study proliferation, differentiation/maturation and 
myelination, it is possible to analyse noxious stimuli mimicking pathological mechanisms. 
OPCs/OLs are highly sensitive to inflammatory mediators and HI. However, mechanisms 
underlying OPCs vulnerability or perturbations in the maturation and myelination process are 
still not well defined.  
As described above, OPCs and mature OLs are sensitive to glutamate excitotoxicity, 
depending on their developmental stage and glutamate is the main triggerer of the HI-induced 
cell death. In order to mimic the HI condition in vitro, the oxygen-glucose deprivation (OGD) 
model has been set up, resembling the fundamental aspects of the in vivo damage: low oxygen 
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pressure, low nutrient levels and reperfusion. This system was initially used in oncology to 
mimic necrosis (Hlatky et al., 1988), than applied to both pure or mixed neuronal/astrocytes 
cultures (Goldberg et al., 1993) and finally transferred to brain and spinal cord slices (Berger 
et al., 1998). The OGD model is particularly interesting in the study of neonatal hypoxic-
ischemic encephalopathy (HIE), a syndrome determined by asphyxia occurring during the 
perinatal period (Kurinczuk et al., 2010), and to screen potential neuroprotective drugs. 
Moreover, this model is also useful to study the extreme form of metabolic stress resulting 
from oxygen and glucose deprivation, such as in cerebral ischemia (stroke) that most 
commonly occurs when the blood supply to a part of the brain is suddenly interrupted by 
occlusion of a vessel. Because in vivo cerebral ischemia often consists of both reversible 
ischemia and blood flow re-perfusion, the cultures in the OGD model are first exposed to in 
vitro HI, then returned to a normal medium in an oxygen atmosphere environment to simulate 
the in vivo blood flow reperfusion period (Goldberg et al., 1993). 
OGD model in neuronal cultures is used in a wide range of conditions and timing and the 
contribution of oxygen or glucose deprivation is not well characterized. Due to the different 
sensitivity of OPCs and OLs to this noxious stimulus and the different possible cell sources, it 
is also not well defined the contribution of HI on OPCs vulnerability in demyelinating 
diseases affecting different stages of the development. 
 
Different in vitro models have been also set up in order to mimic the inflammation 
environment in the CNS. Inflammation is a very complex condition, involving different type 
of cells and molecules, leading to the difficulty of modelling it in vitro. However, these 
models are useful to study the contribution of specific molecules and specific cells to 
inflammation-mediated effects and vulnerability. 
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Lipopolysaccharide (LPS) treatment is the most used inflammation-inducing factor in culture. 
LPS in MO3.13 cell line leads to increased expression and activity of nNOS, leading to the 
activation of reactive nitrogen species decreasing cell survival (Yao SY et al., 2010; Yao S et 
al., 2010). However, inflammation is usually mediated by other glial cells. In this context had 
been proven that preOLs are selective vulnerable to LPS-induced cell death in primary mixed 
glial cultures and that the effect is mediated mainly by microglia activation, but not by 
astrocytes and, in particular, by the cytokines secretion (Li et al., 2009). 
In order to study the interaction between the different cells involved in the inflammation, co-
cultures are useful tools to retain the cell-cell contact between the specific cells. Treatment of 
OPCs cultures with conditioned medium obtained from activated microglia or mixed glia 
cultures allow also the focus on glia-secreted molecules effect on OPCs differentiation and 
survival. 
In a more specific way, it is possible to treat OPCs with specific molecules identified in 
activated glial cultures, in animal models of demyelinating diseases or in human patients. 
Moreover, this model allows studying the role of specific molecule, or molecules mix, 
identified in specific phases of the diseases, on specific developmental/maturational OPCs 
stages (Fernandez et al., 2016). Also in this context, due to the different cell sources, 
contrasting results are reported using different OPCs in vitro models. IFN-c either inhibits 
(postnatal rat purified OPCs primary cultures and adult mice SVZ derived OPCs, Chew et al., 
2005; Pluchino et al., 2008, respectively) or induces (7-days postnatal O/2A OPC primary 
cultures from the corpus callosum, Tanner et al., 2011) cell cycle exit in OPCs, also 
abrogating the T3-induced differentiation (Tanner et al., 2011). TNF-a is cytotoxic and 
inhibits OPCs differentiation (primary OPCs, Su et al., 2011) while IL-17 prevents OPCs 
maturation (OPCs-enriched primary culture from foetal mice NPCs, Kang et al., 2013). IL- 
1b, IL-6, TGF-b1, and TNF-a produced as a result of ischemia shifted OPCs toward the more 
immature form (1-day postnatal rat ischemia, Falahati et al., 2013). 
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All the described in vitro assays and models involve primary cultures in combination complex 
systems of molecules and environmental challenges, used in a wide range of conditions and 
timing. These models thus require protocol standardization and robust and reliable readouts. 
In fact, the high variability of results could come also from the different readouts and human-
biased techniques. Automated morphometric analyses for image-based high-content screening 
(HCS) is based on determining shapes of cells, distinguishing increased branching, and 
quantitating secondary and tertiary process numbers and lengths. HCS algorithms compatible 
with automated digital cell micro-imagers, data acquisition systems and counting software can 
be used for analysis of single or multiple imaging channels. These hardware/software systems 
remove the subjectivity and time-consuming component of visualization and manual 
evaluation (Merrill, 2009). 
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2. AIM OF THE STUDY 
 
Mechanisms underlying OPCs vulnerability and differentiation block, linked to remyelination 
failure, in different demyelinating diseases are still unknown. Foetal and adult OPCs, can be 
both affected by demyelinating insults and, due to their different nature, could differentially 
respond to noxious stimuli.  
The main objective of the present study is the investigation of foetal and adult NSCs-derived 
vulnerability to demyelinating diseases. In order to pursue the main objective the study was 
aimed to establish reliable in vitro systems and studying differences in T3-mediated 
physiological differentiation of foetal and adult OPCs. 
In particular, in order to obtain robust in vitro models, the following objectives were carried 
out: i) cell-based HCS viability and lineage analysis set up; ii) OGD model set up and 
characterization; and iii) OGD translation on disease model and drug testing. 
Since physiological OPCs differentiation is mediated by T3, exerting its action throughout 
NRs, the following objectives were investigated: i) NRs expression in early progenitors, ii) 
gene and protein expression of OPCs/OLs specific markers, iii) RXRγ role in OPCs 
differentiation and, iv) role of PARP in OPCs viability and differentiation. 
Once set up robust in vitro models and readouts and clarified physiological similarity and 
differences in differentiation process, OPCs were challenged with the two main component of 
demyelinating diseases: inflammation and HI.  
The analysis of differences between these two cell populations in physiological and 
pathological environment, will allow the deep understanding of their biology, carrying the 
possibility to develop differential therapies between foetal and adult demyelinating diseases. 
 
 
 
	   45	  
3. MATERIAL AND METHODS 
 
3.1 Neural stem cells and oligodendrocytes precursor cells cultures 
 
All animal protocols described herein were carried out according to the European Community 
Council Directives (86/609/EEC), and comply with the guidelines published in the NIH Guide 
for the Care and Use of Laboratory Animals. 
Mouse foetal and mouse/rat adult NSCs were isolated from E.13-14 foetal forebrain or 
striatum or 2.5 month old mice sub-ventricular zone (SVZ), following the Ahlenius and 
Kokaia protocol (Ahlenius and Kokaia, 2010). Oligodendrocyte differentiation was performed 
following the Chen protocol (Chen et al., 2007) with some modifications (Figure 8). In 
another set of experiments the same protocol was used to differentiate OPCs from 
neurospheres isolated from foetal brain (whole forebrain or striatum) and adult SVZ of 
RXRγ+/+ and RXRγ -/- mice (Krezel et al., 1996).  
Tissues were enzymatically dissociated using trypsin (SIGMA), hyaluronidase (SIGMA) and 
DNase (SIGMA), than mechanically dissociated by piepetting. The solution was filtered, 
centrifuged and the resulting pellet was washed twice in HBSS. After 7 minutes 
centrifugation at 400 × g, the cellular pellet was resuspended in serum-free medium 
(DMEM/F12 GlutaMAX 1 x; 8 mmol/L HEPES; 100 U/100 µg Penicillin/Streptomycin; 0.1 x 
B27; 1 x N-2; 20 ng/mL bFGF; 20 ng/mL EGF) and, after cell count, cells were plated in 
suspension at a density of 10 cells/µl in a final volume of 3 mL in low-attachment 6-well 
plates (NUNC). Half medium was changed every three days, centrifuging the cell suspension 
at 300 × g for 5 minutes and gently resuspending the cellular pellet in fresh medium. 
Neurospheres were allowed to proliferate until they attained a diameter of about 100µm. To	   obtain	   secondary	   neurospheres,	   primary	   neurospheres	   were	   centrifuged,	  mechanically	   dissociated	   in	   single	   cell	   suspension	   and	   replated	   in	   the	   NSCs	   medium	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containing bFGF and EGF. While, in order to obtain oligospheres, single cells were plated at 
a density of 10 cells/µl in a final volume of 3 mL of OPCs medium (DMEM/F12 GlutaMAX 
1 x; 8 mmol/L HEPES; 100 U/100 µg Penicillin/Streptomycin; 0.1 × B27; 1 × N-2; 20 ng/mL 
bFGF; 20 ng/mL PDGF) in low-attachment 6-well plates (NUNC). Oligospheres were 
centrifuged and the pellet was mechanically dissociated to obtain a single cell suspension. 
After cell count, cells were plated at a density of 3000 cells/cm2 on poly-D,L-ornithine 
(50µg/ml)/laminin (5µg/ml) coating, in OPC medium. 
In order to induce oligodendrocyte differentiation and maturation, after 3 DIVs OPC medium 
was replaced with the OL differentiation medium (DMEM/F12 GlutaMAX 1 x; 8 mmol/L 
HEPES; 100 U/100 µ g Penicillin/Streptomycin; 0.1 x B27; 1 x N-2; 50 nM T3; 10 ng/ml 
CNTF; 1x N-acetyl-L-cysteine -NAC-). 
 
3.2 PCR array 
 
The RNeasy Micro Kit (QIAGEN) was used for total RNA extraction and 300 ng were 
retrotranscribed using the RT2 First Strand Kit (QIAGEN) following the manufacturer’s 
instructions. 
For the study of NSCs gene expression, the 96-well QIAGEN PCR array for nuclear receptors 
and co-regulators was used in combination with the RT2 SYBR Green qPCR Mastermix 
(QIAGEN), using 10 ng of cDNA per well.  
Using the web-software STRING [http://string-db.org/], proteins derived from the genes of 
interest were connected in clusters according to their interactions and involvement in 
biological processes. The software allows the identification of net of interactions including 
other proteins closely linked to the one analysed to be extended, in order to obtain a better 
understanding of the possible pathways involved in the differentially expressed genes. 
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3.3 Cell-based High Content Screening set up for NSCs lineage analysis 
 
NSCs were isolated from mice foetal (E13.5) forebrains described above. Secondary 
neurospheres were dissociated and plated at a density of 1 x 104 cells/cm2 in the same culture 
medium without mitogens. To achieve full lineage commitment and cell differentiation, 
seeded cells were cultured for 15 days.  
Cells were seeded on different substrates: Cultrex (Trevigen)-coated glass, laminin (Sigma)-
coated glass, laminin-coated or not PLLA- FILM, laminin-coated or not random and aligned 
electrospun PLLA scaffold. 
In order to study cell viability and lineage specification, cell-based HCS was used. The HCS 
software allow the identification of the nucleus, by nuclear staining, and the study of its 
morphology. Condensed nuclei (smaller and brighter) are recognized as dead cells. Moreover, 
the software allow the identification of the cytoplasmatic fluorescence around the nucleus, 
identified as single cell. 
HCS viability results were than compared with the standard MTT viability assay, in order to  
validate the HCS technique. 
HCS was thus used for the analysis of cell viability and lineage specification markers (see 
section 3.16). 	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Figure 8. Neural stem cells- derived oligodendrocyte precursor cells culture protocol. 
Foetal NSCs cultures were obtained from E13-14 forebrain or striatum, while adult cultures 
were obtained from SVZ of 2.5 months old male mice. Cells divide in suspension generating 
primary neurospheres. After the first splitting, depending on the growth factors added, 
secondary neurospheres (bFGF/EGF) or oligospheres (bFGF/PDGF) were produced. 
Secondary neurospheres were used for the qPCR array analysis. Oligospheres were seeded as 
single cells and, after 3 days, exposed to the differentiation medium, containing T3, for 12 
days. 
Abbreviations: bFGF, basic fibroblast growth factor; CNTF, ciliary neurotrophic factor; 
DIV, day in vitro; EGF, epidermal growth factor; HCS, high content screening; NSCs, neural 
stem cells; OPCs, oligodendrocyte precursor cells; SVZ, sub-ventricular zone; T3, 
triiodothyronine. 	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3.4 PARP inhibitor treatments in mouse OPCs cultures 
 
The following PARPi (PARP inhibitors) were used in this study: TIQ-A (IC50 140-450 nM), 
PJ34 (IC50 20nM) and Olaparib (IC50 5nM; Ferraris, 2010; Hans et al., 2011). First, 
neurospheres and oligospheres PARPi treatment was tested (Figure 9A). Than, OPCs were 
treated 24 h before the T3-mediated differentiation induction (-1 DIV), and cell viability was 
analysed at DIV 12 of differentiation. In order to study effects of PARPi on foetal and adult 
cultures, different treatment were performed: i) in order to study PARP1-2 expression and 
PARP activity, cells were analysed 24 hours after treatment (DIV 0); ii) a dose-response curve 
of PARPi were performed, treating cultures with a series of 7 concentrations (0-10µM). 
PARPi treatments were maintained after the oligodendrocyte differentiation medium change, 
until DIV 12; iii) foetal cultures were also treated with PJ34 10µM and analysed for cell 
number and cell death at DIV 0, 6 and 12; iv) both foetal and adult cultures were treated with 
lower dose of PARPi (1µM and 10µM) and analysed for mature oligodendrocytes at DIV 12; 
v) foetal cultures were treated with PJ34 1µM and analysed for mRNA quantification at DIV 
12 (Figure 9B). 
 
3.5 PARP-1 activity assay 
 
PARP-1 activity was analysed in primary rats neuronal cultures exposed to OGD and 
foetal/adult mice OPCs cultures (0 DIV and 24 h after PARPi treatments). 
Proteins from cell lysates were quantified by Lowry assay (BioRad) following the 
manufacturer's instructions. The same amount of proteins were used for all the samples (400 
ng). PARP enzymatic activity was measured using HT Colorimetric PARP Apoptosis Assay 
Kit (Trevingen), following the manufacturer's instructions. 	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Figure 9. OPCs cultures PARP inhibitors treatment. 
(A) Primary neurospheres or oligospheres were treated with PJ34, TIQ-A or vehicle and cell 
number was measured during the whole period (arrows). 
(B) In another set of experiments cells were exposed to PJ34 before the adding of T3 to the 
medium, for 24 hours, and than lysed in order to study mRNA expression. Cells were also 
treated from the same time point for all the differentiation period and cell viability was 
measured at DIV 0, 6 and 12 (arrows).  
Abbreviations: bFGF, basic fibroblast growth factor; CNTF, ciliary neurotrophic factor; 
DIV, day in vitro; EGF, epidermal growth factor; HCS, high content screening; NSCs, neural 
stem cells; OPCs, oligodendrocyte precursor cells; SVZ, sub-ventricular zone; T3, 
triiodothyronine. 
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3.6 Primary cortical pure neurons and mixed neurons/astrocytes cultures 
 
Cultures of primary cortical neurons were isolated from neonatal (within 24 hours from birth) 
Wistar rats, pooling tissues from different pups, or from single Wt or Tg2576 (Taconic, 
Hudson, NY, USA) mice, according to the standard protocol (Fernandez et al., 2005; Del 
Vecchio et al., 2009; Figure 10A). Briefly, brains were removed, and cortical tissue dissected, 
freed from the meninges, and minced into small pieces. Cells were dispersed in Kreb's buffer 
(0.12 MNaCl, 4.8mMKCl, 1.2mM KH2PO3, 25.4 mM NaHCO3, 14.2 mM glucose, 0.01 
mg/ml phenol red, 1.5 mM MgSO4) containing BSA 0.3% and 0.025% trypsin (Sigma-
Aldrich) for 15 min at 37 °C, followed by mechanical trituration with a Pasteur pipette in 
Kreb's buffer containing 0.004% deoxyribonuclease I (DNaseI), and 0.052% soybean trypsin 
inhibitor (SBTI; Sigma-Aldrich). After centrifugation (500 x g, 5 min), cells were 
resuspended in Neurobasal culture medium supplemented with 2% B27 (Gibco), 2 mM 
glutamine (Sigma-Aldrich), 100 U/ml penicillin, and 100 µg/ml streptomycin (Gibco) and 
plated onto Cultrex 2D substrate (0.25 mg/ml, Trevingen)-coated plates or coverslips. Cells 
were maintained in a humidified incubator at 37 °C with 5% CO2. To obtain pure neuronal 
culture (99% neurons) cells were treated after 24 h with cytosine arabinofuranoside (Sigma-
Aldrich) 10 µM for rats and 5 µM for mouse cultures. For mixed cultures no mitotic inhibitor 
was used. At 4 DIV, half of the medium was changed in both cultures. 
Neurons isolated from Tg2576 mice are denoted as APPswe primary neurons. 
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3.7 Genotyping 
 
Mouse tails were used for genotyping analysis. The mouse genomic DNA was extracted using 
the GenElute Mammalian Genomic DNA MiniPrep Kit (Sigma-Aldrich) according to the 
manufacturer’s instructions and eluted in 100 µl of elution solution. DNA concentration was 
determined using a spectrophotometer and Tg2576 mice were identified by the presence of 
the mutated human APP gene (FW: 5′-GATGAGGATGGTGATGAGGTA-3’; REV: 5′-
ACTGGCTGCTGTTGTAGG-3′) using the Real Time PCR technique and the SYBR Green 
qPCR master mix (Bio-Rad) and 0.4 µM forward and reverse primers. The amount of DNA 
used for each sample was 10 ng and PCR amplification conditions were: 60°C for 30 s. 
 
3.8 Glutamate excitotoxicity on pure neurons and mixed neurons/astrocytes. 
 
At 7 DIV neuronal cultures were treated with glutamate (0.5 mM for rat and 42 µM for mouse 
cultures; Figure 10B). Medium was removed and cells were exposed to Krebs buffer 
containing or not glutamate, for 10 min. After glutamate treatment, Krebs buffer was replaced 
with the former conditioned medium. One group of cells were treated with MK801 (10 µM) 
from 1 h before the treatment to the end of the glutamate exposure (Fernandez et al., 2005). 
 
3.9 Oxygen-glucose deprivation 
 
OGD was performed using an air-tight hypoxia chamber (Billups-Rothenberg Inc., Del Mar., 
CA) saturated with 95% N2- 5% CO2 (Goldberg and Choi, 1993) on rat primary pure 
neuronal cultures and mixed cultures, Wt and APPswe mice pure neurons (Figure 10C) and 
mice foetal/adult neurospheres-derived OPCs (Figure 11B). 
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Glucose deprivation was achieved using a glucose-free complete medium. Oxygen was 
removed by flushing the hypoxia chamber with N2-CO2 mixture for 6-8 min at 25 l/min. The 
flushing was repeated after half the incubation time. The OGD condition was maintained for 3 
h, after which plates were re-oxygenated for 24 h in the old medium in a cell incubator.  
Pure neurons and mixed neurons/astrocytes cultures were exposed at OGD at 7 DIV while 
OPCs at 2 DIVs after plating, 24 h before the T3-differentiation induction. 
In another set of experiments, Wt and APPswe primary cortical neurons, were treated from 2 
DIV to the end of the experiment (8 DIV) with 10 µM LY450139 (Figure 10D). 	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Figure 10. Primary pure neuronal and mixed neurons/astrocytes cultures protocol. 
(A) Primary neuronal cultures were treated or not with Ara-C in order to obtain pure neurons 
(99%) or mixed neurons (50%) /astrocytes (50%) cultures. 
(B) In one set of experiments, pure neuronal cultures were treated for 10 minutes with 
glutamate. Cell viability was analysed after 24 hours. 
(C) In another set of experiments, pure and mixed cultures were exposed for 3 hours at OGD. 
After 24 hours of reoxygenation, cell viability was assessed. 
(D) In the APPswe pure neuronal cultures, LY450139 drug treatment was used in order to 
block the APP cleaving. Cells were also exposed to OGD/reoxygenation during the drug 
treatment.  
Abbreviations: Ara-C, Cytosine arabinoside ; DIV, day in vitro; OGD, oxygen-glucose 
deprivation. 
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3.10 Cytokines exposure 
 
Foetal and adult cultures from rats and mice were exposed to cytokines at different steps of 
the OPCs differentiation. For adult rats/mice and foetal mice cultures, after primary 
neurospheres splitting, cells were divided into two groups: one treated with a mix of six 
different cytokines (TGF-b1, TNF-a, IL-1b, IL-6, IL-17 and IFN-c; 20 ng/mL each) and the 
other treated with vehicle (0.04% of the cytokines solvent: 10% glycerol/100 nM glycine/25 
nM Tris, pH 7.3; Figure 11C). Images of oligospheres were taken at 3, 5 and 7 DIV. 
Oligospheres were centrifuged at 300g for 5 min and the pellet was mechanically dissociated 
to obtain a single cell suspension. After cell count, cells were plated at a density of 3,000 
cells/cm2 on poly-D,L-ornithine (50 mg/mL)/laminin (5 mg/mL) coating, in OPCs medium, 
containing 20 ng/mL bFGF and 20 ng/mL PDGF. 
After 3 DIV, OPCs medium was replaced with the oligodendrocyte differentiation medium 
[DMEM/F12 GlutaMAX 13; 8 mmol/L HEPES; 100 U/100 lg penicillin/streptomycin; 0.13 
B27; 13 N-2; 50 nM T3; 10 ng/mL CNTF; 13 N-acetyl-L-cysteine (NAC)]. For adult rats 
OPCs cultures, the cytokine treated group was then divided into two subgroups: one treated 
with vehicle and the other treated with IOP (10 mM; Figure 11D). Another vehicle-exposed 
experimental group was treated with the cytokine mix during the differentiation phase, while 
the control group was treated with vehicle (Figure 11E). Oligodendrocyte differentiating 
factors (T3, CNTF and NAC) were refreshed every two days. 	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Figure 11. OPCs cultures vulnerability studies protocol. 
(A) Experimental design of the standard NSCs-derived OPCs cultures. 
(B) Foetal and adult cultures were exposed at 3 hours OGD and 24 hours of reoxygenation, 
before the T3-mediated differentiation induction. 
(C) Foetal and adult cultures were exposed to a cytokines mix (…) during the oligospheres 
stage. 
(D) Adult cultures were exposed to the cytokines mix also during the whole differentiation 
phase, from the adding of T3, for 12 DIVs. 
(E) In another set of experiments, proliferation cytokines-exposed adult cultures were exposed 
to IOP during the whole differentiation stage. 
Abbreviations: bFGF, basic fibroblast growth factor; CNTF, ciliary neurotrophic factor; 
DIV, day in vitro; EGF, epidermal growth factor; HCS, high content screening; IOP, 
iopanoic acid; NSCs, neural stem cells; OGD, oxygen-glucose deprivation; OPCs, 
oligodendrocyte precursor cells; SVZ, sub-ventricular zone; T3, triiodothyronine. 	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3.11 Population doubling 
 
Oligospheres images were analyzed using Image Proplus software (Media Cybernetics, 
Bethesda, MD). Counting procedure was performed as already described (Baldassarro et al., 
2013) calculating the cell number based on spheres and single cell area. Population doubling 
was calculated using the following formula: PD= log10 (N/ N0) x 3.33, where PD is the 
Population Doubling, N and N0 are the final and initial number of cells, respectively. 
 
3.12 MTT viability assay 
 
Rat pure neuronal and mixed cultures were tested for cell viability by MTT colorimetric 
assay. Thiazolyl Blue Tetrazolium Bromide (Sigma-Aldrich) was dissolved 6.5 mg/ml in PBS 
and diluted 0.5 mg/ml in OptiMem (Gibco).Medium was removed and cells incubated for 3 h 
in incubator with the MTT solution. Formazan salts were solubilized by adding solubilisation 
solution (80% v/v isopropyl alcohol, 10% v/v HCl 1 N, 10% v/v Triton-X) and shaking the 
plates for 1 h at room temperature (RT). Absorbance wasmeasured with a microplate reader 
(BioRad) at 570 nm. 
 
3.13 LDH activity assay 
 
In order to compare the two colorimetric methods, rat neuronal cultures were also tested for 
LDH activity. Measurement was performed with PIERCE LDH Cytotoxicity Assay Kit, 
following the manufacturer's instructions. Both neuronal and mixed cultures were grown in a 
96well plate (100,000 cells/ well); after the re-oxygenation period, medium was collected and 
the activity of LDH enzyme in the medium was measured. 
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3.14 MitoTracker staining 
 
Cells were stained with MitoTracker Orange (Thermo Scientific, Waltham, MA, USA) 
following the manufacturer’s instructions. Briefly, cells were treated for 30 min at 37°C with 
150 nM MitoTracker. After two washes with PBS, cells were fixed and used in the 
immunocytochemistry procedure. 
 
3.15 Immunocytochemistry 
 
Indirect immunocytochemistry (ICC) was used to identify and quantify specific markers. 
Cells were fixed  with ice-cold 4% paraformaldehyde for 20 min at RT. After a fast wash in 
PBS, cells were incubated for 1 h with BSA 1% and 1% of the specific serum depending on 
the secondary antibody used (Donkey or Goat), in PBS- 0.3% Triton-X 100, then incubated 
overnight at 4°C with primary antibodies. Cells were than washed with PBS and incubated 
with secondary antibodies for 30 min at 37 °C. After immunofluorescence staining, cells were 
incubated with the nuclear dye Hoechst 33258 (1 µg/ml in PBS, 0.3% Triton-X 100) for 20 
min at RT and finally washed in PBS. For 96 well plates, cells were left in PBS (see 3.16 
Cell-based High content screening section) while for microscopy glasses, were coverslipped 
in glycerol and PBS (3:1, v/v) as mounting medium containing 0.1% paraphenylenediamine. 
  
Primary rat pure neuronal and mixed cultures were seeded onto Cultrex 2D substrate (0.25 
mg/ml, Trevingen)-coated coverslips and fixed after treatment. The following primary 
antibodies:  anti-β-III-tubulin (mouse, R&D, 1:1000), anti-GFAP (rabbit, Dako, 1:1000), anti-
Iba-1 (rabbit, Wako, 1:250), anti active caspase 3 (rabbit, BD Pharmingen 1:200) diluted in 
PBS-0.3% Triton-X 100; and the following secondary antibodies: goat Alexa 488-conjugated 
anti mouse and/or goat Alexa 568-conjugated anti-rabbit (Invitrogen), were used.  
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Mouse Wt and APPswe primary neuronal cultures were fixed at 8 DIVs. The following 
primary antibodies: anti-6E10 (mouse; Covance, SIG-39320, batch no. D11AF00145; 
1:1000), anti-β-III-tubulin (mouse; R&D Systems, MAB-1195, batch. no. HGQ0113121; 
1:1000), anti-GFAP (rabbit; Dako, Z0334, batch no. 20005461; 1:1000) and the following 
secondary antibodies: goat Alexa 488-conjugated antimouse, goat Alexa 568-conjugated anti-
rabbit, goat Alexa 658-conjugated anti-mouse (Invitrogen) were used.  
 
Mouse foetal/adult OPCs in the PARP inhibition and differentiation studies were stained at 
different DIV to identify OPCs (NG2- and PDGFαR-positive cells), mature (CNPase- and 
APC-positive cells) and myelinating (MBP-positive cells) OLs, neurons (β-IIItubulin- 
positive cells) and astrocytes (GFAP-positive cells). OPCs in the different stages of 
differentiation were analysed by the triple staining APC/Olig1/Olig2. The following primary 
antisera were used: mouse anti-β-III-tubulin (R&D system, Trento, Italy) 1:3000; rabbit anti-
GFAP (Glial Fibrillary Acidic Protein, Dako) 1:1000; rabbit anti-NG2 (chondroitin sulphate 
proteoglycan, neural/glial antigen 2, Millipore, Merck S.p.a., Milan, Italy) 1:350; rabbit anti-
PDGFαR (Platelet derived frowth factor alpha receptor, Santa Cruz Biotechnology) 1:300; 
mouse anti-CNPase (2', 3'-cyclic nucleotide 3'-phosphodiesterase, Millipore) 1:500; mouse 
IgG2b anti-APC (anti-adenomatous polyposis coli, clone CC1, Calbiochem) 1:100; mouse 
IgG1 anti-Olig1 (Oligodendrocyte transcription factor 1; NeuroMab) 1:500 and mouse IgG1a 
anti-Olig2 (Oligodendrocyte transcription factor 2; Neuromab) 1:500; rabbit anti-MBP 
(Myelin Basic Protein, Dako) 1:500. Donkey Alexa Fluor 488-conjugated anti mouse, goat 
Alexa Fluor 555-conjugated anti- mouse IgG1, goat Alexa Fluor 488-conjugated anti- mouse 
IgG2a, goat Alexa Fluor 647-conjugated anti- mouse IgG2b and donkey Alexa 568-
conjugated anti-rabbit (1:500; ThermoFisher Scientific) were used as secondary antisera. 
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Adult rat OPCs in the cytokine exposure experiment, were fixed and stained at 12 DIV after 
the differentiation induction, Primary antibodies and dilutions used were: mouse anti beta-III-
tubulin (R&D system, Trento, Italy) 1:3000; rabbit anti PDGFαR (platelet derived growth 
factor alpha receptor, Santa Cruz Biotechnology) 1:300; mouse anti NG2 (membrane-
spanning chondroitin sulphate proteoglycan, Millipore), 1:300; mouse anti CNPase (20,30-
cyclic nucleotide 30-phosphodiesterase, Millipore) 1:500; rabbit anti MBP (Myelin Basic 
Protein, Dako) 1:500; rabbit anti GFAP (Glial Fibrillary Acidic Protein, Dako) 1:1,000; goat 
anti D3 (Deiodinase type 3, Santa Cruz Biotechnology), 1:100. Secondary antisera and 
dilutions used were: Alexa488-coniugated affinity-pure Donkey anti-Mouse IgG (Life 
Technologies, Eugene, OR) 1:500, Alexa568-conjugated affinity-pure Donkey anti-Mouse 
IgG (Molecular Probe, Eugene, OR) 1:500, DyLight488-conjugated affinity-pure Donkey 
anti-Goat IgG (Jackson Immunoresearch) 1:100, Alexa568- conjugated affinity-pure Donkey 
anti-Rabbit IgG (Life Technologies) 1: 500, and RRX-conjugated Donkey anti-rabbit IgG 
(Jackson Immunoresearch) 1:500, all diluted in PBS/0.3% Triton X-100. 
 
3.16 Cell-based High content screening 
 
For HCS analysis cells were grown in 96 flat-bottom well HCS plates (NUNC; 100,000 
cells/well). Analysis were performed with Cell Insight™ CX5 High Content Screening (HCS; 
ThermoFisher Scientific). 
 
For rat pure neuronal and mixed cultures, Mitotracker was used to stain mitochondria of 
living cells and GFAP staining to identify GFAP-positive or –negative cells. Analysis of the 
MitoTraker fluorescence was performed on GFAP-negative cells only, identified as neurons. 
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Cells showing a low MitoTracker fluorescence are considered with depolarized mitochondria. 
The software is able to detect nuclei as “object” considering each nucleus a single cell and it 
also detect the fluorescence in the cytoplasm belonging to the identified nucleus. This allows 
to clearly associate positive cells to a specific markers. In the same cultures, the software is 
used to analyse the nuclear morphology based on the fluorescence intensity of the Hoechst 
33258 staining and the nuclear size, using GFAP staining to differentiate neurons and 
astrocytes. Nuclei showing high fluorescence intensity and small size are identified as 
condensed/fragmented. 
Based on nuclear staining, the software is able to recognise nuclei and calculate the 
percentage of high intensity/small sized condensed nuclei. Moreover, based on nuclei 
identification, the software is able to detect the presence of the marker-specific stain in the 
cell body, calculating the percentage of immunoreactive cells and fluorescence intensity. For 
the MitoTracker analysis, the software is able to recognize every single cell by its nuclear 
staining and quantifies the fluorescence intensity inside the cell body. The operator can select 
a fluorescence threshold that allows the software to discriminate between ‘high-intensity 
staining’ and ‘low-intensity staining’. Using the same parameters and the same threshold it is 
possible to perform an automatic, statistically robust and objective analysis. This technique 
avoids also the bias of the analysis of randomly chosen fields, because the analysis is 
performed in all cells. 
Between 60,000 and 100,000 cells/well were analysed. 
 
3.17 Fluorescence microscopy 
 
Coverslips were observed using a Nikon eclipse E600 (Nikon, Italy) equipped with digital 
CCD camera Qimaging Retiga 20002V (Q Imaging, Surry, BC, Canada). All images were 
taken at a magnification of 20× objective, 5 fields per coverslip were considered and at least 2 
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coverslips per condition were analysed from two independent observators. Controls using the 
secondary antibodies, alone,were performed and resulted negatives. 
In order to study the effect of the OGD on caspase-3 activation and the effect of the drugs on 
pure neuronal and mixed cultures we used a fluorescence microscopy approach to analyse the 
nuclear morphology. Immunocytochemistry was performed as described above to identify 
neurons and astrocytes. Percentage of condensed nuclei and active caspase-3 positive cells 
was calculated. 
For adult rat OPCs cultures, Hoechst staining was used to identify the total cell number and 
condensed nuclei, while the different markers were used to identify specific lineage (beta-III-
tubulin for neurons, GFAP for astrocytes, NG2 for OPCs, CNPase for mature 
oligodendrocytes and MBP for myelinating oligodendrocytes). The lineage analysis was 
performed on cells presenting intact, non-condensed nucleus. 
 
3.18 RNA isolation and reverse transcription 
 
Total RNA isolation was performed with the RNeasy Micro kit (Qiagen) following the 
manufacturer’s instructions. Total RNAwas eluted in RNasefree water and concentration 
estimated through absorbance values at 260, 280 and 320 (Nanodrop 2000 spectrophotometer, 
Thermo Scientific). Firststrand cDNAs were obtained using the iScript cDNA Synthesis Kit 
(Bio-Rad), incubating at 42°C for 30 min. An RNA sample with no reverse transcriptase 
enzyme in the reaction mix was processed as a no-reverse transcription control sample. 
 
3.19 Semi-quantitative real-time PCR 
 
Semi-quantitative real-time PCR was performed using the CFX96 real-time PCR system 
(Bio-Rad). The reactions were performed in a final volume of 20 µl consisting of 1× SYBR 
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Green qPCR master mix (Bio-Rad) and 0.4 µM forward and reverse primers. In order to avoid 
possible contamination of genomic DNA in isolated RNA, the sample with no reverse 
transcriptase enzyme was processed in parallel with the others and tested by real-time PCR 
for every pair of primers used. All primers used were designed using Primer Blast software 
(NCBI) and synthesized by IDT (Coralville).  
All primers sequences are listed in Table 1. 
 
Gene  Specie Forward (5’-3’) Reverse (5’-3’) 
VEGFA mouse AAGAGAAGGAAGAGGAGAG ACCCAAGAGAGCAGAAAG 
FLT1 mouse CGTGCAAGGAACCTCAGACA ATCATAGGGCAGCCGTTCAC 
KDR mouse ATGTCCTTGGCTGTGCAAGA CCTTCATTGGCCCGCTTAAC 
PARP-1 mouse GCCACACATCTCAGGGAGAC CCCAAACCTTTGACACTGTGC 
PARP-2 mouse GAAGGACGCAGACAGGACAA ACATGAGCCTTTCCCAGCTT 
Olig1 mouse CCGCCCCAGATGTACTATGC AACCCACCAGCTCATACAGC 
Olig2 mouse GCTTAGATCATCCCTGGGGC AGATCATCGGGTTCTGGGGA 
TRa mouse GCAAACACAACATTCCGC TCCTGATCCTCAAAGACCTC 
TRβ mouse GCAAACACAACATTCCGC CACCAAACTGCTGCTCAA 
Klf9 mouse/rat AGTGGCTTCGAAGGGGAAAC TCCGAGCGCGAGAACTTTTT 
GAPDH mouse/rat GGCAAGTTCAATGGCACAGTCAAG ACATACTCAGCACCAGCATCACC 
 
Table 1. Primers sequences 
Detailed information about primers forward (F) and reverse (R) sequences. 
Abbreviations: FLT1, vascular endothelial growth factor receptor 1; GAPDH, 
glyceraldehyde-3-phosphate dehydrogenase; KDR, vascular endothelial growth factor 
receptor 2; KLF9, kruppel-like factor 9; Olig1 and 2, oligodendrocyte transcription factor 1 
and 2; PARP1 and 2, Poli (ADP-ribose) polymerases 1 and 2; TRα and b, thyroid hormone 
receptor a and b; VEGFA, vascular endothelial growth factor. 
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GAPDH was used as a housekeeping gene to normalize the amount of reverse-transcribed 
RNA used for PCR. Thermal profile of PCR reactions consisted first of a denaturation step 
(95°C, 2 min) and 40 cycles of amplification (95°C for 15 s and 60°C for 60 s). At the end of 
the amplification cycles, the melting curve of amplified products was performed according to 
the following temperature/time scheme: heating from 55°C to 95°C with a temperature 
increase of 0.5°C/s. Primer efficiency values for all primers were 95-102%. The 2(−ΔΔCT) 
method was used for the calculation of gene expression. 	  
3.20	  Statistical	  Analysis	  	  All	   data	  derive	   from	  at	   least	   three	   independent	   experiments.	  The	  number	  of	   technical	  replicates	   included	   in	   each	   experiment	   is	   indicated	   in	   the	   result.	   Prism	   software	  (GraphPad	   Software)	  was	   used	   for	   statistical	   analyses	   and	   the	   preparation	   of	   graphs.	  Data	  in	  histograms	  are	  reported	  as	  mean	  ±	  SEM	  or	  SD	  as	  specified	  in	  the	  figure	  legend.	  Student's	   t-­‐test,	   one-­‐way	   ANOVA	   or	   two-­‐way	   ANOVA	   and	   Dunnett's	   multiple	  comparison	  post-­‐hoc	  test	  were	  used	  to	  analyse	  data.	  Results	  were	  considered	  significant	  when	  the	  probability	  of	  their	  occurrence	  as	  a	  result	  of	  chance	  alone	  was	  less	  than	  5%	  (P	  b	  0.05).	  Exclusion	  criteria	  in	  data	  analysis	  were	  pre-­‐established	  for	  each	  assay	  as	  follows.	  mRNA	  analysis:	   samples	   in	   which	   curves	   not	   fitting	   the	   melting	   temperature	   or	   in	   which	   a	  double	  peak	  was	  observed	  were	  excluded	  from	  the	  analysis;	  HCS	  analysis:	  wells	  in	  which	  the	   software	  was	   unable	   to	   automatically	   identify	   the	   nuclei	   were	   excluded	   from	   the	  analysis.	  The	  final	  number	  of	  data	  per	  group	  is	  reported	  in	  the	  figure	  legends.	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4. RESULTS 
 
4.1 Summary 	  
The main objective of the present study was the investigation of the vulnerability of foetal and 
adult NSCs-derived OPCs to demyelinating diseases. Similarity and differences in response to 
noxious stimuli will enhance the knowledge of the biology of these cells, throughout the 
whole differentiation process and will elucidate the pathological basis of demyelinating 
diseases in foetal and adult life. 
As in vitro model NSCs-derived OPCs, isolated from foetal and adult brain, were used and 
their physiological T3-mediated differentiation and response to noxious stimuli was tested. 
First, a reliable in vitro readout was set up, in order to obtain robust data from a complex and 
mixed cell system, as OPCs differentiated from NSCs. Cell-based HCS was set up in order to 
study cell viability and lineage specification for cultured NSCs, on 2D and semi-3D cell 
growth surfaces and materials. In this study we compared also the standard procedure to test 
cell viability, the MTT assay, with the HCS assay based on nuclear morphology, finding the 
same readouts but a strong statistically significance of the HCS-based assay (Baldassarro et 
al., 2016). HCS was thus chosen as the elective assay for testing in vitro systems used in the 
present study.  
In order to pursue the main objective, the study was first focused on investigating differences 
in T3-mediated physiological differentiation of the two cellular systems. In particular, since 
T3 acts mainly by NRs activation, the physiological differentiation was analysed at different 
levels: i) gene expression of NRs and co-regulators in early progenitors (neurospheres), ii) 
T3-driven OPCs differentiation and maturation (gene expression and OLs-lineage markers 
detection), iii) role of RXRγ in the differentiation process, and iv) role of PARP activity on 
OPCs viability and differentiation. 
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We found that adult NSCs show an higher expression of TRβ and a lower expression of 
RXRγ, two main NRs involved in the OLs development. Moreover we analysed the 
expression of Olig1, Olig2, TRβ, TRα and Klf9, key genes regulating the differentiation 
process, throughout all the stages of in vitro cultures, from NSCs to mature OLs. We found a 
more mature phenotype of adult OPCs in early stages, while foetal OPCs are more responsive 
to T3-induced differentiation. These data were also confirmed by the detection of OPCs 
(PDGFαR and NG2) and OLs (CNPase and MBP) markers, where adult cultures showing less 
myelinating OLs at the end of the differentiation phase. 
T3 exert its action by NRs and the two differentially regulated genes in early precursors (TRβ 
and RXRγ) can form eterodymers in response to T3 binding. In order to study the role of 
RXRγ in OPCs differentiation, we replicate the protocol on cells isolated from RXRγ-/- foetal 
and adult mice. In both cultures this NRs is necessary to reach the T3-mediated maturation of 
OLs. However, RXRγ seems not to directly regulate the differentiation machinery. In fact, 
differentiated OLs present in the RXRγ-/- cultures show the same population pattern of the 
RXRγ+/+. Moreover, analysing the expression of the key genes involved in the differentiation 
24 hours after the T3 exposure, no differences in expression were detected. However, we 
found an increase in OPCs percentage in RXRγ-/- cultures at the end of the differentiation 
phase, suggesting that RXRγ-/- cells are not responsive to the T3-mediated cell cycle exit. 
This was proved analysing the percentage of replicating OPCs by using the double staining 
PDGFαR/Ki67. RXRγ-/- cells show higher percentage of replicating OPCs compared to 
RXRγ+/+. Moreover replicating OPCs are not affected by T3 exposure, while in RXRγ+/+ T3 
treatment decreased the replicating OPCs percentage already 24 hours after the T3 exposure 
(Baldassarro et al., unpublished - a).  
 
No differences were found between foetal and adult cultures in RXRγ-/- cells. However, the 
two systems show totally different responsiveness to PARP inactivation, a factor involved in 
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the regulation of different NRs, including TRβ and also the dymerization between TRβ and 
RXRγ. We showed that PARP1 and PARP2 mRNA expression and PARP activity are much 
higher in foetal than in adult-derived OPCs, suggesting a different role in the two cell 
systems. In fact, PARP inhibition produces substantially different effects in OPCs derived 
from foetal and adult brain. In particular: i) the culture treatment with PARP inhibitors is 
cytotoxic for OPCs derived from foetal, but not from adult, brain; (ii) PARP inhibition 
reduces cell number in proportion to the inhibitory potency of the compounds; (iii) the PARP 
inhibition effect in foetal OPCs is a slow process (iv) PARP inhibition impairs OPC 
maturation into myelinating OL in foetal, but not in adult OPCs, according to the inhibitory 
potency of the compounds. 
Overall, these results suggest that a different PARP signalling in foetal and adult OPCs might 
be part in the biological properties of OPCs at different chronological ages (Baldassarro et al., 
2017 a). 
 
Differences in physiological differentiation may reflect a different response to demyelinating 
challenges. Demeylinating diseases have two major components: inflammation ad HI. As 
inflammation in vitro model we used the exposure to a defined inflammatory cytokines mix, 
while for HI we used the OGD model. 
We first analyse the response of foetal and adult OPCs to cytokine exposure, finding that in 
both cultures cytokines are mediating the OPCs differentiation block. In fact, cells exposed to 
inflammatory cytokines during the proliferation phase, show a severe impairment in the 
differentiation, with a strong decrease in mature/myelinating OLs at the end of the 
differentiation phase (Baldassarro et al., unpublished b). 
Since inflammation is recognized as the main cause of the OPCs differentiation block in MS, 
leading to remyelination failure, we than focused on the effect of inflammation in adult OPCs. 
We found that cytokines exposure is linked to an increase of D3 expressing OPCs. D3 is the 
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enzyme that inactivates T3, thus blocking the OPCs differentiation. This was also confirmed 
by the restoring of differentiation mediated by D3 pharmacological inhibition (Fernandez et 
al, 2016).  
   
Even if no differences between foetal and adult OPCs were found in inflammation exposure, 
they respond in a totally different way to HI. In literature, OGD is a common in vitro HI 
model, however, the model is not well characterized and numbers of variables (cell system, 
percentage of oxygen, timing, readout, ecc.) are not well described or controlled. For this 
purpose, we first set up the OGD system on neuronal cultures, the most widely used cultures 
in HI studies. OGD was tested on both pure neuronal (99% neurons) and astrocyte/neurons 
(50% astrocytes, 50% neurons) cultures derived from neonatal rat cerebral cortex. Different 
assays were used to study cell viability, including standard cell viability-assays (MTT and 
LDH) and cell-based HCS (nuclear morphology, mitochondrial depolarization). 
We first investigated the contribution of glucose- or oxygen-deprivation, alone or in 
combination, to cell viability/death. Both MTT and LDH assay indicated that glucose 
deprivation is the major trigger of cell death in both pure and mixed cultures, while the 
contribution of oxygen deprivation appears to be negligible. 
Since these biochemical assays do not allow any discrimination between the different cell 
types (neurons vs. glia) present in the culture, we also used a morphological approach based 
on cell-specific antigen recognition and coupled to HCS imaging and analysis to distinguish 
the OGD-affected population in mixed cultures (Baldassarro et al. 2018).  
 
In order to test the reliability of the system, we translate the OGD model on a disease/drug 
study. We used pure cortical neurons primary cultures isolated from wild type or APPswe 
mice. These are transgenic animals expressing the human APP gene carrying the Swedish 
mutation, a model for the familial Alzheimer disease, accumulating Aβ fragments, linked to 
	   69	  
the perturbation of the brain vascular system and consequent HI. We showed that APPswe 
neurons are more susceptible to OGD and that a drug treatment blocking the Ab accumulation 
is able to rescue APPswe neurons from OGD-induced cell death (Baldassarro et al., 2017 b). 
 
Once the OGD model was set up and characterized, we exposed foetal and adult OPCs to this 
insult during the OPCs proliferation phase, 24 hours before adding the T3 to the cultures. We 
showed that foetal cells are sensitive to OGD, with a severe increase of cell death and 
consequent strong reduction in cell number. The OGD-mediated cell death is a slow process, 
showing cell death only at the end of the differentiation phase and not soon after OGD 
exposure. In an opposite way, adult OPCs viability is not influenced by OGD exposure. 
Moreover, adult cultures show an increase of cell number and on OPCs percentage in 
response to OGD. On the other end, foetal cultures show a decrease of OPCs and 
mature/myelinating OLs markers in live cells and an OGD-mediated selective OPCs/OLs 
lineage cell death. 
  
Future studies will elucidate the mechanisms underlying the selective foetal-OPCs/OLs death, 
investigating the differences between foetal and adult cells in systems involved in metabolism 
and HI response. We found an increase in D3 expression soon after OGD exposure, 
suggesting a possible role of T3 inactivation in the pathological mechanism (Baldassarro et 
al., unpublished - b). Deeper investigations on D3 and glutamate excitotoxicity involvement 
in the process will elucidate the OGD-induced cell death mechanism. 
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4.2 Nuclear receptors and foetal vs. adult oligodendrocyte precursor cells differentiation 
(Baldassarro et al., unpublished – a). 
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Abstract 
 
Nuclear receptors (NRs) play key roles in the oligodendrocytes (OLs) differentiation, from 
NSCs self-renewal and lineage specification, to OLs maturation. Foetal and adult 
oligodendrocyte precursor cells (OPCs) share the same objective: to wrap and functionally 
myelinate axons, in a process mediated by thyroid hormone (TH), and acting throughout NRs-
signals. In particular, thyroid hormone receptors (TRs) are the main NRs involved in the 
process, acting as homodimer or heterodimer with others NRs, expecially RXRs. Here we 
showed that neural stem cells (NSCs), the progenitors of OPCs, isolated from foetal and adult 
brain, differentially express two fundamental NRs involved in the differentiation process: 
TRβ and RXRγ. We showed that both systems need TH to differentiate in mature OLs. 
However, even if adult cells show a more mature profile in early stages, they are less 
responsive to TH differentiating signal. Moreover, we demonstrated that RXRγ is 
fundamental in both systems to achieve differentiation, showing a severe reduction in 
mature/myelinating OLs in cultures isolated from RXRγ-/- mice. However, RXRγ-/- cultures 
show the same gene expression regulation in response to T3-differentiation induction, 
compares to RXRγ+/+ cultures, suggesting that it is not directly involved in the molecular 
machinery of the maturation process. RXRγ-/- cultures show an higher percentage of 
replicating OPCs and do not show reduction of proliferation in response to T3, indicating a 
role of RXRγ in the control of cell cycle exit. Differences and similarity in T3-mediated OPCs 
differentiation will open new strategies in understanding their biology and developing new 
therapies in demyelinating disease, differentially affecting foetal or adult OPCs.  
 
Keywords 
oligodendrocyte precursor cells, thyroid hormone, retinoic X receptor gamma, myelination, 
remyelination.
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1. Introduction 
 
Oligodendrocytes (OLs) are the glial-subtype myelinating cells of the central nervous system 
(CNS) that derives from oligodendrocytes precursor cells (OPCs; Robertson, 1899; Rio 
Hortega et al., 1921). During embryonic development, the life of an OL is defined by four 
distinct phases: i) birth, migration, and proliferation of OPCs; ii) phenotypic differentiation of 
OPC into myelinating OL; iii) axonal contact, and generation of compact myelin and iv) long-
term trophic and metabolic support of the encased axon (Michalski et al., 2015). During the 
adult life, a substantial number of OPCs persist in the CNS, being responsible for myelin 
turnover, replacement and repair (Dawson et al., 2003; Hughes et al., 2013). 
The oligodendrocyte lineage begins with specification of OPCs from neural stem cells (NSCs) 
during late embryonic life. These multipotent stem cells give rise to neurons, radial glia, 
astrocytes and bipotential astrocyte-oligodendrocyte progenitor cells that colonize the CNS 
(Goldman and Kuypers, 2015). OPCs, recognized as replicating NG2-positive progenitors, are 
not a homogeneous population and they give rise to different progenies in different brain 
regions and in different stages of the development (Viganò and Dimou, 2016), during three 
separate waves, finally defining the whole OLs populations (Kessaris et al., 2006; 
Jakovcevski et al., 2009). 
OPCs generated during the development are distributed in the adult brain and spinal cord, in 
the grey and the white matter, comprising the largest population of dividing cells in the 
mature CNS (Michalski et al., 2015). After lesion, they can proliferate, migrate to axons and 
differentiate in mature oligodendrocytes (Fukushima et al., 2015). In the adult life, new OPCs 
are also generated by proliferation and asymmetric division from NSCs in the subventricular 
zone (SVZ) of the lateral ventricle (Urbán and Guillemot, 2014). 
In the healthy adult brain, new myelin is continually generated, showing a persisting 
remodelling (Yeung et al., 2014). Myelin volume in humans is activity-dependent, and can 
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increase producing	  new	  cells	  or	  new	  membrane	  from	  the	  already	  existing	  cells	  (Bercury	  et	  al.,	  2015),	  for	  example	  when	  practicing new skills (Bengtsson	  et	  al.,	  2005) or in learning 
a language (Schlegel	  et	  al.,	  2012).	  In	  fact,	  myelination	  is	  a	  conserved	  process	  during	  adult	  life,	  showing	  high	  plasticity.	  Moreover,	  an	  effective	  remyelination	  can	  occurs	  also	  after	  demyelination	   insults,	   leading	   to	   a	   complete	   anatomical	   and	   functional	  myelin	   sheath	  restoration,	  thus	  representing	  a	  true	  regenerative	  capability	  of	  the	  CNS	  (Crawford	  et	  al.,	  2013).	  
Remyelination process is not performed by pre-existing mature OLs, but involves the 
generation of new cells from the quiescent OPC pool distributed throughout the CNS or from 
the SVZ. Different soluble factors, also produced from activated microglia, stimulate local 
OPCs to switch from quiescent state to a regenerative phenotype, to migrate to demyelinated 
areas and generate mature OLs (Bradl and Lassmann, 2010), in a process that is believed to be 
similar to the developmental myelination (Franklin & Hinks 1999). 
The progression of OPCs along the myelination process is tightly regulated in all the stages, 
by signals including growth factors, protein kinases and extracellular matrix molecules, all of 
which influence epigenetic modifications, transcriptional and translational regulation, and the 
actin cytoskeleton arrangement (Bercury et al., 2015). 
One of the most important factors regulating the OPCs differentiation process is thyroid 
hormone (TH; Billon et al., 2002, 2004; Calzà et al., 2017). Triiodothyronine (T3), the active 
form of TH, acts via genomic, epigenetic and non-genomic mechanisms (Lee and Petratos, 
2016), inducing OPCs cell cycle exit and terminal differentiation (Durand & Raff, 2000). T3 
mediates its action by binding thyroid hormone receptors (TRs; TRα and TRβ), a class of 
nuclear receptors (NRs) that migrate into the nucleus and regulate the expression of specific 
genes controlling OPCs cell cycle exit and regulating the expression of premyelinating genes 
(Baxi et al., 2014; Casaccia-Bonnefil and Liu, 2003; Dugas, et al., 2012). Other nuclear 
receptors are also involved in OPC differentiation. In particular, RXRγ (Retinoic X Receptors 
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gamma) has been shown to be a positive regulator of the differentiation process (de la Fuente 
et al., 2015) also acting as TR/RXR heterodimer (Lee and Privalsky, 2005). 
In order to dissect the respective contribution of TRs and RXR in foetal and adult OPC 
differentiation, in this study we explored the T3-mediated differentiation of OPC derived from 
foetal and adult NSCs. In particular, in these cell preparations we analysed (i) the differential 
expression level of NR, related co-represser and coactivators, and target genes; (ii) T3-
mediated differentiation; (iii) OPC generation from RXRγ -/- mice. 
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2. Materials and methods  
 
2.1 Cell Cultures 
 
All animal protocols described herein were carried out according to the European Community 
Council Directives (86/609/EEC), and comply with the guidelines published in the NIH Guide 
for the Care and Use of Laboratory Animals. 
Foetal and adult NSCs were isolated from E.13-14 foetal forebrain or 2.5 month old adult 
SVZ, following the Ahlenius and Kokaia protocol (Ahlenius and Kokaia, 2010). 
Oligodendrocyte differentiation was performed following the Chen protocol (Chen et al., 
2007) with some modifications. 
Ion another set of experiments the same protocol was used to differentiate OPCs from 
neurospheres isolated from foetal brain (whole forebrain or striatum) and adult SVZ of 
RXRγ+/+ and RXRγ -/- mice (Krezel et al., 1996).  
Tissues were enzymatically dissociated using trypsin (Sigma-Aldrich), hyaluronidase (Sigma-
Aldrich) and DNase (Sigma-Aldrich), than mechanically dissociated by piepetting. The 
solution was filtered, centrifuged and the resulting pellet was washed twice in HBSS. After 7 
minutes centrifugation at 400 × g, the cellular pellet was resuspended in serum-free medium 
(DMEM/F12 GlutaMAX 1 x; 8 mmol/L HEPES; 100 U/100 µg Penicillin/Streptomycin; 0.1 x 
B27; 1 x N-2; 20 ng/mL bFGF; 20 ng/mL EGF) and, after cell count, cells were plated in 
suspension at a density of 10 cells/µl in a final volume of 3 mL in low-attachment 6-well 
plates (NUNC). Half medium was changed every three days, centrifuging the cell suspension 
at 300 × g for 5 minutes and gently resuspending the cellular pellet in fresh medium. 
Neurospheres were allowed to proliferate until they attained a diameter of about	  100µm. 
To obtain secondary neurospheres, primary neurospheres were centrifuged at 300 x g for 5 
minutes. The pellet was mechanically dissociated by pipetting and cells were counted and 
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plated again at a density of 10 cells/µl under the same condition. While, to obtain 
oligospheres, the single cell culture were plated in a final volume of 3 mL of OPCs medium 
(DMEM/F12 GlutaMAX 1 x; 8 mmol/L HEPES; 100 U/100 µg Penicillin/Streptomycin; 0.1 × 
B27; 1 × N-2; 20 ng/mL bFGF; 20 ng/mL PDGF) in low-attachment 6-well plates (NUNC). 
Oligospheres were centrifuged and the pellet was mechanically dissociated to obtain a single 
cell suspension. After cell count, cells were plated at a density of 3000 cells/cm2 on poly-D,L-
ornithine (50µg/ml)/laminin (5µg/ml) coating, in OPC medium. 
In order to induce oligodendrocyte differentiation and maturation, after 3 DIVs OPC  medium 
was replaced with the oligodendrocyte differentiation medium (DMEM/F12 GlutaMAX 1 x; 8 
mmol/L HEPES; 100 U/100 µg Penicillin/Streptomycin; 0.1 x B27; 1 x N-2; 50 nM T3; 10 
ng/ml CNTF; 1x N-acetyl-L-cysteine -NAC-). 
 
2.2 RNA isolation and reverse transcription 
 
Total RNA isolation was performed with the RNeasy Mini kit (Qiagen, Milan, Italy) 
following manufacturer’s instructions. Total RNA was eluted in RNase Free Water and 
concentration estimated through absorbance values at 260, 280 and 320 (Nanodrop 2000 
spectrophotometer, Thermo Scientific). First strand cDNAs were obtained using the iScript™ 
cDNA Synthesis Kit (BioRad), incubating at 42°C for 30 min. An RNA sample with no 
reverse transcriptase enzyme in the reaction mix was processed as a no-reverse transcription 
control sample. 
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2.3 PCR array 
 The	   RNeasy	   Micro	   Kit	   (Qiagen)	   was	   used	   for	   total	   RNA	   extraction	   and	   300	   ng	   were	  retrotranscribed	   using	   the	   RT2	   First	   Strand	  Kit	   (Qiagen)	   following	   the	  manufacturer’s	  instructions.	  For	   the	   study	   of	   NSC	   gene	   expression,	   the	   96-­‐well	   Qiagen	   PCR	   array	   for	   nuclear	  receptors	   and	   co-­‐regulators	  was	  used	   in	   combination	  with	   the	  RT2	  SYBR	  Green	  qPCR	  Mastermix	  (Qiagen),	  using	  10	  ng	  of	  cDNA	  per	  well.	  	  STRING	   software	   (version	   10.0;	   European	   Molecular	   Biology	   Laboratory,	   Heidelberg,	  Germany;	   https://string-­‐db.org/)	   was	   used	   to	   analyse	   the	   protein-­‐protein	   interaction	  (PPI)	  of	  proteins	  derived	  from	  the	  genes	  differentially	  expressed	  between	  fetal	  and	  adult	  NSCs	   (fold	   of	   difference	   <	   2).	   The	   STRING	   database	   provides	   interaction	   information	  from	   different	   panels,	   including	   protein	   and	   PubMed	   queries,	   connecting	   proteins	   in	  clusters	  according	  to	  their	  interactions	  and	  involvement	  in	  biological	  processes.	  In	  order	  to	   fit	   the	   strength	   of	   protein	   interactions	   the	   default	   options	   were	   used	   (minimum	  confidence,	   0.400).	   The	   proteins	   were	   processed	   by	   the	   undirected	   edges	   method.	  STRING	  software	  allows	  the	  identification	  of	  net	  of	  interactions	  including	  other	  proteins	  closely	   linked	   to	   the	   one	   analysed,	   in	   order	   to	   obtain	   a	   better	   understanding	   of	   the	  possible	  pathways	  involved	  in	  the	  differentially	  expressed	  genes.	  
 
2.4 Semi-quantitative real-time PCR 
 
Semi-quantitative real-time PCR was performed using the CFX96 real-time PCR system 
(BioRad, CA, USA). The reactions were performed in a final volume of 20 µl consisting of 1x 
SYBR Green qPCR master mix (BioRad) and 0.4 µM forward and reverse primers. In order 
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to avoid possible contamination of genomic DNA in isolated RNA, the sample with no 
reverse transcriptase enzyme was processed in parallel with the others and tested by real-time 
PCR for every pair of primers used. All primers used were designed using Primer Blast 
software (NCBI, MD, USA) and synthesised by IDT (Coralville, IA, USA). The following 
primer sequences were used: Olig1 (FW: 5’- CCGCCCCAGATGTACTATGC -3’; REV: 5’- 
AACCCACCAGCTCATACAGC -3’), Olig2 (FW: 5’- GCTTAGATCATCCCTGGGGC -3’; 
REV: 5’- AGATCATCGGGTTCTGGGGA -3’), TRα (FW: 5’- 
GCAAACACAACATTCCGC -3’; REV: 5’- TCCTGATCCTCAAAGACCTC -3’),TRβ(FW: 
5’- GCAAACACAACATTCCGC -3’; REV: 5’- CACCAAACTGCTGCTCAA -3’), Klf9 
(FW: 5’- AGTGGCTTCGAAGGGGAAAC -3’; REV: 5’- TCCGAGCGCGAGAACTTTTT -
3’). GAPDH (FW: 5'- GGCAAGTTCAATGGCACAGTCAAG -3'; REV: 5'- 
ACATACTCAGCACCAGCATCACC -3') was used as housekeeping gene to normalize the 
amount of reverse-transcribed RNA used for PCR. Thermal profile of PCR reactions 
consisted first of a denaturation step (95°C, 2 min) and 40 cycles of amplification (95°C for 
15 sec and 60°C for 60 sec). At the end of the amplification cycles the melting curve of 
amplified products was performed according to the following temperature/time scheme: 
heating from 55°C to 95°C with a temperature increase of 0.5°C/sec.  
Primers efficiency values for all primers were 95-102%. The 2 (-ΔΔCT) method was used for the 
calculation of gene expression. 
 
2.5 Immunocytochemistry  
 
Indirect immunofluorescence was used to identify OPCs (NG2- and PDGFαR-positive cells), 
mature (CNPase- and APC-positive cells) and myelinating (MBP-positive cells) OLs, neurons 
(β-III-tubulin-positive cells), astrocytes (GFAP-positive cells), replicating cells (Ki67-positive 
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cells) and Olig1 and Olig2 expressing cells. The following primary antisera were used: mouse 
anti-β-III-tubulin (R&D system, Trento, Italy) 1:3000; rabbit anti-GFAP (Glial Fibrillary 
Acidic Protein, Dako) 1:1000; rabbit anti-NG2 (chondroitin sulphate proteoglycan, 
neural/glial antigen 2, Millipore, Merck S.p.a., Milan, Italy) 1:350; rabbit anti-PDGFαR 
(Platelet derived frowth factor alpha receptor, Santa Cruz Biotechnology) 1:300; mouse anti-
CNPase (2', 3'-cyclic nucleotide 3'-phosphodiesterase, Millipore) 1:500; mouse IgG2b anti-
APC (anti-adenomatous polyposis coli, clone CC1, Calbiochem) 1:100; rabbit anti-MBP 
(Myelin Basic Protein, Dako) 1:500; anti-Ki67 (Calbiochem) 1:250; mouse IgG1 anti-Olig1 
(Oligodendrocyte transcription factor 1; NeuroMab) 1:500 and mouse IgG1a anti-Olig2 
(Oligodendrocyte transcription factor 2; Millipore) 1:500. Donkey Alexa Fluor 488-
conjugated anti mouse, goat Alexa Fluor 555-conjugated anti- mouse IgG1, goat Alexa Fluor 
488-conjugated anti- mouse IgG2a, goat Alexa Fluor 647-conjugated anti- mouse IgG2b and 
donkey Alexa 568-conjugated anti-rabbit (1:500; ThermoFisher Scientific) were used as 
secondary antisera. After immunofluorescence staining, cells were incubated with the nuclear 
dye Hoechst 33258 (1 µg/mL in PBS, 0.3% Triton-X 100) for 20 min at RT. Cells were 
finally washed in PBS and mounted in glycerol and PBS (3:1, v/v) containing 0.1% 
paraphenylendiamine. 
 
2.6 Confocal microscopy 
 
Confocal microscopy was used to study the culture lineage composition of RXRγ+/+ and 
RXRγ-/- cultures. Galsses were scanned with a Nikon Ti-E fluorescence microscope coupled 
to an A1R confocal system (Nikon). A diode laser system with 405 wavelength output, air-
cooled Argon-Ion laser system with 488 wavelength output and Yellow diode-pumped solid 
state laser system with 561 wavelength output were used. Images were acquired with 20x 
objective with an optical resolution of 0.18 micron, using Nis-Elements AR 3.2 software. All 
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the z-stacks were collected in compliance with optical section separation (z-interval) values 
suggested by Nis-Elements AR 3.2 software (1µm). Major intensity projections were used for 
the image analysis 
The percentage of APC-, MBP- and NG2-positive cells were quantified, based on the total 
number of cells identified by the nuclear staining. Using the triple staining APC/Olig1/Olig2, 
the OPCs/OLs populations were identified, according to their positivity to these three 
different markers (Nakatani et al., 2013). Moreover, the effect of the RXRγ gene knock out on 
the cell cycle was analysed by using the double staining PDGFαR/Ki67. The percentage of 
the double positive PDGFαR+/Ki67+ were calculated on the total number of PDGFαR-
positive cells. Double positive cells represent the percentage of replicating OPCs. Five 
random fields per glass (duplicate per sample) were used for the analysis. 
 
2.7 High Content Screening 
 
For HCS analysis cells were grown in 96 flat-bottom well HCS plates (NUNC). Analysis of 
condensed nuclei, cell number and lineage/differentiation markers were performed with Cell 
Insight™ CX5 High Content Screening (HCS; Thermo Scientific), using the Compartmental 
analysis BioApplication. Based on nuclear staining, the software is able to recognise nuclei 
and calculate the percentage of high intensity/small sized condensed nuclei. Moreover, based 
on the nuclei identification, the software is able to detect the presence of the marker-specific 
stain in the cell body, calculating the percentage of the immunoreactive cells. 
Lineage/differentiation markers analysis was performed only on cells showing intact nuclei, 
excluding condensed nuclei from the percentage calculation. 
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2.8 Statistical Analysis 
 
Data are reported as mean ± SEM. Prism software (GraphPad) was used for statistical 
analyses and graph generation. Student’s t test, one-way ANOVA or two-way ANOVA and 
Dunnett’s multiple comparison post-hoc were used to analyse data. Results were considered 
significant when the probability of their occurrence as a result of chance alone was less than 
5% (P < 0.05). 
 
3. Results 
 
3.1. TRβ and	  RXRγ	  are	  differentially	  expressed	  in	  foetal	  and	  adult	  neurospheres	  
	  In	   order	   to	   study	   possible	   roles	   of	   NRs	   in	   OPCs	   lineage	   and	   differentiation,	   we	   first	  analysed	  the	  NRs	  and	  co-­‐regulators	  mRNA	  expression	  in	  very	  early	  precursors.	  For	  this	  purpose	   we	   lysate	   secondary	   foetal	   and	   adult	   neurospheres,	   extracted	   the	   RNA	   and	  analysed	  the	  expression	  of	  all	  NRs	  and	  co-­‐regulators	  by	  using	  the	  PCR	  array	  technology	  (Fig	  1	  A).	  The	  list	  of	  all	  the	  analysed	  gene	  is	  presented	  in	  supplementary	  material	  (Table	  1).	  Results	   we	   analysed	   by	   comparing	   adult-­‐	   to	   foetal-­‐derived	   NSC	   gene	   expression,	   and	  expressed	  as	  fold	  of	  increase.	  Adult	  NSCs	  show	  a	  general	  up-­‐regulated	  profile	  compared	  to	   foetal	   cells	   (Figure	   1	   B).	   Genes	   showing	   a	   difference	   in	   expression	   equal	   or	   higher	  than	  2	   folds	  were	  considered	  as	   significantly	  differentially	  expressed.	   In	  particular,	   28	  NRs	  and	  co-­‐regulators	  are	  more	  expressed	  and	  3	  genes	  are	   less	  expressed	  in	  the	  adult	  compared	   to	   foetal	   NSCs	   (Figure	   1	   C).	   The	   list	   of	   all	   differentially	   regulated	   genes	   is	  included	  in	  the	  figure	  (Figure	  1	  D).	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Different	  genes	  related	  to	  androgens	  (Ar,	  Med12,	  Med13	  and	  Nr1i3),	  estrogen	  (Ncoa6),	  glucocorticoids	   (Ncoa6	   and	  Nr3c1),	   vitamin	  D	   (Med12	   and	  Med13),	   steroid	   hormones	  (Nr1d1,	   Nr1h3,	   Nr2c1,	   Nr2f2,	   Nr3c2,	   Ppara,	   Rarg,	   Rora,	   Rxra,	   Thrb),	   retinoic	   acid	  receptors	  (Ncoa6,	  Rarg,	  Rxra	  and	  Rxrg)	  and,	  in	  particular	  to	  THs	  (Med12,	  Med13,	  Ncoa4,	  Nr1d1,	  Nr1h3,	  Nr1i3,	  Trip4	  and	  Thrb)	  are	  differentially	  regulated.	  	  In	   particular,	   two	   key	   genes	   involved	   in	   OPCs	   differentiation	   were	   differentially	  expressed	  in	  adult	  compared	  to	  foetal	  OPC:	  TRβ	  (Trhb)	  and	  RXRγ	  (Rxrg).	  TRβ	  is	  12.52	  folds	   more	   expressed,	   while	   RXRγ	   is	   9.27	   folds	   less	   expressed	   in	   adult	   compared	   to	  foetal	  NSCs.	  The	  net	  of	  the	  proteins	  encoded	  by	  differentially	  regulated	  genes	  were	  analysed	  by	  the	  STRING	  software.	  The	  software	  uses	  the	  interactions	  between	  proteins	  in	  order	  to	  build	  a	   network,	   where	   nodes	   are	   represented	   by	   interconnected	   proteins	   encoded	   by	   the	  selected	  genes.	  The	  analysis	  of	   the	   interactions	  shows	  that	  all	   the	  proteins	  encoded	  by	  the	   differentially	   regulated	   genes	   are	   functionally	   interconnected.	   TRβ	   is	   in	   the	   core,	  indicating	   its	   central	   role	   in	   the	   net	   	   (red	   arrow,	   Fig	   1	   E).	   Protein	   encoded	   by	   genes	  involved	  in	  retinoic	  acid	  metabolism	  (Rorb,	  Rxrg	  and	  Rora)	  show	  also	  a	  central	  position,	  and	  a	  strong	  interaction	  with	  TRβ. 
 
3.2 Foetal	  and	  adult	  NSCs-­‐derived	  OPCs	  need	  T3	  to	  differentiate	  in	  mature	  OLs	  
 We	  then	  confirmed	  the	  role	  of	  T3	  as	  key	  agent	  in	  the	  OPC	  differentiation	  process	  from	  NSC.	   Both	   foetal	   and	   adult	   NSCs	   cultures	   were	   used	   for	   the	   differentiation	   protocol	  described	  in	  figure	  2	  A.	  The	  lineage	  progression	  was	  analysed	  by	  counting	  the	  number	  of	  differentiated	  cells,	  using	  CNPase	  as	  marker	  for	  pre-­‐myelinating	  PL,	  and	  MBP	  as	  marker	  for	   myelinating	   OL.	   Both	   cultures	   need	   T3	   to	   differentiate	   in	   mature/myelinating	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CNPase-­‐/MBP-­‐	  positive	  OLs.	  In	  fact,	  in	  the	  absence	  of	  T3	  very	  few	  CNPase	  (foetal:	  12%;	  adult:	  9%)	  and	  MBP	  (foetal:	  5%:	  adult:	  8%)-­‐positive	  cells	  are	  observed	  compared	  to	  T3	  exposed	   cultures	   (data	   not	   shown).	   Representative	   images	   of	   vehicle-­‐	   or	   T3-­‐treated	  cultures	  at	  the	  end	  of	  the	  differentiation	  process	  are	  showed	  in	  Figure	  2	  B-­‐I.	  	  
3.3	  Adult	  NSCs-­‐derived	  OPCs	  have	  the	  same	  expression	  pattern	  of	  OLs	  markers	  compared	  to	  
foetal,	  but	  different	  yield	  of	  maturation	  
	  In	  order	   to	  dissect	   the	  molecular	   steps	   involved	   in	   the	  differentiation	  process	   in	  adult	  and	   foetal-­‐derived	   OPC,	   we	   analysed	   the	   expression	   of	   five	   key	   genes	   in	   the	  differentiation	  process	  (Olig1,	  Olig2,	  TRα,	  TRβ	  and	  Klf9)	  in	  all	  the	  differentiation	  step	  of	  NSCs-­‐derived	  OPCs,	   from	  neurospheres	   to	  myelinating	  OLs	   (Fig	  3	  A).	   These	   genes	   are	  regulators	  of	  the	  cell	  cycle	  exit	  and	  of	  the	  maturation	  of	  OLs	  and	  are	  tightly	  functionally	  connected	  (Fig	  3	  B).	  Olig1,	   Olig2,	   TRα,	   TRβ	   and	   Klf9	   mRNA	   expression	   level	   is	   regulated	   by	   time	   and	  differentially	   expressed	   between	   the	   two	   cultures	   (Two-­‐way	   ANOVA:	   Olig1,	   time,	   p	   <	  0.0001,	  age,	  p	  =	  0.0021	  interaction,	  p	  <	  0.0001;	  Olig2	  time,	  p	  <	  0.0001,	  age,	  p	  =	  0.0035,	  interaction,	  p	  <	  0.0001;	  TRα,	  time,	  p	  =	  0.0143,	  age,	   	  p	  <	  0.0001	  interaction,	  p	  =	  0.0002;	  TRβ,	  time,	  p	  <	  0.0001,	  age,	  p	  =	  0.0127	  interaction,	  p	  =	  0.0006;	  Klf9,	  time,	  p	  <	  0.0001,	  age,	  p	  <	  0.0001	  interaction,	  p	  <	  0.0001).	  In	  particular,	  adult	  cultures	  show	  higher	  expression	  of	   Olig1,	   Olig2,	   TRβ	   and	   Klf9	   at	   neurospheres	   and	   oligospheres	   stages	   (Olig1,	  neurospheres	   p	   <	   0.0001,	   oligospheres	   p	   <	   0.0001;	   Olig2,	   neurospheres	   p	   <	   0.0001,	  oligospheres	   p	   <	   0.0001;	   TRβ,	   neurospheres	   p	   <	   0.0001,	   oligospheres	   p	   =	   0.0229	   and	  Klf9,	  neurospheres	  p	  <	  0.0001,	  oligospheres	  p	  <	  0.0001).	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However,	   in	   later	   stages	  of	  differentiation,	   at	  OPCs	   level	   (0	  DIV)	   and	  after	  T3-­‐induced	  differentiation	   (6	   and	   12	   DIVs),	   foetal	   cells	   are	   more	   responsive	   to	   differentiation	  stimuli,	  showing	  an	  higher	  expression	  of	  Olig1	  at	  6	  DIV	  (p	  <	  0.0001)	  and	  Olig2	  and	  TRα	  at	  all	  the	  differentiation	  time	  points	  studied	  (Olig2,	  0	  DIV,	  p	  =	  0.0001	  ,	  6	  DIV,	  p	  <	  0.0001,	  12	  DIV,	  p	  =	  0.0248;	  TRa,	  0	  DIV,	  p	  =	  0.001;	  6	  DIV,	  p	  <	  0.0001,	  12	  DIV,	  p	  =	  0.0128).	  Notably,	   even	   if	   Klf9	   expression	   is	   retained	   in	   adult	   cells	   at	   early	   stages	   (0DIV,	   p	   <	  0.0001),	  Klf9	  expression	  is	  higher	  in	  the	  foetal	  cultures	  in	  later	  stages	  (6	  DIV,	  p	  =	  0.0111;	  12	  DIV,	  p	  =	  0.0007;	  Fig.	  3	  C-­‐F),	  after	  T3	  exposure.	  We	  then	  analysed	  how	  this	  gene	  expression	  profiles	  correlate	  with	  the	  OLs	  maturation	  by	   analysing	   different	   markers	   during	   the	   differentiation	   process	   (0,	   6	   and	   12	   DIV;	  Figure	  4	  A),	  e.g.	  PDGFαR	  and	  NG2	  for	  OPCs,	  CNPase	  for	  mature	  OLs,	  MBP	  for	  myelinating	  OLs,	  GFAP	  for	  astrocytes	  and	  beta-­‐III-­‐tubulin	  for	  neurons.	  Results	  were	  analysed	  by	  two-­‐way	  ANOVA	  for	  each	   lineage	  marker.	  The	  percentage	  of	  PDGFαR-­‐	  positive	  cells	  varies	  according	  to	  the	  culture	  time	  in	  both	  foetal	  and	  adult	  OPC	  (time,	  p	  =	  0.0108,	   F	   (2,24)	  =	  5.499;	   interaction,	  p	  <	  0.0001),	  with	   a	  decrease	   in	   foetal	  cultures	  at	  6	  DIV	  (0	  vs.	  6	  DIV,	  p	  =	  0.0006)	  and	  an	  increase	  at	  the	  same	  time	  point	  in	  the	  adult	   (0	   vs.	   6	   DIV,	   p	   =	   0.0007),	   but	   reaching	   the	   same	   percentage	   at	   the	   end	   of	  differentiation	  (12	  DIV;	  Fig	  4	  B-­‐D).	  However,	  NG2-­‐positive	  cells	  percentage	  is	  affected	  by	  both	  time	  and	  age	  (time,	  p	  =	  0.0029,	  F	  (2,24)	  =	  7.516;	  age,	  p	  =	  0.0058,	  F	  (2,24)	  =	  9.159;	  Fig	   4E-­‐G).	   Mature,	   CNPase-­‐positive	   OLs,	   show	   no	   age	   (foetal	   vs.	   adult)	   or	   time	  differences,	  but	  the	  two	  parameters	  are	  significantly	  interacting	  (interaction,	  p	  =	  0.001;	  Fig	   4	  H-­‐J).	  However,	  MBP-­‐positive	   cells	   percentage	   is	   significantly	   affected	   by	   the	   age	  parameter	  (age,	  p	  <	  0.0001;	  F	  (2,24)	  =	  32.66;	  interaction,	  p	  =	  0.0007;	  F	  (2,24)	  =	  9.987),	  with	   a	   significant	   low	   percentage	   in	   adult-­‐derived	   cultures	   at	   the	   end	   of	   the	  differentiation	  process,	  compared	  to	  foetal-­‐derived	  cells	  (12	  DIV,	  p	  =	  0.0020;	  Fig	  4	  K-­‐M).	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In	  term	  of	  morphological	  phenotype,	  cells	  derived	  from	  foetal	  NSCs	  show	  a	  more	  mature	  phenotype	  compared	  to	  cells	  derived	  from	  adult	  NSCs,	  as	  illustrated	  by	  MBP-­‐IR	  (Fig	  4	  L	  and	  M).	  Moreover,	  since	  NSCs-­‐derived	  cultures	  are	  mixed	  culture	   including	  also	  astrocytes	  and	  neurons,	  we	  also	  evaluated	  these	  cell	  population:	  GFAP-­‐positive	  cells	  are	  around	  40%	  of	  the	   cultures	   in	   both	   cell	   cultures,	   at	   the	   end	   of	   the	   differentiation	   phase,	   and	   a	   little	  percentage	   of	   neurons	   (foetal,	   5%;	   adult,	   1%;	   data	   not	   shown)	   was	   also	   detected	  throughout	  the	  whole	  culture.	  
	  
3.4 Foetal	  and	  adult	  NSCs-­‐derived	  OPCs	  need	  RXRγ	  to	  differentiate	  in	  mature	  OLs	  
	  In	  order	  to	  study	  the	  role	  of	  RXRγ,	  a	  NR	  differentially	  expressed	  in	  foetal	  and	  adult	  early	  precursors,	  we	  isolated	  NSCs	  from	  foetal	  and	  adult	  brain	  of	  RXRγ+/+	  and	  RXRγ-­‐/-­‐	  mice.	  For	  foetal	  cultures,	  cells	  were	  isolated	  both	  from	  the	  whole	  forebrain	  or	  selectively	  from	  the	  striatum,	  the	  region	  where	  RXRγ	  is	  more	  expressed	  in	  the	  brain;	  while	  for	  adult	  NSCs	  were	  isolated	  from	  the	  SVZ.	  The	  same	  differentiation	  protocol	  was	  used	  (Fig	  5	  A).	  Cells	  isolated	  from	  RXRγ-­‐/-­‐	  animals	  show	  a	  reduced	  percentage	  of	  mature	  OLs	  at	  the	  end	  of	   the	   differentiation	   process,	   (Student’s	   t	   test:	   APC-­‐positive	   cells;	   E13.5,	   RXRγ-­‐/-­‐	   p	   =	  0.0001;	  RXRγ-­‐/-­‐	  p	  =	  0.0007;	  adult	  RXRγ-­‐/-­‐	  p	  <	  0.0001;	  Fig	  5B)	  and	  myelinating	  (MBP-­‐positive	  cells;	  E13.5,	  RXRγ-­‐/-­‐	  p	  <	  0.0001;	  RXRγ-­‐/-­‐	  p	  <	  0.0001;	  adult	  RXRγ-­‐/-­‐	  p	  <	  0.0001;	  Fig	  5C).	  Panel	  in	  figure	  5	  D-­‐K	  shows	  representative	  images	  of	  the	  cultures.	  Results	  were	  similar	   for	   foetal	   cells	   isolated	   either	   from	   the	   whole	   forebrain	   or	   from	   the	   striatum	  (data	  not	  shown).	  Using	  the	  anti-­‐APC	  antibody,	  in	  combination	  with	  the	  detection	  of	  Olig1	  and	  Olig2,	  it	   is	  possible	  to	  discriminate	  between	  the	  different	  populations	  of	  OPCs	  and	  OLs	  at	  different	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stages	  of	  maturation.	  Progenitors	  (OPCs)	  are	  APC-­‐	  and	  Olig1-­‐	  negative,	  but	  positive	  for	  Olig2.	   APC-­‐positive	   cells	   can	   be	   divided	   in	   a	   crescent	   level	   of	   maturation	   in	   Olig1-­‐/Olig2+,	  Olig1+/Olig2+	  and	  Olig1-­‐/Olig2+	  (Nakatani	  e	  al.,	  2013).	  Both	  in	  foetal	  and	  adult	  cultures,	  the	  cells	  reaching	  APC-­‐positivity	  display	  the	  same	  pattern	  of	  distribution	  of	  the	  different	  population.	  However,	  foetal	  cells	  isolated	  from	  the	  whole	  forebrain,	  compared	  to	  RXRγ+/+,	  show	  a	  higher	  percentage	  of	  APC-­‐negative	  cells	  (black	  column,	  p	  =	  0.0246)	  and	  less	  APC+/Olig1-­‐/Olig2+	  cells	  (p	  =	  0.0473),	  corresponding	  to	  the	  most	  mature	  OLs	  population	  (Fig	  5	  L).	  	  
3.5	  RXRγ	  is	  involved	  in	  T3-­‐mediated	  cell	  cycle	  exit	  
 In	  order	  to	  investigate	  the	  possible	  role	  of	  RXRγ	  receptors	  in	  the	  expression	  regulation	  of	   key	   genes	   involved	   in	  OLs	  maturation	   and	   in	   cell	   cycle	   exit,	  we	   isolated	   foetal	   cells	  from	   the	   whole	   forebrain	   of	   RXRγ-­‐/-­‐	   and	   RXRγ+/+	   mice	   (Fig	   6A).	   Foetal	   cultures	   of	  NSCs-­‐derived	  OPCs	  were	  lysed	  before	  adding	  T3	  (0	  h),	  and	  after	  6	  and	  24	  h	  after	  the	  T3-­‐differentiation	   induction.	   No	   differences	   in	   expression	   levels	   were	   detected	   in	   TRα1,	  TRβ,	  Olig1,	  Olig2	  and	  Klf9	  expression	  (Fig	  6	  B).	  T3	   is	   the	   best-­‐known	  differentiating	   agent	   in	  OPCs	   being	   the	   key	   regulator	   of	   the	   cell	  cycle	  from	  undifferentiated	  precursors	  (Billon	  et	  al.,	  2001).	  Thus,	  in	  order	  to	  analyse	  the	  effect	   of	   RXRγ	   gene	  KO	   in	   the	   cell	   cycle	   regulation,	  were	  measured	   the	   percentage	   of	  OPCs	   generated	   from	   cells	   isolated	   from	   the	   whole	   foetal	   forebrain	   of	   RXRγ-­‐/-­‐	   and	  RXRγ+/+	  mice,	   after	   24	   h	   of	   the	   T3-­‐mediated	   differentiation,	   compared	  with	   cultures	  that	  were	  not	  treated	  with	  T3.	  RXRγ-­‐/-­‐	  cultures	  show	  an	  higher	  number	  of	  NG2-­‐positive	  cells	  at	  the	  end	  of	  the	  differentiation	  phase,	  compared	  to	  RXRγ+/+	  cultures	  (p	  <	  0.0001;	  Fig	  6	  C-­‐E),	  suggesting	  a	  possible	  dysregulation	  of	  the	  T3-­‐induced	  cell	  cycle	  exit.	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Cells	  were	  then	  stained	  for	  PDGFαR,	  in	  order	  to	  identify	  OPCs,	  and	  for	  Ki67,	  in	  order	  to	  identify	   replicating	   cells.	   T3	   induces	   a	   reduction	   in	   Ki67-­‐positive	   OPCs,	   compared	   to	  RXRγ+/+	   cultures	   treated	  with	   vehicle	   (p	  =	  0.0486).	  RXRγ-­‐/-­‐	   cultures	   show	  an	  higher	  percentage	   in	   replicating-­‐OPCs	   compared	   to	   RXRγ+/+	   (p	   =	   0.0315).	   Moreover,	   the	  percentage	  of	  Ki67-­‐positive	  OPCs	  is	  not	  affected	  by	  T3	  treatment	  and	  the	  level	  remains	  higher,	  compared	  to	  RXRγ+/+	  cells	  treated	  with	  T3	  (p	  <	  0.0001;	  Fig	  6	  F-­‐J).	  
 
4. Discussion 
 
OPCs are the key cells for myelin formation and repair in the CNS. Thus, understanding the 
molecular mechanisms underlying their maturation from the precursor until the myelinating 
stage would provide fundamental information also in view of therapeutic opportunities for 
demyelinating diseases and lesions (Hydleburg abd D’Aversa, 2014). In spite of the fact that 
most of OPCs populating the mature CNS are developmentally derived, the foetal and mature 
OPCs show substantial differences in molecular and biological properties. For instance, we 
demonstrated that the enzymatic activity of Poly (ADP-ribose) polymerase (PARP) family 
members is much higher in foetal than in adult- OPCs derived from NSCs, and that PARP 
inhibition is cytotoxic for OPCs derived from foetal, but not from adult brain (Baldassarro et 
al., 2017). Moreover, in vivo and in vitro studies indicate that OPCs have substantially 
different properties according to their chronological age (Cui et al., 2012); the sensitivity of 
OL lineage to apoptosis is maturation-dependent (Butts et al., 2008); and adult OPC have a 
longer cell cycle than perinatal OPC (Tang et al., 2000). In view of the key role of several 
members of NRs superfamily in OPC biology, in this study we investigated the differentiation 
process of OPCs obtained from NSCs derived from foetal (E13.5) and adult brain (SVZ), 
focusing on the role of NRs. This cell system was preferred to primary and purified OPCs to 
better mimic developmental biology of OPC, including lineage specification, 
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proliferation/survival and differentiation. This culture contains also astrocytes, fundamental 
players in the THs metabolism and signalling, expressing also TRs and affected by T3 
exposure (see Trentin, 2006 for a review). 
We showed that (i) the mRNA expression level of several NR and co-regulators is different in 
foetal and adult OPCs at comparable differentiation stages; (ii) adult NSCs-derived OPCs 
have a different yield of maturation compared to foetal-derived OPC; (iii) both foetal and 
adult NSCs-derived OPCs need RXRγ to complete the T3-dependent maturation, and this 
effects is probably related to the cell cycle exit. 
 
4.1.	  NR	  signalling	  in	  foetal	  vs	  adult	  OPC.	  
	  
NRs play fundamental roles in all the differentiation stages of OLs, from NSCs self-renewal 
and lineage specification, to OPCs cell cycle exit and OLs maturation. NRs members include 
the thyroid hormone receptors (TRs), the retinoic acid receptors (RARs), the retinoid X 
receptors (RXRs), the peroxisome proliferator-activated receptors (PPARs), the liver X 
receptors (LXRs), the estrogen receptors (ERs), the mineralocorticoid receptor (MR), the 
glucocorticoid receptor (GR), as well as orphan nuclear receptors, for which no known 
cognate endogenous ligands have yet been identified (Stergiopoulos, 2013). According to the 
classical view, most of these receptors act at genomic level either in the presence or absence 
of the endogenous ligand, modulating expression or repression of the target genes, 
respectively (Mendoza and Hollenberg, 2017). 
Here we showed that foetal and adult NSCs show a different expression level of two key NRs 
involved in OLs lineage and differentiation. In particular, NSCs derived from the SVZ of the 
adult brain has much higher TRβ and a much lower RXRγ mRNA expression level than NSCs 
derived from foetal brain. Moreover, differentiated cultures obtained from adult animals also 
show an higher expression of Olig1, Olig2 and Klf9 mRNAs expression level in early stages 
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of the differentiation (until oligospheres for Olig1 and 2 and until OPCs, 0 DIV, for Klf9), 
compared to foetal brains. Olig1 and Olig2 are closely related transcription factors playing 
critical roles in OLs specification and differentiation. They are structurally similar but only 
partially functionally redundant in OPCs differentiation, whit a major role of Olig2. The main 
target of Olig2 are Sox10 and Sip1, factors enhancing the OPCs differentiation, inhibiting 
neuronal differentiation of multipotent precursors. The expression of the two Oligs is 
temporally regulated, with a later expression of Olig1, inducing the expression of mature OLs 
genes (Mbp and Plp1; see Maijer et al., 2012 for a Review). Klf9 is a T3-target gene, which is 
critically involved in OPC maturation and directly induced by T3 (Dugas et al., 2012). In 
embryonic NSCs, TRβ participates in the regulation of neuronal differentiation and 
oligodendrogenesis, while in adult NSCs acts inhibiting the proliferation and regulating the 
gliogenesis (Gkikas et al., 2017). RXRγ induces gliogenesis in foetal NSCs (Takouda et al., 
2017), while no data are available in adult-derived NSCs. Primary OPC cell cultures need T3 
to differentiate into myelinating OL, and here we confirmed that also OPC derived from foetal 
and adult NSC also need T3. T3 acts as TRs ligand (Billon et al., 2002), being the α and β TR 
isoforms, ligand-regulated transcription factor for target genes. We showed that foetal cells 
are more responsive to T3-induced differentiation, reaching higher level of the T3-target gene 
Klf9. The higher T3-responsiveness in foetal cultures is also showed by the analysis of OLs 
markers during the differentiation process, proving that foetal differentiated cultures are more 
enriched of MBP-positive OLs compared to adult at the end of the in vitro differentiation 
process, according also to the higher expression of mRNA encoding for differentiation factors 
(Olig1, Olig2 and Klf9) in the late stages of the differentiation. Moreover, the morphological 
phenotype of CNPase and MBP-positive cells is more mature in foetal than adult cultures, 
suggesting a possible delay in the differentiation of adult cultures. 
These results support the general view that T3 action on differentiation process of  different 
cell precursors is spatially and timely controlled. In fact, T3-dependent gene expression 
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regulation is spatially and temporally regulated. The same gene can be differentially regulated 
according to the developmental stage and according to the cell type, possibly according to a 
differential expression of co-regulators (Mohácsik et al., 2011). In particular, it is now clear 
that TRs can regulate negatively or positively gene target transcription, through mechanisms 
involving co-repressor and co-activators. These proteins interact with either ligand-bound or 
unliganded NRs, acting as a bridge between receptors and the transcription machinery (see 
Astapova, 2016 for a review). 
 
4.2.	  RXRγ	  involvement	  in	  T3-­‐mediated	  OPC	  cell	  cycle	  exit	  
 
It is well known that T3 regulates the cell cycle of different cells, including OPCs. According 
to the classical experiments by Raff and collaborators (Billon et al., 2001), T3 drives the OPC 
out from the cell cycle after a defined number of cell replication (or corresponding time), 
possibly acting through p27 protein, directly enhancing the expression of the gene (Perez-
Juste and Aranda, 1999). T3 is also needed to start differentiation, proven by the fact that the 
accumulation of p27 protein in OPCs is enough to block cell cycle, but cells fail to 
differentiate in absence of T3. Infact, in absence of T3, and in the presence of mitogens, OPCs 
keep proliferating with no chances to differentiate (Tokumoto et al., 2002). 
During development, OPCs start showing TH sensitivity at E14 in mice, due to the expression 
of TRs, giving to them the role of the timer controller of the differentiation (Gao et al., 1998; 
Billon et al., 2001).  T3 directly regulates different proteins involved in cell cycle control. For 
example, T3-mediated action of TRs decreases the expression of E2F1 and c-myc, molecules 
involved in the transcriptional activation of different positive regulators of cell cycle (e.g. 
cyclin E, cyclin A and cdk2) and reduces the expression of cyclin D1 (Puzianowska-Kuznicka 
et al., 2006). The regulation of TH sensitivity is also dependent on the cell cycle phase, as 
suggested by in vitro data. In particular there is no TRs  expression in early S phase, but TRs 
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expression progressive increase during late S and G2 until maximal level at G2/M, showing 
also an increase in TH binding capability (Maruvada et al., 2004). 
Apart from TRs, other NRs are involved in the gene expression regulation in OPCs, acting as 
homodimers or heterdimers also with TRs (Zhuang et al., 2013; Kanakasabai et al., 2012). In 
this context, the retinoic acid receptors RXRs are of particular interest, namely RXRγ. The 
activation of RXR by pharmacological and genetic manipulation stimulates oligodendrocyte, 
differentiation enhancing remyelination (Huang et al., 2011; de la Fuente et al., 2015), and the 
TR/RXR heterodimer is proposed to be the primary mediators of the target gene regulation by 
T3 (vedi geni indagati) (Lee and Privalsky, 2005). Moreover, an upregulation of RXRγ 
mRNA expression level has been described during remyelination, being expressed in OLs in 
remyelinating lesions in rat CNS (ref) and in tissue from individuals with multiple sclerosis 
(MS), a disease characterized by extensive demyelination and remyelination attempts (ref).  
Here we showed that the lack of RXRγ severly impairs OLs maturation both in foetal and 
adult cultures. We showed that the percentage of mature and myelinating OLs at the end of 
the T3-differentiation mediated phase is much lower in cell isolated from RXRγ-/- than from 
WT animals, indicating a substantial impairment in OPC differentiation in the absence of 
RXRγ. However, the small number of the mature OLs present in RXRγ-/- cultures shows the 
same maturation pattern of the RXRγ+/+ cells, and no differences in key genes mRNA 
expression level (Olig1, Olig2, Klf9) involved in the differentiation process were detected 
after 6 and 24 hours from the T3-mediated differentiation induction. These results support a 
major role of RXRγ in the T3-mediated OPCs differentiation, and suggest that this effect is 
not mediated by the molecular machinery at the base of the differentiation process.  
An alternative possibility is that RXRγ is involved in the T3-mediated cell cycle exit. In fact, 
foetal cultures of NSCs-derived OPCs isolated from RXRγ-/- mice, show an higher number of 
OPCs compared to OPCs isolated from RXRγ+/+ mice, suggesting that T3 failed to induce 
cell cycle exit and OPCs do not stop proliferating. This hypothesis was confirmed by the 
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PDGFαR/Ki67 double staining experiments, allowing the quantification of replicating OPCs. 
RXRγ-/- OPCs show an higher number of replicating OPCs in the absence of differentiation 
stimuli and also 24 hours after the T3- differentiation induction, as indicated by the 
unchanged number of Ki67-positive OPCs. 
 
In conclusion, we showed that foetal and adult NSCs-derived OPCs differentially respond to 
T3-mediated differentiation. This process needs T3 in both cultures. Moreover, in both 
cultures RXRγ is fundamental to trigger the differentiation, probably acting as heterodimer 
with TRs. RXRγ is directly affecting OPCs differentiation, probably by affecting the T3-
mediated OPCs cell cycle exit. Further studies will elucidate the interactions between TRs and 
RXRγ in this process. 
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Figure captions 
 
Figure 1. Nuclear receptors and coregulators in adult vs. foetal neurospheres 
 
(A) Experimental design: in order to study nuclear receptors and co-regulators expression in 
foetal and adult early precursors, secondary neurospheres were lysed and mRNA expression 
was analysed using the PCRarray technology. 
(B) Heat Plot representation of the whole array, showing expression of adult vs. foetal 
neurospheres. Fold of change is expressed in colours code from green (down-regulated) to red 
(up-regulated). 
(C) Gene list of the differentially expressed genes (fold of change > 2). 
(D) Graphic elaboration of the STRING software interaction analysis. Proteins encoded by the 
differentially expressed genes were analysed by the STRING software in order to study the 
interaction net. In the centre of the net, the TRβ is highlighted by the red arrow. 
 
Figure 2. T3-driven foetal and adult NSCs-derived OPCs differenitation in mature OLs 
 
(A) Experimental design: 3 DIV after OPC seeding, cells were exposed to vehicle (DMSO) or 
T3 (50nM). At the end of the differentiation phase (12 DIV) cells were stained for mature 
OLs markers. 
(B-E) Images show the vehicle treated groups, stained for CNPase (B, C) and MBP (D, E) 
markers, in foetal (B, D) and adult (C, E) cultures. 
(F-I) Images show the T3 treated groups, stained for CNPase (F, G) and MBP (H, I) markers, 
in foetal (F, H) and adult (G, I) cultures. 
Abbreviations: CNPase, 2’,3’-cyclic nucleotide 3’-phosphodiesterase; MBP, myelin basic 
protein. 
 
Figure 3. Gene expression in foetal and adult NSCs-derived OPCs 
 
(A) Experimental design: gene expression was analysed during the whole differentiation 
process, from early progenitors to mature OLs. Arrows show the time point of the analysis: 
neurospheres, oligospheres, 0 DIV (before the T3 differentiation induction), 6 DIV, 12 DIV. 
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(B) The active form of the thyroid hormone (T3) exert its action throughout nuclear receptors 
(NRs), including thyroid hormone nuclear receptors alpha and beta. In this way, T3 actives 
the molecular machinery, involving Olig1 and Olig2 expression dynamics and Klf9 
activation, allowing the OPC cell cycle exit and maturation process. 
(C-G) Gene expression analysis of five key genes involved in the differentiation process: 
Olig1 (C), Olig2 (D), TRα (E), TRβ (F) and Klf9 (G). Results are showed as fold of changes 
of all foetal and adult time points normalized on foetal neurospheres. 
Statistical analysis: Two-way ANOVA followed by Tukey’s post-hoc. Asteriscs represent 
differences in the expression at the same time point between foetal and adult cultures (* P < 
0.5; ** P < 0.1; *** P < 0.01; **** P < 0.001). 
Bars represent mean value + SEM. Statistical analysis: Two-way ANOVA followed by 
Tukey’s post-hoc; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. 
Abbreviations: Klf9, kruppel-like factor 9; Olig1, Oligodendrocyte transcription factor 1; 
Olig2, Oligodendrocyte transcription factor 2; TRα, Thyroid hormone receptor alpha; TRb, 
thyroid hormone receptor beta. 
 
Figure 4. OLs differentiation markers in foetal and adult NSCs-derived OPCs 
 
(A) Experimental design: cell morphology and OPCs/OLs markers expression were analysed 
during the differentiation process. Arrows show the time point of the analysis: 0 DIV (before 
the T3 differentiation induction), 6 DIV, 12 DIV. 
(B-D) Graph shows the percentage of the PDGFαR-positive cells during the three analysed 
time point in foetal (red line) and adult (blue line) cultures (B). Images represent foetal (C) 
and adult (D) cultures at the end of the differentiation process (12 DIV). 
(E-G) Graph shows the percentage of the NG2-positive cells during the three analysed time 
point in foetal (red line) and adult (blue line) cultures (E). Images represent foetal (F) and 
adult (G) cultures at the end of the differentiation process (12 DIV). 
(H-J) Graph shows the percentage of the CNPase-positive cells during the three analysed time 
point in foetal (red line) and adult (blue line) cultures (H). Images represent foetal (I) and 
adult (J) cultures at the end of the differentiation process (12 DIV). 
(K-M) Graph shows the percentage of the MBP-positive cells during the three analysed time 
point in foetal (red line) and adult (blue line) cultures (K). Images represent foetal (N) and 
adult (M) cultures at the end of the differentiation process (12 DIV). 
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Statistical analysis: Two-way ANOVA followed by Tukey’s post-hoc. Asteriscs represent 
differences in the expression at the same time point between foetal and adult cultures (* P < 
0.5; ** P < 0.1; *** P < 0.01; **** P < 0.001). 
Bars represent mean value + SEM. Statistical analysis: Two-way ANOVA followed by 
Tukey’s post-hoc; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. 
Abbreviations: CNPase, 2’,3’-cyclic nucleotide 3’-phosphodiesterase; MBP, myelin basic 
protein; NG2, chondroitin sulphate proteoglycan, neural/glial antigen 2; PDGFαR, platelet 
derived growth factor alpha receptor. 
 
Figure 5. Effect of RXRγ gene knock out in NSCs-derived OPCs differentiation 
 
(A) Experimental design: cell morphology and OLs markers expression were analysed in 
RXR+/+ and RXRγ-/- NSCs-derived OPCs cultures at the end of the differentiation process. 
Arrow show the time point of the analysis: 12 DIV. 
(B-C) Graphs show the percentage of APC-positive (B) and MBP-positive (C) cells in 
RXRγ+/+ (white column) and RXRγ-/- (grey column), foetal and adult cultures.  
(D-K) ) Images show APC- (D, E, H, I) and MBP- (F, G, J, K) stained cells in RXRγ+/+ (D-
G) and RXRγ -/- (H-K), in foetal (D, H, F, J) and adult (E, I, G, K) cultures. 
(L) Graph shows the OPCs/OLs population analysis, based on the APC/Olig1/Olig2 staining. 
Cells are divided in four different population, with crescent degree of maturation: APC-
/Olig1-/Olig2+; APC+/Olig1-/Olig2+; APC+/Olig1+/Olig2+ and APC+/Olig1+/Olig2-. 
Statistical analysis: One-way ANOVA followed by Dunnet’s post-hoc, on the RXRγ+/+ 
groups. Asteriscs represent differences between RXRγ-/- and RXRγ+/+ groups (* P < 0.5; ** 
P < 0.1; *** P < 0.01; **** P < 0.001).  
Bars represent mean value + SEM. Statistical analysis: Student’s t test (B, C), One-way 
ANOVA followed by Tukey’s post-hoc (L); * p < 0.05, *** p < 0.001, **** p < 0.0001. 
Abbreviations. APC, anti-adenomatous polyposis coli; MBP, Myelin basic protein; O1 
(Olig1), Oligodendrocyte transcription factor 1; O2 (Olig2), Oligodendrocyte transcription 
factor 2; OLs, oligodendrocytes. 
 
Figure 6. RXRγ role in differentiation and cell cycle 
 
(A) Experimental design. Foetal RXRγ+/+ and RXRγ-/- cultures gene expression was 
analysed 0, 6 and 24 (red arrow) hours after T3-induced differentiation. At the last time point 
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(red arrow) cells were also fixed and stained for PDGFαR and Ki67 in order to analyse the 
percentage of replicating OPCs. At the end of the differentiation process, cells were fixed and 
analysed for the percentage of NG2-positive cells in the culture (black arrow). 
(B) Gene expression analysis of five key genes involved in the differentiation process: TRa, 
TRb, Olig1, Olig2, Klf9. 
(C-E) Graph shows the percentage of the NG2-positive cells at the end of the differentiation 
process (12 DIV) in foetal RXRγ+/+ and RXRγ-/- cultures (C). Images represent RXRγ+/+ 
(D) and RXRγ-/- (E) NG2-stained cultures. 
(F-J) Graph shows the percentage of double positive PDGFαR/Ki67 cells on the total number 
of PDGFαR-positive cells, in vehicle- and T3-treated, RXRγ+/+ and RXRγ-/- cultures (F). 
Imges show vehicle- (G, H) and T3- (I, J) treated, RXRγ+/+ (G, I) and RXRγ-/- (H, J) 
cultures. 
Bars represent mean value + SEM. Statistical analysis: Two-way ANOVA followed by 
Tukey’s post-hoc (B), Student’s t test (C), One-way ANOVA followed by Tukey’s post-hoc 
(F); * p < 0.05, **** p < 0.0001. 
Abbrevaitions: Klf9, kruppel-like factor 9; NG2, chondroitin sulphate proteoglycan, 
neural/glial antigen 2; Olig1, Oligodendrocyte transcription factor 1; Olig2, Oligodendrocyte 
transcription factor 2PDGFαR, platelet derived growth factor alpha receptor; TRa, Thyroid 
hormone receptor alpha; TRb, thyroid hormone receptor beta. 
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Supplementary material 
 
GenBank Symbol Description 
NM_013464 Ahr Aryl-hydrocarbon receptor 
NM_013476 Ar Androgen receptor 
NM_009709 Arnt 
Aryl hydrocarbon receptor nuclear 
translocator 
NM_030147 Brd8 Bromodomain containing 8 
NM_009939 Cops2 
COP9 (constitutive photomorphogenic) 
homolog, subunit 2 (Arabidopsis thaliana) 
NM_001025432 Crebbp CREB binding protein 
NM_007840 Ddx5 
DEAD (Asp-Glu-Ala-Asp) box polypeptide 
5 
NM_007956 Esr1 Estrogen receptor 1 (alpha) 
NM_010157 Esr2 Estrogen receptor 2 (beta) 
NM_007953 Esrra Estrogen related receptor, alpha 
NM_011934 Esrrb Estrogen related receptor, beta 
NM_011935 Esrrg Estrogen-related receptor gamma 
NM_008228 Hdac1 Histone deacetylase 1 
NM_008229 Hdac2 Histone deacetylase 2 
NM_010411 Hdac3 Histone deacetylase 3 
NM_207225 Hdac4 Histone deacetylase 4 
NM_010412 Hdac5 Histone deacetylase 5 
NM_010413 Hdac6 Histone deacetylase 6 
NM_019572 Hdac7 Histone deacetylase 7 
NM_008261 Hnf4a Hepatic nuclear factor 4, alpha 
NM_026348 Itgb3bp 
Integrin beta 3 binding protein (beta3-
endonexin) 
NM_020005 Kat2b K(lysine) acetyltransferase 2B 
NM_178637 Kat5 K(lysine) acetyltransferase 5 
NM_013634 Med1 Mediator complex subunit 1 
NM_021521 Med12 
Mediator of RNA polymerase II 
transcription, subunit 12 homolog (yeast) 
NM_001080931 Med13 Mediator complex subunit 13 
NM_012005 Med14 Mediator complex subunit 14 
NM_198107 Med16 Mediator complex subunit 16 
NM_144933 Med17 Mediator complex subunit 17 
NM_011869 Med24 Mediator complex subunit 24 
NM_026119 Med4 
Mediator of RNA polymerase II 
transcription, subunit 4 homolog (yeast) 
NM_054081 Mta1 Metastasis associated 1 
NM_010881 Ncoa1 Nuclear receptor coactivator 1 
NM_008678 Ncoa2 Nuclear receptor coactivator 2 
NM_008679 Ncoa3 Nuclear receptor coactivator 3 
NM_019744 Ncoa4 Nuclear receptor coactivator 4 
NM_019825 Ncoa6 Nuclear receptor coactivator 6 
NM_011308 Ncor1 Nuclear receptor co-repressor 1 
NM_011424 Ncor2 Nuclear receptor co-repressor 2 
NM_019408 Nfkb2 
Nuclear factor of kappa light polypeptide 
gene enhancer in B-cells 2, p49/p100 
NM_023144 Nono 
Non-POU-domain-containing, octamer 
binding protein 
NM_010928 Notch2 Notch gene homolog 2 (Drosophila) 
NM_007430 Nr0b1 
Nuclear receptor subfamily 0, group B, 
member 1 
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NM_011850 Nr0b2 
Nuclear receptor subfamily 0, group B, 
member 2 
NM_145434 Nr1d1 
Nuclear receptor subfamily 1, group D, 
member 1 
NM_011584 Nr1d2 
Nuclear receptor subfamily 1, group D, 
member 2 
NM_009473 Nr1h2 
Nuclear receptor subfamily 1, group H, 
member 2 
NM_013839 Nr1h3 
Nuclear receptor subfamily 1, group H, 
member 3 
NM_009108 Nr1h4 
Nuclear receptor subfamily 1, group H, 
member 4 
NM_010936 Nr1i2 
Nuclear receptor subfamily 1, group I, 
member 2 
NM_009803 Nr1i3 
Nuclear receptor subfamily 1, group I, 
member 3 
NM_011629 Nr2c1 
Nuclear receptor subfamily 2, group C, 
member 1 
NM_011630 Nr2c2 
Nuclear receptor subfamily 2, group C, 
member 2 
NM_013708 Nr2e3 
Nuclear receptor subfamily 2, group E, 
member 3 
NM_010151 Nr2f1 
Nuclear receptor subfamily 2, group F, 
member 1 
NM_009697 Nr2f2 
Nuclear receptor subfamily 2, group F, 
member 2 
NM_010150 Nr2f6 
Nuclear receptor subfamily 2, group F, 
member 6 
NM_008173 Nr3c1 
Nuclear receptor subfamily 3, group C, 
member 1 
NM_001083906 Nr3c2 
Nuclear receptor subfamily 3, group C, 
member 2 
NM_010444 Nr4a1 
Nuclear receptor subfamily 4, group A, 
member 1 
NM_139051 Nr5a1 
Nuclear receptor subfamily 5, group A, 
member 1 
NM_010264 Nr6a1 
Nuclear receptor subfamily 6, group A, 
member 1 
NM_173440 Nrip1 Nuclear receptor interacting protein 1 
NM_008829 Pgr Progesterone receptor 
NM_011144 Ppara 
Peroxisome proliferator activated receptor 
alpha 
NM_011145 Ppard 
Peroxisome proliferator activator receptor 
delta 
NM_011146 Pparg 
Peroxisome proliferator activated receptor 
gamma 
NM_008904 Ppargc1a 
Peroxisome proliferative activated 
receptor, gamma, coactivator 1 alpha 
NM_133249 Ppargc1b 
Peroxisome proliferative activated 
receptor, gamma, coactivator 1 beta 
NM_008948 Psmc3 
Proteasome (prosome, macropain) 26S 
subunit, ATPase 3 
NM_008950 Psmc5 
Protease (prosome, macropain) 26S 
subunit, ATPase 5 
NM_009024 Rara Retinoic acid receptor, alpha 
NM_011243 Rarb Retinoic acid receptor, beta 
NM_011244 Rarg Retinoic acid receptor, gamma 
NM_009035 Rbpj 
Recombination signal binding protein for 
immunoglobulin kappa J region 
NM_013646 Rora RAR-related orphan receptor alpha 
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NM_011305 Rxra Retinoid X receptor alpha 
NM_011306 Rxrb Retinoid X receptor beta 
NM_009107 Rxrg Retinoid X receptor gamma 
NM_054089 Tgs1 
Trimethylguanosine synthase homolog (S. 
cerevisiae) 
NM_178060 Thra Thyroid hormone receptor alpha 
NM_009380 Thrb Thyroid hormone receptor beta 
NM_019797 Trip4 Thyroid hormone receptor interactor 4 
NM_009504 Vdr Vitamin D receptor 
NM_007393 Actb Actin, beta 
NM_009735 B2m Beta-2 microglobulin 
NM_008084 Gapdh 
Glyceraldehyde-3-phosphate 
dehydrogenase 
NM_010368 Gusb Glucuronidase, beta 
NM_008302 Hsp90ab1 
Heat shock protein 90 alpha (cytosolic), 
class B member 1 
 
Table 1 Gene list of the PCRarray for Nuclear Receptors and co-regulators 
GenBank codes, genes symbol and descriptionof gene analysed by PCR array for Nuclear Receptors and co-
regulators (Figure 1 ) are listed in the table. 
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4.3 In Vitro Testing of Biomaterials for Neural Repair: Focus on Cellular Systems and High-
Content Analysis (Baldassarro et al., 2016). 
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Abstract
Biomimetic materials are designed to stimulate speciﬁc cellular responses at the molecular level. To improve the
soundness of in vitro testing of the biological impact of new materials, appropriate cell systems and technologies
must be standardized also taking regulatory issues into consideration. In this study, the biological and molecular
effects of different scaffolds on three neural systems, that is, the neural cell line SH-SY5Y, primary cortical neurons,
and neural stem cells, were compared. The effect of poly(L-lactic acid) scaffolds having different surface geo-
metry (conventional two-dimensional seeding ﬂat surface, random or aligned ﬁbers as semi3D structure) and
chemical functionalization (laminin or ECM extract) were studied. The endpoints were deﬁned for efﬁcacy (i.e.,
neural differentiation and neurite elongation) and for safety (i.e., cell death/survival) using high-content analysis.
It is demonstrated that (i) the deﬁnition of the biological properties of biomaterials is profoundly inﬂuenced by
the test system used; (ii) the deﬁnition of the in vitro safety proﬁle of biomaterials for neural repair is also inﬂu-
enced by the test system; (iii) cell-based high-content screening may well be successfully used to characterize
both the efﬁcacy and safety of novel biomaterials, thus speeding up and improving the soundness of this critical
step in material science having medical applications.
Keywords: Good Laboratory Practice guidelines; neural cell lines; neural primary culture; neural stem cells
high-content analysis; poly(lactic acid)
Introduction
The potential applications of tissue engineering prod-
ucts for regenerative medicine in acute and chronic dis-
eases of the nervous system are quite wide. There is an
extensive literature aimed to compare the biological
impact of different scaffolds for neural repair, consider-
ing the chemical composition of the materials, architec-
ture, functionalization, etc.1 However, these studies
often brought to contradictory results when translated
in animals, and this could be at least partially due to
the different cell systems and readout technologies
used.2 In fact, key biological differences in the cellular
test systems (i.e., cellular composition, maturation
time, culture media composition, growth factor pro-
duction, etc.) make it very hard to compare results
and judge the ‘‘biomaterial effect on neural cells’’.3,4
Therefore, in this work we compared the biological
and molecular effects of different materials on three
cell systems commonly used for these purposes, that is,
the neural cell line SH-SY5Y, primary cortical neurons,
and neural stem/precursor cells (NSC). We investigated
glass substrates and poly(L-lactic acid) (PLLA) scaffolds
having different surface geometry (conventional two-
dimensional seeding [2D] ﬂat surface, random or aligned
ﬁbers as semi3D structure) and chemical functionaliza-
tion (laminin or ECM extract).
We investigated deﬁned endpoints for efﬁcacy (i.e.,
neural differentiation and neurite elongation) and
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safety (i.e., cell death/survival). We also introduced
high-content analysis compared with conventional bio-
chemical and morphological readout methods, and the
international guidelines for the ‘‘mutual acceptance of
data’’ for safety/toxicology tests (Organization for Eco-
nomic Co-operation and Development–OECD-).5,6
Materials and Methods
Detailed methods are provided in the Supplementary
Data, Materials and Methods section.
Materials
PLLA (Lacea H.100-E) (Mw= 8.4· 104 g/mol, PDI= 1.7)
was supplied by Mitsui Fine Chemicals. Dichlorome-
thane (DCM), dimethylformamide, dimethyl sulfoxide,
bovine serum albumin, laminin 1mg/mL, Triton, para-
formaldehyde, retinoic acid (RA), penicillin, and strep-
tomycin were purchased from Sigma-Aldrich and were
used without any further puriﬁcation. Hoechst 33258,
Cultrex basement membrane extract (Trevigen),
DMEM-F12, 1X Minimum Essential Medium/Non
Essential Aminoacids, and 1X Penicillin–Streptomycin pur-
chased from Gibco-Invitrogen, fetal bovine serum
(Euroclone), and NaOH 10mM (Carlo Erba) were used.
Cell substrates fabrication, characterization,
and chemical functionalization
PLLA ﬁlms were prepared by the solvent cast method,
from a 10% w/v polymer solution in DCM at room
temperature. Electrospun scaffolds were fabricated by
using a commercial electrospinning machine equipped
with a temperature and humidity control system (Spin-
bow S.r.l.). The electrospun scaffolds were character-
ized by means of scanning electron microscopy (SEM)
and static water contact angle (WCA) measurements.
Electrospun PLLA random and aligned scaffolds,
and PLLA-ﬁlm were cut and assembled by means of
CellCrown supports (Scaffdex) in a 24-well. Cover
glasses and electrospun were sterilized and functional-
ized with laminin and Cultrex BME.
Cell cultures
Human neuroblastoma SH-SY5Y cells were differ-
entiated on different surfaces (Cultrex-coated glass,
laminin-coated glass, laminin-coated or not PLLA-
FILM, laminin-coated or not random and aligned elec-
trospun PLLA scaffold) using 10lM RA and cultured
for 7 days.
Primary neurons were isolated from newborn mice
cortex and cytosine-arabinofuranoside (10lM; Sigma)
was added to the culture medium, to inhibit prolifera-
tion of the glial cells,7 and cultured for 15 days.
NSCs were obtained from embryos forebrain and
secondary neurospheres were dissociated and plated
at a density of 1 · 104 cells/cm2 in the same culture me-
dium without mitogens.8,9 To achieve full lineage com-
mitment and cell differentiation, seeded cells were
cultured for 15 days.
Animal care and treatment were in accordance with
the EU Directive 2010/63/EU and approved by the
Ethics Committee of Animal Experimentation, Univer-
sity of Bologna.
Viability assays
Cell viability was determined by high-content analysis
(HCS) as the percentage of pyknotic nuclei calculated
by Cellomics Compartmental Analysis BioApplica-
tion, using ‘‘population characterization’’ parameter.
MTT assay was performed on primary cortical neurons
seeded on 2D Cultrex-coated surface and semi3D-
aligned uncoated scaffolds. Absorbance was measured
at 570 nm.
Immunocytochemistry
Cells were ﬁxed with 4% paraformaldehyde. Cell-
speciﬁc proteins were identiﬁed by indirect immuno-
ﬂuorescence using mouse anti-b-III-tubulin (1:2000;
R&D Systems); rabbit anti-GFAP (1:500; Dako) and
rabbit anti-MBP (1:250; Dako) antisera. The anti-
rabbit DyLight 568- and anti-mouse AlexaFluor 488-
labeled (1:500; Invitrogen) were used as secondary
antisera. For nuclear staining, cells were incubated
with 1 lg/mL Hoechst 33258.
Fluorescence microscopy, image analysis, and HCS
Fluorescence images were taken with 10X objective
(10X/0.45 N.A. Plan Fluor Nikon) using NIKON
Eclipse E600 (Nikon) equipped with digital CCD cam-
era QImaging Retiga 20002V (QImaging), and ana-
lyzed using Imaging NIS Elements software (Nikon).
To analyze neurites outgrowth of SH-SY5Y cells, the
length of individual neurites in each acquired images
was measured. Each sample was repeated twice and
data were expressed as mean length– SEM.
HCS was performed using CellInsight NXT (Thermo
Scientiﬁc) equipped with digital CCD camera Photo-
metric X1. All images were taken with 10X objective
(10X/0.30N.A. Plan Fluor Olympus) using 4· 4 bin-
ning (552· 552) and analyzed using Cellomics Scan
Version 6.4.4 (Thermo Scientiﬁc). For each well
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examined, multiple ﬁelds were sampled. Within each
ﬁeld, matched ﬂuorescent images of Hoechst-labeled
nuclei, b-III-tubulin/AlexaFluor 488-labeled cells were
acquired using 386/23 (Channel1), 485/20 (Channel2)
ﬁlters, respectively. Neurite analysis was performed
with Cellomics Neuronal Proﬁling BioApplication.
Identiﬁcation of nuclei, cell bodies, and neurites was
optimized using 10 representative images for each con-
dition tested.
Lineage analysis was performed by Cellomics Com-
partmental Analysis BioApplication, using ‘‘population
characterization.’’ After the nuclei identiﬁcation, the
user chooses the area around the nucleus and the ﬂuo-
rescence intensity threshold.
Statistical analysis
The study design included at least three independent
experiments and data reported in graphs are the
mean – standard deviation (SD) of the different exper-
iments. Statistical testing was performed with ANOVA
followed by appropriate post-hocmultiple comparisons
test (see legend to the ﬁgures for details). Student’s
t-test was also used. A probability level of p< 0.05
was considered to be statistically signiﬁcant.
Results
The following variables were included in the study: (A)
materials and topography of cell substrates: conven-
tional glass/plastic 2D, semi three-dimensional random
electrospun PLLA scaffolds (semi3D, random) and
semi three- dimensional aligned electrospun PLLA
scaffolds (semi3D, aligned); (B) substrate chemical
functionalization: no-coating, laminin coating of the
above materials and whole ECM extract coating of
the above materials; (C) neural cell type: SH-SY5Y neu-
ral differentiated cell line, primary cortical neurons,
and neural stem cells; (D) assay and technologies for
toxicology testing: conventional low-throughput and
cell-based high throughput screening.
Scaffold fabrication and chemical functionalization
PLLA ﬁlms and electrospun ﬁbrous scaffolds were fab-
ricated to study the inﬂuence of substrate topography
on neuron viability and differentiation. Scaffolds
made of random and aligned ﬁbers were compared
(Fig. 1A,B). PLLA ﬁbers without bead defects were
obtained with comparable micrometric mean diame-
ters (semi3D-random: 1.8 – 0.4 lm; semi3D-aligned:
1.8 – 0.6lm). To improve wettability and, thus, bio-
compatibility of the polymer, electrospun scaffolds
were coated with ECM proteins, that is, laminin
(Fig. 1C), and the ECM extract Cultrex containing lam-
inin, collagen IV, entactin, and heparin sulfate proteo-
glycan (Fig. 1D).
In both cases, the morphology of the coated ﬁbers
did not appear to be signiﬁcantly altered by the ECM
proteins, and the coating was found to cover quite ho-
mogeneously the ﬁber surface (Fig. 1K,N), without
modifying the porous structure of the scaffold.
To investigate the surface hydrophilicity of the scaf-
folds, WCA measurements were performed and results
are shown in Figure 2A,B, where the meanWCA values
are reported for all investigated samples, together with
the representative behavior of the WCA versus time
for selected samples and the water drop images corre-
sponding to a highly hydrophobic (top), intermediate
(middle), and hydrophilic (bottom) scaffold. As
expected, the semi3D-random and the semi3D-aligned
electrospun scaffolds show a similar hydrophobic be-
havior with aWCA higher than that of the correspond-
ing PLLA ﬁlm (Fig. 2A), due to their high porosity and
air entrapment into pores. Laminin and ECM treat-
ment dramatically lowered theWCA of the electrospun
scaffolds (Fig. 2A,B), whereas the laminin coating of
the PLLA ﬁlm increased only slightly the hydrophilic-
ity (Fig. 2A). In the semi3D-laminin-coated scaffold
and semi3D-Cultrex-coated scaffold the water drop
was spread out instantaneously and immediately pene-
trated into the scaffold, resulting in a change of the
WCA from about 120 to about 20 (or lower) in less
than 10 sec.
Figure 1E–P illustrates cell deposition (SH-SY5Y) on
the semi3D-uncoated (E–J) and laminin-coated (K–P)
PLLA scaffolds, having random (E–G; H–J) and aligned
(K–M; N–P) topography, as visualized by conventional
microscopy (E, H, K, N) and HCS (F, G, I, J, L, M, O, P).
Scaffolds and neural differentiation
The biological properties of the three different neural
systems included in the study were compared on the
different 2D/ semi3D substrates and functionaliza-
tion, in the same experimental assay and using high-
throughput analysis. Neurite elongation was taken as
primary endpoint for morphological maturation
using the cytoskeleton marker b-III-tubulin.
The use of HCS automatic procedure versus conven-
tional computerized morphometry was ﬁrst validated
on semi3D cell systems using SH-SY5Y grown on
laminin-coated and uncoated random electrospun
scaffolds (Fig. 3A). For conventional morphometry,
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FIG. 1. Scaffold characterization: morphology and cell seeding. SEM micrographs of (A) semi3D-random
scaffold; (B) semi3D-aligned scaffold; (C) semi3D-random scaffold coated with laminin; (D) semi3D-random
scaffold coated with Cultrex. Scale bar: 10 lm. (E–P) Conventional ﬂuorescence micrographs showing the SH-
SY5Y cell deposition (labeled by b-III-tubulin) on the semi3D uncoated (E–J) and laminin-coated (K–P; laminin
is in red) PLLA scaffolds, having random (E–G; K–M) and aligned (H–J; N–P) topography (E, H, K, N); HCS
visualization of the same cell preparations (semi3D, uncoated, random: F,G; semi3D, uncoated, aligned: I,J;
semi3D, laminin-coated, random: L,M; semi3D, laminin-coated, aligned: O,P). HCS, high-content analysis;
PLLA, poly(L-lactic acid); SEM, scanning electron microscopy.
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FIG. 2. Scaffold characterization: wettability. (A) mean WCA values; (B) representative WCA behavior
for semi3D-random scaffold (white diamonds), semi3D-random scaffold laminin coated (black diamonds),
PLLA-FILM (black squares) and PLLA-FILM laminin coated (white squares); representative images of the water
drop are also reported. WCA, water contact angle.
FIG. 3. Effect of different scaffolds on neural differentiation. (A) Neurite length of SH-SY5Y cells grown on
different scaffolds, as measured by conventional quantitative microscopy and HCS. (B) Neurite length of
SH-SY5Y cell line, as measured by HCS; (C) Neurite length of primary cortical neurons, as measured by HCS;
(D) Neurite length of neurons derived from NSCs, as measured by HCS. In all cell systems, conventional 2D,
semi3D-random and semi3D-aligned scaffolds having different coatings are compared. Data are expressed as
mean – SD, and represent the mean of three independent experiments. Statistical analysis: two-way ANOVA
(SH-SY5Y F[9, 100] = 5.165; primary cortical neurons F[14,45] = 6.317; NSCs F[18,60] = 15.40) followed by Tukey’s
post hoc test. Asterisks represent the difference between the semi3D group versus the relative 2D control group
within the same DIV (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001), letters indicate the difference between
coated semi3D groups versus the relative uncoated semi3D control group (a = p < 0.05; b = p < 0.01;
d = p < 0.0001). 2D, two-dimensional seeding; SD, standard deviation.
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at least nine different ﬁelds were taken to obtain a min-
imum number of 300 neurites (200 cells), whereas for
HCS analysis all the cells (a mean of 100,000 cells)
were analyzed. The mean length of neurites obtained
with the two techniques was equivalent and, as
expected in view of the larger number of cells analyzed,
the SD derived from HCS analysis was four times
smaller compared with conventional morphometry.
We then compared the neurite elongation of the
three different neural cells by using HCS. Results are
presented in Figure 3, where panel B refers to SH-
SY5Y, panel C to primary neurons, and panel D to neu-
ral stem cells. In each graph, results are grouped
according to the topographic conditions (2D, semi3D
random, semi3D aligned), chemical functionalization
(PLLA alone, laminin, Cultrex, as indicated in the
graphs), and maturation times (3, 7, 15DIV). The sta-
tistical analysis is reported in the ﬁgure legend.
In all topographic conditions PLLA alone im-
pairs neurite elongation in all cell systems, whereas
chemical functionalization with ECM extract favors
neurite elongation of both SH-SY5Y and NCSs, an ef-
fect that is maximized by alignment. Conversely and
regardless of the chemical coating of the PLLA scaf-
fold, semi3D topography impairs maturation of pri-
mary cortical neurons. Actually, while SH-SY5Y
cells attach to 2D PLLA and then survive, primary
neurons and NSC do not attach to 2D PLLA. Notably,
semi3D topography seems to overcome this problem
even in the absence of chemical coating with ECM ex-
tracts or proteins. Moreover, aligned PLLA clearly
directs the neurite elongation in a fashion parallel to
the ﬁbers.
Scaffolds and glial/neuronal lineage
The capability of PLLA to inﬂuence cell lineage in
primary cultures (Supplementary Fig. S1) and NSCs
(Fig. 4) was then investigated, both as a chemical entity
and as regards the topographic arrangement. In both
cell systems, the semi3D PLLA arrangement strongly
increases the percentage of astrocyte (GFAP-positive
cells) in the culture, both at early (3DIV) and late
(7DIV) time in culture. Chemical functionalization
does not substantially modify the astroglial fate from
NSC, whereas it decreases the PLLA effect in primary
neurons. In the same experimental conditions, also the
oligodendroglial lineage and maturation was analyzed
by evaluating the percentage of cells expressing MBP,
which is a protein expressed in terminally differentiated
oligodendrocytes (Fig. 5). First of all, it was observed
that the PLLA coating of 2D substrate completely pre-
vents adhesion of oligodendrocyte precursors, and so
nomature cells are observed. Semi3D topography allows
a better adhesion, and Cultrex coating maximizes the ef-
fect of topography. However, it should be mentioned
that the culture conditions were optimized for neural
differentiation, and so chemical agents known to im-
prove oligodendroglial lineage and maturation were
not included in the culture medium.
Effect of scaffolds on cell viability
Safety and toxicology testing is a critical step in the bio-
materials development as required by the regulatory
agencies. We ﬁrst evaluated the possibility of applying
HCS to semi3D cell systems to determine cell viability
compared with conventional biochemical methods.
Both MTT and HCS-based nuclear morphology indi-
cate that the semi3D-aligned ﬁbers strongly reduce
cell survival (Supplementary Fig. S2). HCS was then
used to study the toxicity of materials on SH-SY5Y, pri-
mary neurons, and neural stem cells, by evaluating the
percentage of pyknotic nuclei over all seeded cells.
Results are presented in Figure 6, grouped according
to the effect of different scaffolds and substrates on
SH-SY5Y (A), primary cortical neurons (B), and neural
stem/progenitor cells (C). A mean of 300,000 cells/
wells, three wells/condition were included in the anal-
ysis (mean cell number in each analysis was 900,000
cells/group). In 2D conventional culture conditions,
cells from the different systems display substantial dif-
ferences in viability. Viability of SH-SY5Y cells is not
affected by any of the investigated experimental condi-
tions (Fig. 6A), whereas primary cortical neurons show
a higher spontaneous cell death even when grown in
ideal culture conditions (Cultrex) (percentage of
pyknotic nuclei on 2D Cultrex-coated glass: SH-SY5Y
0.26 – 0.07; primary cortical neurons 9.10– 0.59; p<
0.0001). The impact of semi3D topography on cell via-
bility was then examined by comparing the semi3D
(e.g., PLLA scaffolds) versus the relative 2D (e.g., con-
ventional glass/plastic seeding) control group at the
same DIV (asterisks), whereas the effect of the coating
was analyzed by comparing the semi3D-coated versus
the related uncoated semi3D control group (letters),
by one-way ANOVA followed by the Tukey’s test.
When using NSCs as cell system, a dramatic effect
of semi3D PLLA scaffold on cell viability is observed
in fully differentiated cells, when PLLA random and
aligned ﬁber distribution causes 20% and 40% cell
death, respectively (Fig. 6C). Notably, both laminin
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FIG. 4. Effect of different scaffolds in the neural and astroglial speciﬁcation of NSCs. (A, B) Representative
images of plated NSCs at 7DIV grown on 2D (A) and semi3D scaffolds (B), stained with b-III-tubulin (green), GFAP
(red) and Hoechst (blue). (C, D) The graphs indicate the percentage of GFAP (C) and b-III-tubulin (D)-positive cell,
according to the PLLA topography and coating. Data are expressed as mean– SD, and represent the mean of
three independent experiments. Statistical analysis: two-way ANOVA (GFAP F[7, 32]= 3.404; b-III-tubulin F[7,
30]= 7.136) followed by Tukey’s post test. Asterisks represent the difference between the semi3D group versus
the relative 2D control group within the same DIV (*p< 0.05; **p< 0.01; ***p< 0.001; ****p< 0.0001).
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and Cultrex functionalization protects cell viability al-
most completely.
Discussion
In this study, we showed that the effect of biomaterials
on both neuron viability and differentiation is strongly
inﬂuenced by the cellular system used for the test. We
also showed that cell-based HCS technology can be ap-
plied to biomaterial in vitro testing, thus improving ro-
bustness and statistical consistency of the results.
The right cell-culture has actually been recognized as
one of the six most important technical determinants of
project success and pipeline quality by the pharmaceuti-
cal industry.10We then tested the effect of PLLA scaffold
on viability and differentiation using three cell sys-
tems widely used in the ﬁeld, that is, the SH-SY5Y cell
line, cortical primary neurons, and neural stem cells.
The SH-SY5Y neuroblastoma cell line is derived from
human tissue, can be easily differentiated toward a
neuronal-like cell line, and is a widely available, easy-
to-handle, and highly reproducible system.11 However,
its sensitivity to a wide range of toxic stimuli is lower
compared with primary neurons,12 and neurite out-
growth may be different from that occurring in primary
neurons.13,14 Primary neurons and neural stem cells are
more physiologically signiﬁcant and the possibility of
FIG. 5. Effect of different scaffolds on oligodendroglial speciﬁcation of NSCs. (A, B) Representative images of
plated NSCs at 7DIV grown on 2D (A) and semi3D scaffolds (B), stained with MBP (red) and Hoechst (blue).
(C) The graph represents the percentage of MBP positive cells. Data are expressed as mean – SD, and represent
the mean of three independent experiments. Statistical analysis: two-way ANOVA (F[7, 28] = 4.739) followed by
Tukey’s post test. Asterisks represent the difference between the semi3D group versus the relative 2D control
group within the same DIV (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001).
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FIG. 6. Effect of different scaffolds on cell viability of SH-SY5H cell line (A), primary cortical neurons (B), and
NSCs (C). The graphs represent the percentage of pyknotic nuclei measured using HCS technology. Data are
expressed as mean– SD, and represent the mean of three independent experiments. Statistical analysis: two-
way ANOVA (n= 3; SH-SY5Y F[9, 60] = 5.682; primary cortical neurons F[14, 40] = 4.164; NSCs F[18, 60] = 23.57)
followed by Tukey’s post test. Asterisks represent the difference between the semi3D group versus the relative
2D control group within the same DIV (*p < 0.05; ***p < 0.001; ****p < 0.0001), letters indicate the difference
between coated semi3D groups versus the relative uncoated semi3D control group (a = p < 0.05; b = p < 0.01;
d = p < 0.0001).
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false positives and negatives is smaller compared with
cell lines, thus meeting the basic requirement for
in vitro safety testing, that is, to represent the in vivo sit-
uation as closely as possible. However, both require se-
lective skills for handling and result interpretation.15,16
The most relevant result from this study is the differ-
ent safety proﬁles of the same biomaterial obtained
using different neural systems. While viability of SH-
SY5Y cells is not modiﬁed by the substrates, either
primary neurons and neurons derived from stem cell
showed a very high degree of mortality on PLLA,
that is almost completely prevented by chemical coat-
ing with ECM proteins. This result also has implica-
tions to establish the appropriate guidelines to test
the safety-proﬁle of the materials and fabrication for
regulatory decision makers.3,17
On the contrary, the effect of PLLA scaffold on dif-
ferentiation, as established by neurite elongation and
branching, is quite similar in all neural cell types. In
particular, it was demonstrated that all three cell sys-
tems are negatively affected by the PLLA uncoated
scaffolds in terms of neurite length, but that ECM pro-
tein coating differentially affects the neuron maturation
process. Cultrex coating strongly favors neurite elonga-
tion of SH-SY5Y cells on semi3D scaffolds, whereas
semi3D surfaces, whether coated or not, negatively af-
fect the neurite elongation of primary cortical neurons.
Conversely, PLLA scaffolds impair the neurite elonga-
tion of neurons derived from NSCs, but this effect is
exceeded by Cultrex coating. As already reported,18–20
aligned ﬁbers display the best ability to guide cell orienta-
tion. Our results conﬁrm that the incorporation of ECM
molecules favors biological processes, such as cell adhe-
sion, neurite elongation, and cell differentiation.21–27
However, the different cell compositions in primary
cultures and NSC might also be considered. Primary
neurons and NSC-derived neurons contain a different
percentage of astrocytes, also according to the chemis-
try and topography of the substrate. In the same condi-
tions in which we observed an increased percentage of
astroglial fate from NSC, also an increase in neurite
length was observed, thus raising the question of
whether this is because of a direct effect of the topogra-
phy and chemistry of the culture substrate, or to an in-
direct effect due to the supporting action of astrocytes
on neurons. Astroglial cells actually attach more
strongly to microfabricated pillars than to smooth sub-
strates,28 and the presence of more astrocytes in the test
system could itself affect neuronal maturation, neurite
elongation, and branching.
Conclusions
Improving the standards for basic and preclinical re-
search is a recognized need to overcome the weakness
that pervades the current system of basic and preclini-
cal research, and to increase reproducibility in sci-
ence.4,29–31 The statistical consistency of the in vitro
data could be improved by the extensive use of high-
throughput techniques compared with low-throughput
conventional analysis. Cell-based high-throughput
technology combining cellular imaging with high-
throughput data analysis,14 is successfully applied to
drug screening,32,33 and it was also used to set up stan-
dard procedures according to the ECVAMGood Cellu-
lar Culture Practice guidelines.34 In this study we used
HCS, combining in the same assay the safety proﬁle
(i.e., nuclear morphology) with the efﬁcacy proﬁle
(i.e., neurite elongation). We conﬁrmed that HCS is a
quite robust technological platform for in vitro testing
for materials35 that can truly improve the pipeline of
‘‘third-generation biomaterials’’ development.36
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Poly (ADP-ribose) polymerase (PARP) familymembers are ubiquitously expressed and play a key role in cellular
processes, including DNA repair and cell death/survival balance. Accordingly, PARP inhibition is an emerging
pharmacological strategy for cancer and neurodegenerative diseases. Consistent evidences support the critical in-
volvement of PARP family members in cell differentiation and phenotype maturation. In this study we used an
oligodendrocyte precursor cells (OPCs) enriched system derived from fetal and adult brain to investigate the
role of PARP in OPCs proliferation, survival, and differentiation. The PARP inhibitors PJ34, TIQ-A and Olaparib
were used as pharmacological tools. The main results of the study are: (i) PARP mRNA expression and PARP ac-
tivity are much higher in fetal than in adult-derived OPCs; (ii) the culture treatment with PARP inhibitors is cy-
totoxic for OPCs derived from fetal, but not from adult, brain; (iii) PARP inhibition reduces cell number, according
to the inhibitory potency of the compounds; (iv) PARP inhibition effect on fetal OPCs is a slow process; (v) PARP
inhibition impairs OPCs maturation into myelinating OL in fetal, but not in adult cultures, according to the inhib-
itory potency of the compounds. These results have implications for PARP-inhibition therapies for diseases and
lesions of the central nervous system, in particular for neonatal hypoxic/ischemic encephalopathy.
© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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1. Introduction
Oligodendrocytes, the cells wrapping the axons of the central ner-
vous system (CNS) with the myelin sheath, derive from the oligoden-
drocyte precursor cells (OPCs) generated during development from
multipotent neuroectodermal derivatives in the cortex and spinal cord
(Bergles and Richardson, 2015). These cells proliferate and migrate to
populate the entire adult CNS, where they account for approximately
5–8% of the entire cell population (Dawson et al., 2003). New OPCs
can be also generated in the adult CNS from neural stem cells (NSCs;
Agathou et al., 2013) and bymitosis, as OPCs are themajor proliferating
population of the CNS under appropriate stimuli (Fernandez-Castaneda
and Gaultier, 2016). These cells are responsible for myelin formation
during development (Bergles and Richardson, 2015), and for myelin
turnover and repair during adulthood (Young et al., 2013).
The process of myelin formation is highly orchestrated in time and
space, involves different cell types, and a key step of this process is the
OPC maturation toward myelinating oligodendrocyte (Zuchero and
Barres, 2013). Internal and external cues targeting genetic, epigenetic
and cytoplasmic mechanisms provide the appropriate microenviron-
ment that regulates the molecular machinery triggering OPCs out of
the cell cycle to terminal differentiation (Zuchero and Barres, 2013;
Liu et al., 2016; Fernández et al., 2016).
It has been suggested that remyelination after lesions in the adult
CNS recapitulates developmental myelination (Franklin and Hinks,
1999). However, substantial differences could well be expected be-
tween a normal turnover process and a repair process (Fancy et al.,
2011) triggered by pathological events like inﬂammation and hypoxic/
ischemic damage. These events actually mobilize a large number of in-
hibitory factors leading to a differentiation block of OPC (Gaesser and
Fyffe-Maricich, 2016). Thus, there is an urgent need tomore clearly elu-
cidate the molecular bases of the relationship between OPCs prolifera-
tion and differentiation, carefully dissecting developmental
myelination vs. myelin turnover in adulthood, and physiological vs.
pathological conditions.
In the present study, we investigated the role of poly(ADP-ribose)
polymerases (PARPs) in OPCs survival, proliferation and differentiation.
PARPs are members of nuclear enzyme family that catalyse the forma-
tion of (ADP-ribose)n chains from NAD+ on acceptor proteins after
DNA double strands breaks (Amé et al., 2004). Because of the PARPs
well described role in DNA repair and apoptosis induction (Heeres and
Hergenrother, 2007), PARPs inhibition is currently considered a
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therapeutic option for cancer, including glioblastoma (Curtin and Szabo,
2013). Moreover, PARPs inhibition was proposed as a neuroprotec-
tive strategy for neonatal asphyxia and hypoxia/ischemia encepha-
lopathy (Neira-Peña et al., 2015), a CNS injury that occurs during a
critical period of developmental myelination (Dimou and Götz,
2014). In order to study the effect of PARP inhibition in all stages of
differentiation, from NSCs to mature oligodendrocytes, we used
OPCs-enriched cultures obtained from the fetal forebrain- and the
adult sub-ventricular zone of the mouse to study the different role
of PARPs in adult and fetal OPCs differentiation and maturation. We
used PARP inhibitors having a different inhibitory concentration as
pharmacological toll, including the clinically approved Olaparib
(LYNPARZA™).
2. Materials and methods
2.1. Cell cultures
All animal protocols described herein were carried out according to
the European Community Council Directives (86/609/EEC), and comply
with the guidelines published in the NIH Guide for the Care and Use of
Laboratory Animals.
Fetal and adult NSCs were isolated from E.13–14 fetal mouse fore-
brain or 2.5 month old mice sub-ventricular zone (SVZ), following the
Ahlenius and Kokaia protocol (Ahlenius and Kokaia, 2010). Oligoden-
drocyte differentiation was performed following the Chen protocol
(Chen et al., 2007)with somemodiﬁcations. Tissueswere enzymatically
dissociated using trypsin (SIGMA), hyaluronidase (SIGMA) and DNase
(SIGMA), than mechanically dissociated by piepetting. The solution
was ﬁltered, centrifuged and the resulting pellet was washed twice in
HBSS. After 7min centrifugation at 400×g, the cellular pellet was resus-
pended in serum-free medium (DMEM/F12 GlutaMAX 1×; 8 mmol/L
HEPES; 100 U/100 μg Penicillin/Streptomycin; 0.1 × B27; 1 × N-2;
20 ng/ml bFGF; 20 ng/ml EGF) and, after cell count, cells were plated
in suspension at a density of 10 cells/μl in a ﬁnal volume of 3 ml in
low-attachment 6-well plates (NUNC). Half medium was changed
every three days, centrifuging the cell suspension at 300 ×g for 5 min
and gently resuspending the cellular pellet in fresh medium.
Neurosphereswere allowed to proliferate until they attained a diameter
of about 100 μm.
To obtain oligospheres, primary neurospheres were centrifuged at
300 ×g for 5 min. The pellet was mechanically dissociated by pipetting
and cells were counted and plated again at a density of 10 cells/μl in a
ﬁnal volume of 3 ml of OPCs medium (DMEM/F12 GlutaMAX 1×;
8 mmol/L HEPES; 100 U/100 μg Penicillin/Streptomycin; 0.1 × B27;
1 × N-2; 20 ng/ml bFGF; 20 ng/ml PDGF) in low-attachment 6-well
plates (NUNC). Oligospheres were centrifuged and the pellet was me-
chanically dissociated to obtain a single cell suspension. After cell count,
cells were plated at a density of 3000 cells/cm2 on poly-D,L-ornithine
(50 μg/ml)/laminin (5 μg/ml) coating, in OPC medium.
In order to induce oligodendrocyte differentiation and maturation,
after 3 DIVs OPCmediumwas replacedwith the oligodendrocyte differ-
entiation medium (DMEM/F12 GlutaMAX 1×; 8 mmol/L HEPES;
100 U/100 μg Penicillin/Streptomycin; 0.1 × B27; 1 × N-2; 50 nM T3;
10 ng/ml CNTF; 1× N-acetyl-L-cysteine-NAC-).
2.2. PARP inhibitor treatments
The following PARPi (PARP inhibitors) were used in this study: TIQ-
A (IC50 140–450 nM), PJ34 (IC50 20 nM) and Olaparib (IC50 5 nM;
Ferraris, 2010; Hans et al., 2011). OPCs were treated 24 h before the
T3-mediated differentiation induction (−1 DIV), and cell viability was
analysed at DIV 12 of differentiation (Fig. 1A). In order to study effects
of PARPi on fetal and adult cultures, different treatment were per-
formed: i) in order to study PARP1–2 expression and PARP activity,
cells were analysed 24 h after treatment (DIV 0; Fig. 1A); ii) a dose-
response curve of PARPi were performed, treating cultures with a series
of 7 concentrations (0–10 μM). PARPi treatments weremaintained after
the oligodendrocyte differentiation medium change, until DIV 12 (Fig.
2A); iii) fetal cultures were also treated with PJ34 10 μM and analysed
for cell number and cell death at DIV 0, 6 and 12 (Fig. 3A); iv) both
fetal and adult cultures were treated with lower dose of PARPi (1 μM
and 10 μM) and analysed for mature oligodendrocytes at DIV 12 (Fig.
4A).
2.3. Immunocytochemistry
Indirect immunoﬂuorescence was used to identify OPCs (NG2-posi-
tive cells), mature (CNPase-positive cells) and myelinating (MBP-posi-
tive cells) OLs, neurons (β-III-tubulin-positive cells) and astrocytes
(GFAP-positive cells). The following primary antisera were used:
mouse anti-β-III-tubulin (R&D system, Trento, Italy) 1:3000; rabbit
anti-GFAP (Glial Fibrillary Acidic Protein, Dako) 1:1000; rabbit anti-
NG2 (chondroitin sulphate proteoglycan, neural/glial antigen 2,
Millipore, Merck S.p.a., Milan, Italy) 1:350; mouse anti-CNPase (2′, 3′-
cyclic nucleotide 3′-phosphodiesterase, Millipore) 1:500; rabbit anti-
MBP (Myelin Basic Protein, Dako) 1:500. Donkey Alexa 488-conjugated
anti mouse and donkey Alexa 568-conjugated anti-rabbit (Invitrogen)
were used as secondary antisera. After immunoﬂuorescence staining,
cells were incubated with the nuclear dye Hoechst 33,258 (1 μg/ml in
PBS, 0.3% Triton-X 100) for 20 min at RT. Cells were ﬁnally washed in
PBS and mounted in glycerol and PBS (3:1, v/v) containing 0.1%
paraphenylendiamine.
2.4. High content screening
For HCS analysis cells were grown in 96 ﬂat-bottomwell HCS plates
(NUNC). Analysis of condensed nuclei, cell number and lineage/differ-
entiationmarkerswere performedwith Cell Insight™ CX5High Content
Screening (HCS; Thermo Scientiﬁc), using the Compartmental analysis
BioApplication. Based on nuclear staining, the software is able to recog-
nise nuclei and calculate the percentage of high intensity/small sized
condensed nuclei. Moreover, based on the nuclei identiﬁcation, the soft-
ware is able to detect the presence of the marker-speciﬁc stain in the
cell body, calculating the percentage of the immunoreactive cells. Line-
age/differentiationmarkers analysis was performed only on cells show-
ing intact nuclei, excluding condensed nuclei from the percentage
calculation.
2.5. RNA isolation and reverse transcription
Total RNA isolation was performed by using the RNeasy Mini kit
(Qiagen, Milan, Italy) following manufacturer's instructions. Total RNA
was eluted in RNase Free Water and concentration estimated through
absorbance values at 260, 280 and 320 (Nanodrop 2000 spectropho-
tometer, Thermo Scientiﬁc). First strand cDNAs were obtained using
the iScript™ cDNA Synthesis Kit (BioRad), incubating samples at 42 °C
for 30 min. An RNA sample with no reverse transcriptase enzyme in
the reaction mix was processed as a no-reverse transcription control
sample.
2.6. Semi-quantitative real-time PCR
Semi-quantitative real-time PCR was performed using the CFX96
real-time PCR system (BioRad, CA, USA). The reactions were performed
in a ﬁnal volume of 20 μl consisting of 1× SYBR Green qPCRmaster mix
(BioRad) and 0.4 μM forward and reverse primers. In order to avoid pos-
sible contamination of genomic DNA in isolated RNA, the no-reverse
transcriptase sample was processed in parallel with the others and test-
ed by real-time PCR for every pair of primers used. All primers
used were designed using Primer Blast software (NCBI, MD, USA) and
synthesised by IDT (Coralville, IA, USA). The following primer
55V.A. Baldassarro et al. / Stem Cell Research 22 (2017) 54–60
sequences were used: PARP-1 (FW: 5′-GCCACACATCTCAGGGAGAC-3′;
REV: 5′-CCCAAACCTTTGACACTGTGC-3′), PARP-2 (FW: 5′-
GAAGGACGCAGACAGGACAA-3′; REV: 5′-ACATGAGCCTTTCCCAGCTT-
3′). GAPDH (FW: 5′-GGCAAGTTCAATGGCACAGTCAAG-3′; REV: 5′-
ACATACTCAGCACCAGCATCACC-3′) was used as housekeeping gene to
normalize the amount of reverse-transcribed RNA used for PCR.
Thermal proﬁle of PCR reactions consisted ﬁrst of a denaturation step
(95 °C, 2 min) and 40 cycles of ampliﬁcation (95 °C for 15 s and 60 °C
for 60 s). At the end of the ampliﬁcation cycles themelting curve of am-
pliﬁed products was performed according to the following tempera-
ture/time scheme: heating from 55 °C to 95 °C with a temperature
increase of 0.5 °C/s.
Primers efﬁciency values for all primerswere 95–102%. The 2(−ΔΔCT)
method was used for the calculation of gene expression.
2.7. PARP activity assay
Fetal and adult OPCs at DIV 0, after 24 h of PARPi treatment, were
lysed and proteins were quantiﬁed using the Lowry method (BioRad)
following the manufacturer's instruction. PARP enzymatic activity was
measured using HT Colorimetric PARP Apoptosis Assay Kit (Trevingen),
following manufacturer's instructions.
2.8. Statistical analysis
Data are reported as mean ± SD. Prism software (GraphPad) was
used for statistical analyses and graph generation. Student's t-test or
one-way ANOVA and Dunnett's multiple comparison post-hoc were
used to analyse data. Results were considered signiﬁcant when
the probability of their occurrence as a result of chance alone was b5%
(P b 0.05).
3. Results
3.1. PARP expression and activity in fetal and adult OPCs
The cell systems used in this study are presented in Fig. 1. After cell
expansion as neurospheres and oligospheres, cells were seeded for 3
DIVs inOPCmedium, and then differentiated for 12 days in the presence
of T3 (Fig. 1A). Lineage progression from NG2-positive OPC (DIV0)
through CNPase-mature OL as far as myelinating MBP-positive OL is il-
lustrated in Fig. 1C–E (representative images). The culture composition
changes during the 12 DIV differentiation period, starting from DIV0,
where the majority of cells are NG2 positive (NG2-positive cells 80%;
CNPase-positive cells 5%), passing thorough DIV 6, where CNPase cells
are growing in number (NG2-positive cells 60%; CNPase-positive cells
Fig. 1. PARP activity and expression in OPCs-enriched cultures. (A) Experimental design: in order to study PARPmRNA expression and activity, cells were treated for 24 h, formDIV−1 to
DIV 0, with PJ34 10 μM. Arrow shows the time point of the represented analysis. Vehicle treated cells were also cultured for 12 DIV after T3-differentiation induction. Gray rectangles
represent T3 exposure phase. (B) Fetal and adult OPC culture composition at 12 DIV. Speciﬁc markers were used in order to visualize neurons (beta-III-tubulin), astrocytes (GFAP; Glial
Fibrillary Acidic Protein), OPCs (NG2; chondroitin sulphate proteoglycan, neural/glial antigen 2), Mature oligodendrocytes (CNPase; 2′,3′-cyclic nucleotide 3′-phosphodiesterase) and
myelinating oligodendrocytes (MBP; myelin basic protein). (C–E) Representative images of oligodendrocyte maturation at 0, 6 and 12 DIV. Bar: 40 μm. (F–G) PARP1 and 2 mRNA level
quantiﬁcation in vehicle-treated cells (F) and in cells exposed for 24 h to PJ34 10 μM (G; dashed line represents the level of expression in vehicle-treated cells). (H) PARP activity
assay, performed on fetal and adult OPCs at DIV 0, treated or untreated with PJ34 for 24 h. Data are represented as mean ± SD. Statistical analysis: Student's t-test. Asterisks indicate
differences between adult and fetal (*P b 0.05; **P b 0.01; ***P b 0.001; ****P b 0.0001), letters represent differences between treated and non-treated cultures (a= P b 0.05; c= P b 0.001).
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30%), reaching the end of the differentiation with CNPase/MBP positive
cells representing themajority of cells. Culture composition at 12 DIV is
presented in Fig. 1B. Adult cultures after 12 DIVs of differentiation show
a less mature cell composition, with a high percentage of NG2-positive
cells (P = 0.016) and less CNPase (P b 0.0001) and MBP (P = 0.008)
positive cells. Fetal cultures show less astrocytes (GFAP-positive cells;
P = 0.0023) and around 6% of neurons (β-III-tubulin positive cells)
that are not detected in adult cultures (P= 0.002).
In order to characterize the effect of PARP inhibition in fetal and
adult OPCs on oligodendrocyte differentiation and maturation, cells
were exposed to PARPi 24 h before differentiation induction (Fig. 1A).
Weﬁrst investigated the gene expression of the twomajor andmore ex-
tensively studied PARPs, PARP-1 and 2 (Fig. 1F–G), and PARP activity
(Fig. 1H), before the induction of differentiation, 24 h after PARPi treat-
ment (DIV 0). Both genes are expressed in fetal (ΔCq = 3.28 ± 0.08)
and adult (ΔCq = 5.79 ± 0.4) OPCs; gene expression is signiﬁcantly
higher in fetal compared to adult OPCs (PARP-1, P b 0.0001; PARP-2,
P=0.0002; Fig. 1F), and PJ34 treatment did not inﬂuence themRNAex-
pression levels (Fig. 1G). PARP activity analysis was based on the capa-
bility of PARP to parrylate histons in an ELISA-based assay. PARP activity
was signiﬁcantly higher in fetal OPCs compared to adult (P b 0.0001),
and PJ34 treatment was able to decrease the activity in both cultures
(fetal, P= 0.0005; adult P= 0.0284), thus conﬁrming that the enzyme
is active in both cell systems (Fig. 1H).
3.2. Effect of PARP inhibition on fetal and adult OPCs viability
In order to establish the cytostatic/toxic proﬁle of PARPs inhibition
on OPCs, we ﬁrst constructed a dose-response curve on the cell culture
which displayed the higher activity and expression of PARPs, i.e. fetal
OPCs, using two standard PARPi, i.e. PJ34 and TIQ-A. The cytostatic effect
is evaluated by the cell number (Fig. 2B), the cytotoxic effect by the
Fig. 2. Effect of PARP inhibition on fetal and adult OPC viability. (A) Experimental design: in order to study PARP inhibition effect on cell number and cell viability, cells were treated with
PARPi form DIV−1 to DIV 12. Gray rectangles represent T3 exposure phase; arrow shows the time point of the represented analysis. (B\\C) Dose-response curves of PJ34 and TIQ-A
treatment of fetal OPCs cultures. Results are shown as number of cells (B; total number of nuclei detected by the HCS software) and percentage of condensed nuclei (C) obtained at 12
DIV. (D–E) Comparison between percentage of number of cells (D) and condensed nuclei (E) at 12 DIV (day in vitro) in fetal and adult cultures treated with PJ34 and TIQ-A at 10 μM.
(F–G) Dose-response curves of Olaparib treated fetal and adult OPCs. Results are shown as number of cells (F) and percentage of condensed nuclei (G) at 12 DIV. Data are
represented as mean ± SD. Statistical analysis: One-way ANOVA followed by Dunnet's post hoc. Asterisks represent difference between treated and untreated groups
(*P b 0.05; **P b 0.01; ***P b 0.001; ****P b 0.0001).
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percentage of condensed nuclei (Fig. 2C), as established by HCS in three
independent experiments. The cytostatic effect was observed at 1 μM
and 10 μM using TIQ-A (P b 0.0001); at 10 μM using PJ34 (P b 0.0001).
Bothmolecules induced an increase in the percentage of condensed nu-
clei at the highest concentration (10 μM) according to the respective po-
tency (TIQ-A, P b 0.0001; PJ34, P= 0.0362).
We then investigated the effect of PJ34 and TIQ-A on adult OPCs
using the toxic concentration for fetal OPCs (10 μM) ﬁnding that PJ34,
but not TIQ-A, reduced the cell number in adult cultures (Fig. 2D; P=
0.0004) without affecting the percentage of condensed nuclei (Fig. 2E).
We also tested the Olaparib, a clinically approved PARPi, showing
the highest PARP inhibitory activity. Olaparib treatment caused a reduc-
tion in cell number in both fetal and adult cultures at low concentrations
(Fig. 2F; 10−1 nM; P b 0.0001) but is cytotoxic only for fetal OPCs (Fig.
2G; 101 nM; P b 0.0001).
In order to better elucidate the timing of the PARP inhibition effect,
we performed a time course analysis of cell number and cell death, by
using PJ34 at a 10 μM toxic dose, (Fig. 3A). We found that after 24 h
from the treatment there were no effects on cell number (Fig. 3B) and
cell death (Fig. 3C). In vehicle treated cells, cell number increases over
time, while in PARPi-treated cells remain at the same level for the
whole differentiation period (Two Ways ANOVA, time F(2, 90) =
20.37, P b 0.0001; treatment F(1, 90) = 63.13, P b 0.0001; interaction
F(2, 90) = 15.28, P b 0.0001), leading to a strong difference between
the two groups at DIV 6 (P b 0.0001) and DIV 12 (P b 0.0001; Fig. 3B).
In the opposite way, the percentage of condensed nuclei remain con-
stant in the vehicle-treated, while increasing over time in the PARPi-
treated group (Two Ways ANOVA, time F(2, 86) = 12.49, P b 0.0001;
treatment F(1, 86) = 46.65, P b 0.0001; interaction F(2, 86) = 15.60,
P b 0.0001), starting from DIV6 (P = 0.0003) and reaching N30% at
DIV 12 (P b 0.0001; Fig. 3C).
3.3. Effect of PARP inhibition on fetal and adult OLs maturation
We ﬁnally investigated the effect of PARP inhibition on the differen-
tiation of remaining OPCs using the two highest concentrations, being
either toxic or non-toxic. Fetal OPCs were treated with TIQ-A, PJ34 and
Olaparib at 1 μM (non-toxic concentration of TIQ-A and PJ34, toxic con-
centration of Olaparib) and 10 μM (toxic concentration of all PARPi).
Adult OPCs were treated with all 10 μM and 1 μM (both non-toxic con-
centration of all PARPi). Representative HCS images of CNPase/MBP-
positive cells in the different treatments of both fetal and adult OPCs
are presented in Fig. 4B; results of the quantitative HCS analysis in Fig.
4C (fetal) and Fig. 4D (adult). The number of cells included in this anal-
ysis ranged from 1199 to 7152/well. Three wells were included in each
experiment. PARP inhibition impairs OPCsmaturation in fetal, but not in
adult, cultures. In cell preparations derived from fetal brain, TIQ-A, the
less potent PARPi, does not affect OPC maturation, as indicated by the
percentage of MBP-IR cells. On the contrary, PJ34 treatment, already at
non-toxic concentrations (1 μM) resulted in a reduction of mature
OPCs (P = 0.0013), as when used in a toxic dose (10 μM) (P b
0.0001). Olaparib treatment at both concentrations resulted in a strong
reduction of the percentage of mature and myelinating OPCs (P b
0.0001). Notably, all PARPi had no effect on adult OPC differentiation
(1 μM treatment, data not shown).
4. Discussion
Several in vivo and in vitro studies indicate that OPCs have substan-
tially different properties according to their chronological age. For ex-
ample, human fetal OPCs from different gestational stages exhibit
differences in the myelination proﬁle (Cui et al., 2012), such as human
OPCs derived from fetal brain during the period of maximum
oligoneogenesis or from adult subcortical white matter (Windrem et
al., 2004). However, the mechanisms behind the different age-related
OPC biological properties are not known. The aim of this study was to
investigate if PARP is involved in determining the age-related OPCs
properties. Thus, we compared OPCs derived from NSCs obtained from
fetal and adult brains. This cell systemwas preferred to primary and pu-
riﬁedOPCs to bettermimic developmental biology of OPC, including lin-
eage speciﬁcation, proliferation/survival and differentiation. PARP is a
family of enzymes comprising 17 homologues involved in multiple
cell functions (Jubin et al., 2016a). Apart from the role in DNA repair,
PARP-1 and 2 participate in cell homeostasis maintenance (Bai, 2015),
intracellular transports (Abd Elmageed et al., 2012), cell cycle
(Madison et al., 2011) inﬂammation and immunity (Bai and Virág,
2012) and gene expression regulation (Bock et al., 2015) through
N100 substrates (Hottiger, 2015). Moreover, PARPs are critically in-
volved in inﬂammation and in the tissue damage caused by ischemia/
reperfusion conditions (Li et al., 2015).
We ﬁrst showed that PARP mRNA expression and PARP activity are
much higher in fetal- than in adult-derived OPCs. Due to the role of
Fig. 3. Time course of PARP inhibition effect on fetal OPCs. (A) Experimental design: in order to study PARP inhibition effect on cell number and cell viability, cells were treatedwith PARPi
form DIV−1 to DIV 12. Gray rectangles represent T3 exposure phase; arrows show the time points of the represented analysis. (B\\C) Time course analysis of number of cells (B) and
percentage of condensed nuclei (C) in fetal OPCs treated with vehicle or PJ34 10 μM. Data are represented as mean ± SD. Statistical analysis: Two-way ANOVA followed by Tukey's
post hoc. Asterisks represent difference between treated and untreated groups at the same time point (*P b 0.05; ****P b 0.0001).
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PARPs in DNA repair and apoptosis induction (Heeres and
Hergenrother, 2007), the reduction in PARP mRNA expression level
and activity observed in adult compared to fetal-derived OPC might re-
ﬂect the age-related decrease of DNA repair capability (Bürkle et al.,
2015). In fact, PARP activity also varies according to the age in different
brain regions (Strosznajder et al., 2000), and PARylation is developmen-
tally regulated (Jubin et al., 2016b).
We then showed that PARP inhibition produces substantially differ-
ent effects in OPCs derived from fetal and adult brain. In particular: (i)
the culture treatmentwith PARP inhibitors is cytotoxic for OPCs derived
from fetal, but not from adult, brain; (ii) PARP inhibition reduces cell
number in proportion to the inhibitory potency of the compounds;
(iii) the PARP inhibition effect in fetal OPCs is a slow process (iv) PARP
inhibition impairs OPC maturation into myelinating OL in fetal, but not
in adult OPCs, according to the inhibitory potency of the compounds.
A primary role of PARP in the differentiation process of different cell
types was recently recognized, possibly though chromatin plasticity
and epigenetic regulation (Li et al., 2015). In embryonic stem cells,
PARP interacts with theWnt pathway, Sonic Hedgehog and Pax6 signal-
ling (Hemberger et al., 2003; Yoo et al., 2011). PARP-1 has also a role in
neuroectoderm differentiation (Yoo et al., 2011) and favours the transit
of NSCs toward a glial fate (Plane et al., 2012). Here we conﬁrmed and
further extend this latter observation, showing that PARP inhibition re-
duced proliferation in fetal-derived neurospheres and oligospheres (see
supplemental material), and reduces OPCs differentiation into mature
OLs. Notably, key transcription factors involved in OPC maturation, i.e.
retinoic acid receptors, thyroid hormone receptors and their hetero-di-
merization, such as PDGF signalling, a critical pathway for OPC biology,
are targets of PARP regulation (Pavri et al., 2005; Allen, 2008). Overall,
these results suggest that a different PARP signalling in fetal and adult
OPCsmight be part in the biological properties of OPCs at different chro-
nological ages.
These results have also therapeutic implications. In fact, PARP inhibi-
tion has even been proposed as a pharmacological strategy in a number
of acquired inﬂammation/demyelinating disorders inwhichOPCs play a
key pathogenic role, occurring both in perinatal/neonatal (e.g. neonatal
Fig. 4.Effect of PARP inhibition on oligodendrocytematuration. (A) Experimental design: inorder to studyPARP inhibition effect onOLsmaturation, cellswere treatedwith PARPi formDIV
−1 to DIV 12. Gray rectangles represent T3 exposure phase; arrow shows the time point of the represented analysis. (B) Representative HCS images of fetal and adult cultures at 12 DIV.
Speciﬁc markers were used in order to visualize mature (CNPase; 2′,3′-cyclic nucleotide 3′-phosphodiesterase) and myelinating (MBP; myelin basic protein) oligodendrocytes. Bar: 100
μm. (C–D) Percentage of CNPase- andMBP-positive cells at 12 DIV in fetal (C) or adult (D) cultures. Data are represented asmean± SD. Statistical analysis: One-way ANOVA followed by
Dunnet's post hoc. Asterisks represent difference between treated and untreated groups (**P b 0.01; ***P b 0.001; ****P b 0.0001).
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hypoxia/ischemia encephalopathy) and adult age (e.g. spinal cord inju-
ry and multiple sclerosis; Komjáti et al., 2005; Moroni, 2008; Cavone
and Chiarugi, 2012). Contradictory results have been obtained in mice
models of inﬂammatory/demyelinating diseases (Selvaraj et al., 2009;
Veto et al., 2010; Casaccia, 2011; Kamboj et al., 2013). PARP-2 deletion
in conventional transgenicmice results in a protection from experimen-
tal allergic encephalomyelitis (EAE), the most widely used animal
model for multiple sclerosis (Kamboj et al., 2013). Conversely, knock-
out of PARP-1 gene leads to an exacerbated EAE and an increase in the
mortality rate (Selvaraj et al., 2009). Pharmacological PARP inhibition
in EAEmice has a protective effect, preventingOL death and attenuating
inﬂammation (Veto et al., 2010), although this effect is attributed to the
reduction of CNS inﬂammation and immunomodulation (Scott et al.,
2004).
Our data, showing that PARP inhibition is cytotoxic in OPCs derived
from the fetal brain, suggest that the OPCs chronological age should be
taken into account in considering PARP inhibition as a neuroprotective
strategy. In particular, PARP inhibition in ischemic damage should dis-
tinguish perinatal/neonatal from adult conditions, considering that the
time-window for the treatment of neonatal hypoxia/ischemia encepha-
lopathy is the key period for OPCs proliferation, maturation and devel-
opmental myelination.
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4.5 Cell death in pure-neuronal and neuron-astrocyte mixed primary culture subjected to 
oxygen-glucose deprivation: The contribution of poly(ADP-ribose) polymerases and 
caspases (Baldassarro et al., 2018). 
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Primary cortical neurons subjected oxygen-glucose deprivation (OGD) is an in vitromodel that mimics funda-
mental aspects of neonatal hypoxic-ischemic encephalopathy (HIE) and is widely used to test neuroprotective
treatments. However, controversial results characterize the existing literature on the OGD model. To shed
some light on the initial cell death triggers in OGD, we ﬁrst investigated the contribution of glucose- or oxy-
gen-deprivation, alone or in combination, to cell viability/death in two cell systems, i.e. pure neuronal: 98% neu-
rons; 2% astrocytes- vs. mixed neuron/astrocytes: 50% neurons; 50% astrocytes- culture. Cell viability was
evaluated biochemically (MTT, and LDH release) and morphologically by high-content screening. We ﬁrst
found that neuronal death triggered by OGD (3 h OGD + 24 h re-oxygenation) was mainly driven by glucose
rather than oxygen deprivation. Astrocytes survival was not substantially affected. Caspase-3 activation was
found both in neuronal and mixed neuron/astrocytes cultures, whereas PARP activation was evident only in
pure neuronal cultures. To pharmacologically dissect the contribution of these pathways, wemeasured the effect
of TIQ-A (PARP 1 inhibitor) and ZVAD-fmk (pan-caspase inhibitor), individually or in combination, on culture vi-
ability after 3 h OGD. We found that only the combination treatment exerts a signiﬁcant neuroprotective effect
particularly evident in pure neuronal cultures. In sum, glucose deprivation is the major cell death trigger in
OGD and neurons are more sensitive to OGD than astrocytes. Both PARP and caspases are concurrently activated
in pure neuronal cultures and both contribute to neuronal cell death suggesting that neuroprotective strategies
may require the simultaneous inhibition of multiple death pathways to be effective.
© 2016 Elsevier B.V. All rights reserved.
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1. Introduction
To better comprehend the molecular pathways associated with
brain ischemia, in vitro models have been used increasingly in recent
years. Oxygen-glucose deprivation (OGD) is an in vitro organotypic or
cellular model that mimics fundamental aspects of hypoxia/ischemia
(HI) damage: low oxygen pressure, low nutrient levels and reperfusion.
This system was initially used in oncology to mimic necrosis [1], then
applied to either pure neuronal or mixed neuron/astrocytes cultures
[2] and ﬁnally transferred to brain and spinal cord slices [3]. From that
moment, OGDmodelwaswidely used to study brain ischemia and a va-
riety of other pathologies and lesions involvingHI in the central nervous
system (CNS), such as stroke-like conditions and trauma [4].
The OGD model has been extensively characterized for its ability to
mimic energy failure, recapitulating the in vivo situation better than
other challenges, such as excitotoxicity exerted by direct exposure to
glutamate agonists [5]. This model is particularly interesting in the
study of neonatal hypoxic-ischemic encephalopathy (HIE), a syndrome
determined by asphyxia occurring during the perinatal period [6], and
to screen potential neuroprotective drugs. Moreover, this model is also
useful for extreme form of metabolic stress resulting from oxygen and
glucose deprivation, such as in cerebral ischemia (stroke) that most
commonly occurs when the blood supply to a part of the brain is
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suddenly interrupted by occlusion of a vessel. Because in vivo cerebral
ischemia often consists of both reversible ischemia and blood ﬂow re-
perfusion, the cultures in the OGDmodel are ﬁrst exposed to in vitro is-
chemia, then returned to a normal medium in an oxygen atmosphere
environment to simulate the in vivo blood ﬂow reperfusion period. Al-
though OGD is a combination of two metabolic insults, there is not a
clear picture on what is the individual contribution of glucose and oxy-
gen deprivation to cell death.
Two main molecular players have captured the attention as poten-
tial therapeutic targets for HIE and stroke induced cell death: caspases,
which are the hallmark of apoptosis [7,8], and Poly(ADP-ribose) poly-
merases (PARP), which are nuclear proteins mainly known for their
role in DNA double strand repair [9,10]. Caspases are a major player in
neuronal death, but can also exacerbate inﬂammation and alter glial
function [11]. PARP are a family of nuclear enzymes that catalyse the
formation of (ADP-ribose)n chains from NAD+ on acceptor proteins
like histones and PARP itself, after DNA double strand breaks [12].
Among the 18 putative PARP sequences in the human genome, PARP-
1 and PARP-2 are the best characterized and most abundant isoforms
[13] that seem to be deeply involved in neuronal loss after ischemic
damage [14]. When the damage is mild, PARP activity repairs DNA
breaks and promotes cell survival, but in the presence of extensive
DNA damage, over-activation of these enzymes causes massive NAD+
consumption and consequent energy depletion and necrotic cell death
[15]. PARP is also involved in the caspase-independent apoptosis path-
way mediating Apoptosis Inducing Factor (AIF) translocation from mi-
tochondrial matrix to nucleus, where it cleaves DNA into high
molecular weight fragments [16].
However, not only neurons, but also astrocytes play a major role
during HIE, being either neuroprotective or augmenting neuronal
death during hypoxia, depending on the hypoxia conditions and timing
[17]. The aim of the present study is to characterize an in vitro model
widely used to test new neuroprotectivemolecules after hypoxia/ische-
mia damage, focusing on PARPs and caspases as putative molecular tar-
get. In particular (i) we ﬁrst characterized the in vitromodel of OGD (3 h
OGD+24 h re-oxygenation), in primary “pure neuronal culture” and in
“mixedneurons-astrocytes culture” obtained fromneonatal rats; (ii)we
examined the relative contribution of glucose and oxygen deprivation,
and their combination in inducing neuronal death; (iii) we utilized
comparatively the most widely used biochemical viability methods
(MTT and LDH) and the more recently introduced cell-based high con-
tent techniques (mitochondria function and nuclear morphology); (iv)
we evaluated the effect of PARP (TIQ-A) and caspase (ZVAD-fmk) inhib-
itors, alone and in combination, in “pure neuronal” vs.mixed “astrocyte-
neuronal” cultures subjected to OGD.
2. Materials and methods
2.1. Cell cultures
Cortical neurons from neonatalWistar rats were prepared according
to standard protocol [18,19]. Brieﬂy, brains were removed, and cortical
tissue dissected, freed from themeninges, andminced into small pieces.
Cells were dispersed in Kreb's buffer (0.12 M NaCl, 4.8 mMKCl, 1.2 mM
KH2PO3, 25.4 mM NaHCO3, 14.2 mM glucose, 0.01 mg/ml phenol red,
1.5 mM MgSO4) containing BSA 0.3% and 0.025% trypsin (Sigma-Al-
drich) for 15 min at 37 °C, followed by mechanical trituration with a
Pasteur pipette in Kreb's buffer containing 0.004% deoxyribonuclease I
(DNaseI), and 0.052% soybean trypsin inhibitor (SBTI; Sigma-Aldrich).
After centrifugation (500 g, 5 min), cells were resuspended in
Neurobasal culture medium supplemented with 2% B27 (Gibco),
2 mM glutamine (Sigma-Aldrich), 100 U/ml penicillin, and 100 μg/ml
streptomycin (Gibco) and plated onto Cultrex 2D substrate
(0.25 mg/ml, Trevingen)-coated plates or coverslips. Cells were main-
tained in a humidiﬁed incubator at 37 °C with 5% CO2. To obtain neuro-
nal culture (99% neurons) cells were treated after 24 h with 10 μM
cytosine arabinofuranoside (Sigma-Aldrich). For mixed cultures no mi-
totic inhibitor was used. At 4 DIV, half of the medium was changed in
both cultures.
2.2. Glutamate treatment
At 7 DIV neuronal cultures were treated with glutamate 0.5 mM.
Brieﬂy, medium was removed and cells were exposed to Krebs buffer
containing or not glutamate, for 10 min. After glutamate treatment,
Krebs buffer was replaced with the former conditioned medium. One
group of cellswere treatedwithMK80110 μMfrom1h before the treat-
ment to the end of the glutamate exposure.
2.3. OGD induction and treatments
OGD was performed using an air-tight hypoxia chamber (Billups-
Rothenberg Inc., Del Mar., CA) saturated with 95% N2- 5% CO2 [2]. Glu-
cose deprivation was achieved using a glucose-free Neurobasal medi-
um, supplemented with B27, glutamine and penicillin/streptomycin,
using the above-mentioned concentration. At 7 DIV cells were pre-
treated for 1 hwith TIQ-A 10 μMand ZVAD-fmk30 μM(alone or in com-
bination). MK801 10 μMwas used as reference compound. Oxygen was
removed by ﬂushing the hypoxia chamber with N2-CO2 mixture for 6–
8 min at 25 lt/min. The ﬂushing was repeated after half the incubation
time. The OGD condition was maintained for three hours, after which
plates were re-oxygenated for 24 h in cell incubator in the pre-treat-
ment culture medium.
2.4. PARP-1 activity assay
Proteins from cell lysates were quantiﬁed by Lowry assay (BioRad)
following themanufacturer's instructions. The same amount of proteins
were used for all the samples (400 ng). PARP enzymatic activity was
measured using HT Colorimetric PARP Apoptosis Assay Kit (Trevingen),
following the manufacturer's instructions in pure neuronal and mixed
cultures.
2.5. MTT viability assay
Cell viability was measured by MTT colorimetric assay. Thiazolyl
Blue Tetrazolium Bromide (Sigma-Aldrich) was dissolved 6.5 mg/ml in
PBS and diluted 0.5 mg/ml in OptiMem (Gibco). Mediumwas removed
and cells incubated for 3 h in incubator with the MTT solution.
Formazan salts were solubilized by adding solubilisation solution (80%
v/v isopropyl alcohol, 10% v/v HCl 1 N, 10% v/v Triton-X) and shaking
the plates for 1 h at room temperature (RT). Absorbance was measured
with a microplate reader (BioRad) at 570 nm.
2.6. LDH activity assay
LDH activity measurement was performed with PIERCE LDH Cyto-
toxicity Assay Kit, following the manufacturer's instructions. Both neu-
ronal and mixed cultures were grown in a 96well plate (100,000 cells/
well); after the re-oxygenation period, medium was collected and the
activity of LDH enzyme in the medium was measured.
2.7. Immunocytochemistry
To evaluate neurotoxic stimulus effect on neurons and astrocytes,
immunocytochemistry (ICC) was performed. Cells were seeded onto
Cultrex 2D substrate (0.25 mg/ml, Trevingen)-coated coverslips and
ﬁxed after treatment with ice-cold 4% paraformaldehyde for 20 min at
RT. After a fast wash in PBS, cells were incubated for 1 h with BSA 1%,
0.5% goat serum, 0.5% donkey serum in PBS- 0.3% Triton-X 100, then in-
cubated overnight with primary antibody anti-β-III-tubulin (mouse,
R&D, 1:1000), anti-GFAP (rabbit, Dako, 1:1000), anti-Iba-1 (rabbit,
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Wako, 1:250), anti-active caspase 3 (rabbit, BD Pharmingen 1:200) di-
luted in PBS-0.3% Triton-X 100. Cells were washed with PBS and incu-
bated with secondary antibody goat Alexa 488-conjugated anti mouse
and/or goat Alexa 568-conjugated anti-rabbit (Invitrogen) for 30 min
at 37 °C. After immunoﬂuorescence staining, cells were incubated
with the nuclear dye Hoechst 33258 (1 μg/ml in PBS, 0.3% Triton-X
100) for 20min at RT. Cells were ﬁnallywashed in PBS and coverslipped
in glycerol and PBS (3:1, v/v) as mounting medium containing 0.1%
paraphenylenediamine.
2.8. Cell-based high content screening
For HCS analysis cells were grown in 96 ﬂat-bottomwell HCS plates
(NUNC; 100,000 cells/well). The mixed culture was stained following
the immunocytochemistry protocol described above, using primary
anti-Iba1 (rabbit, Wako, 1:250). Nuclei were stained with Hoechst
33258 as described above. Analysis of the percentage of Iba-1 positive
cells was performed with Cell Insight™ CX5 High Content Screening
(HCS) (ThermoFisher Scientiﬁc). Neurons and astrocytes were discrim-
inated by nuclear size, while microglia by Iba1-immunostaining.
Mitotracker Red CMXRos (ThermoFisher Scientiﬁc) was used to
stainmitochondria of living cells. After reperfusion cells were incubated
with the ﬂuorescent dye (100 nM) for 15 min at 37 °C. After a washing
step using growthmedium, cellswere then ﬁxed using ice-cold 4%para-
formaldehyde for 20 min at RT. Cells were rinsed 2 times with PBS and
stained following the immunocytochemistry protocol described above,
using primary anti-GFAP (rabbit, Dako, 1:1000) and secondary anti-rab-
bit Alexa 488-conjugated (Invitrogen, 1:500).
Using Cell Insight™ CX5 HCS, cells were discriminated as GFAP-pos-
itive or -negative cells and ﬂuorescence analysis of theMitoTraker ﬂuo-
rescence was performed on GFAP-negative cells only, identiﬁed as
neurons. Cells showing a low MitoTracker ﬂuorescence are considered
with depolarized mitochondria. The software is able to detect nuclei
as “object” considering each nucleus a single cell and it also detect the
ﬂuorescence in the cytoplasm belonging to the identiﬁed nucleus. This
allows to clearly associate positive cells to a speciﬁc markers.
In the same cultures, the software is used to analyse the nuclear
morphology based on the ﬂuorescence intensity of the Hoechst 33258
staining and the nuclear size, using GFAP staining to differentiate neu-
rons and astrocytes. Nuclei showing high ﬂuorescence intensity and
small size are identiﬁed as condensed/fragmented.
2.9. Fluorescence microscopy
To study the effect of the OGD on caspase-3 activation and the effect
of the drugs on pure neuronal and mixed cultures we used a ﬂuores-
cence microscopy approach to analyse the nuclear morphology. Immu-
nocytochemistry was performed as described above to identify neurons
and astrocytes.
Coverslips were observed using a Nikon eclipse E600 (Nikon, Italy)
equippedwith digital CCD cameraQ imagingRetiga 20002V (Q Imaging,
Surry, BC, Canada). Percentage of condensed nuclei and active caspase-3
positive cells was calculated. All imageswere taken at amagniﬁcation of
20× objective, 5 ﬁelds per coverslip were considered and at least 2 cov-
erslips per conditionwere analysed from two independent observators.
Controls using the secondary antibodies, alone, were performed and re-
sulted negatives.
2.10. Statistical design and analysis
All data derive from at least three independent experiments. The
number of technical replicates included in each experiment is indicated
in the result. Prism software (GraphPad Software) was used for statisti-
cal analyses and the preparation of graphs. Data in histograms are re-
ported as mean ± SEM. Student's t-test or one-way ANOVA and
Dunnett's multiple comparison post-hoc test were used to analyse
data. Results were considered signiﬁcant when the probability of their
occurrence as a result of chance alone was b5% (P b 0.05).
3. Results
3.1. Cell system, glutamate toxicity, OGD characterization and analytical
methods
We ﬁrst characterized the cell populations obtained in the presence
(“pure neural”) and in the absence (“mixed neural-astrocyte”) of Ara-C
treatment. Representative micrographs of mixed (A, B) and pure (C)
neuronal cultures are reported in Fig. 1, where β-III-tubulin (green)
identiﬁes neurons, GFAP (red in A and C) astrocytes and Iba1 (red in
B)microglia. Quantitative results are reported in Fig. 1D. Themixed cul-
ture is composed of around50% of GFAP-positive astrocytes, around 50%
of β-ΙΙΙ-tubulin-positive neurons and 1% Iba1-positive microglial cells
(Fig. 1D). “Pure” neuronal cultures were obtained by Ara-C treatment,
leading to b5% of astrocytes in the culture (Fig. 1D).
Primary cortical neurons at 7 DIVs express the active form of NMDA
receptors [20], especially when isolated from new-born pups [21]. In
order to conﬁrm that our culture system is sensitive to glutamate,
pure neuronal cultures were used to characterize the response of neu-
rons at 7DIV to glutamate toxicity (Fig. 1E). Cells viability in neurons ex-
posed to 0.5 mM of glutamate for 10 min was severely affected leading
to N60% of cell death compared to control (P b 0.0001). Treatment with
the NMDA antagonist MK801 totally rescued cell viability in the cell
system.
Pure neuronal and mixed neuronal-astrocytes cells systems were
then used in parallel in all the experiments. We ﬁrst investigated the
contribution of glucose- or oxygen-deprivation, alone or in combina-
tion, to cell viability/death. The schedule of the experiment is reported
in Fig. 2. The same sets of experiments were analysed by different ana-
lytical methods exploring mitochondrial function and cell death, i.e. the
mitochondria-basedMTT viability assay; the LDH assay based on the re-
lease of the cytoplasmic enzyme; cell-based mitochondrial membrane
potential by Mitotracker and nuclear morphology by Hoechst 33258
using cell-based high content screening. Results are reported in Fig. 3,
where treatments are also indicated on the X-axis. Both MTT (Fig. 3A)
and LDH assay (Fig. 3B) indicated that glucose deprivation is the
major trigger of cell death in both “pure” and “mixed” cultures (MTT:
mixed culture P = 0.0017; pure neuronal culture P b 0.0001; LDH
mixed culture P = 0.0138; pure neuronal culture P = 0.0014), while
the contribution of oxygen deprivation appears to be negligible. Since
these biochemical assays do not allow any discrimination between the
different cell types (neurons vs. glia) present in the culture, we also
used a morphological approach based on cell-speciﬁc antigen recogni-
tion and coupled to high-throughput imaging and analysis to distin-
guish the OGD-affected population in mixed cultures. We ﬁrst
analysed the mitochondrial depolarization in neurons (recognized as
GFAP-negative cells) as early event in neurodegeneration [22] occurring
shortly after the OGD exposure [23], conﬁrming that neurons are much
less sensitive to OGD when cultured in the presence of astrocytes (Fig.
3C; mixed culture: P = 0.0007; pure neuronal culture P b 0.0001).
Using this technique we also showed that viability of astrocytes (recog-
nized as GFAP-positive cells) is not affected by the OGD conditions used
in this study (data not shown).
We then investigated the effect of the OGD on nuclear morphology,
as a late event in neurodegeneration (Fig. 3D). In mixed cultures show-
ing mitochondrial depolarization, astrocytes are not affected by OGD,
while neurons show vulnerability to both glucose deprivation and
OGD (glucose deprivation P=0.03; OGD P=0.0008), but not to oxygen
deprivation alone. Cell death analysed by nuclear morphology in the
pure neuronal culture produces results that are in line with those ob-
tained with the MTT assay (OGD, P b 0.0001). Additionally, the analysis
of cell death by nuclear morphology allows the determination of the af-
fected cell type in the mixed cultures.
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3.2. Involvement of PARP and caspase-3 to OGD-induced cell death
To conﬁrm the involvement of caspases- and PARP-pathways in the
OGDmodel,weﬁrstmeasured caspase activation and PARP activity (Fig.
4B and C, respectively). Caspase activation, as visualized by caspase-3-
immunoreactivity (Fig. 4A), was compared to the percentage of con-
densed nuclei as a marker of cell death. Caspase-3 is activated in both
pure neuronal (40% of total neurons; P b 0.0001) and mixed cultures
(20% of total neurons; P = 0.0019), and cell death was higher in pure
neurons (80% of total neurons; P b 0.0001) than in mixed cultures
(40% of total neurons; P b 0.0001) (Fig. 4B). Since caspase activation in
OGD neurotoxicity is driven by glutamate [2], we utilized the NMDA re-
ceptor antagonist MK801 to counteract OGD-induced cell death. When
used 1 h before OGD exposure, MK801 decreased cell death and cas-
pase-3 activation (Fig. 4B). This analysis in the mixed cultures do not
distinguished between astrocytes and neurons.
Results for the direct measure of PARP activity are shown in Fig. 4C.
In mixed cultures, where cell death is lower than in pure neuronal cul-
tures, PARP activity is not affected by OGD, while in pure neuronal cul-
tures we observed an increase in PARP activity (P= 0.0061). The PARP
inhibitor TIQ-A completely abolished the increase of PAPR activity trig-
gered by OGD. Conversely, MK801 is ineffective in counteracting PARP
activation by OGD.
The effect of PARP-inhibitor (TIQ-A) and a pan-caspase inhibitor
(ZVAD-fmk), alone or in combination, were tested on cell viability
upon OGD (Fig. 5). Neither TIQ-A nor ZVAD-fmk affected cell viability
in control cultures (concentration curve: TIQ-A and ZVAD-fmk, 0.1 nM
till 10 μM, 8points; data not shown). Treatmentswere performed 1 h be-
fore OGD exposure. When used alone, neither TIQ-A nor ZVAD-fmk
counteracted OGD-induced neurotoxicity in both pure and mixed neu-
ronal cultures. Interestingly, the co-treatment with both TIQ-A and
ZVAD-fmk resulted in a partial restoration of cell viability as assessed
both by biochemical (MTT, combination vs. OGD P= 0.001) and mor-
phological (% condensed nuclei, combination vs. OGD, mixed cultures
P= 0.0113; neuronal cultures P= 0.0012) assays.
4. Discussion
Standardization of in vitromodels is a crucial step towards providing
reliable, technically straightforward, and robust data for drug discovery
and decreasing the attrition rate, as also recommended in the Good Cell
Culture Practice ECVAM guidelines (European Union Reference Labora-
tory for alternatives to animal testing) [24]. Although used for testing
neuroprotective strategies in the case of many neurological lesions
and diseases, including stroke and HIE, the in vitro OGD model has not
been yet fully characterized and standardized [4,25,26,27]. In this
study we characterized the cytotoxic effect of OGD and its individual
components, namely glucose and oxygen deprivation, in two cell sys-
tems, i.e. “pure neurons” vs. “mixed astrocyte-neuron” cultures, com-
monly utilized for testing of neuroprotective strategies. We
concentrated on the inhibition of two main pathways involved in cell
death/survival after hypoxia/ischemia damage, e.g. caspases and PARP
[14,28,29,30,31]. We also compared different viability tests, based on
biochemical and morphological analytical methods.
We ﬁrst compared the contribution of oxygen and glucose depriva-
tion, respectively. Very few and contradictory data consider moderate
Fig. 1.Composition of the two cell systems. A–C: Representative images (ﬂuorescencemicroscopy) ofmixed (A and C) and neuronal (B) cultures. Neurons are labelled by anti-β-III-tubulin
antibody (green); astrocytes are labelled by anti-GFAP antibody (red; A and C);microglia is labelled by anti-Iba-1 antibody (red; B). Bar=50 µm. D: Cell composition in the two systems is
quantiﬁed as a percentage of immunoreactive cells. E: Cell viability measured by MTT assay. Data were represented as percentage of cell viability, where the control group accounts for
100% of viability. Data are presented as mean ± SEM. Statistical analysis: D, Student's t-test; ****P b 0.0001; E, One-way ANOVA and Dunnet's multiple comparison post-test, where the
control group is glutamate−/MK801 -; ****P b 0.0001. Abbreviations: Ara-C, cytosine arabinofuranoside; GFAP, Glial ﬁbrillary acidic protein; Iba-1, Ionized calcium binding adaptor
molecule.
Fig. 2. Experimental design. The cell systems (+/−Ara-C) were allowed to mature for
7 days and then pre-treated with the drugs 1 h before OGD exposure. OGD lasted 3 h,
and viability was then analysed after 24 h of reperfusion. Abbreviations: Ara-C, cytosine
arabinofuranoside; OGD, oxygen-glucose deprivation.
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(1–2% oxygen) or severe (absence) hypoxia in vitro as a cell death in-
ducing factor [32,33,34], or as protective in associationwith hypoxia-in-
ducible factors-1 (HIF-1) up-regulation and VEGF action [35]. We found
that the absence of glucose is themajor trigger of cell death in both pure
and mixed neuronal cultures in the standard OGD conditions used in
this study. This is in line with previously published data, indicating
Fig. 3. Relative contribution of oxygen- and glucose-deprivation to cell death in the OGD model. A: Cell viability measured by MTT assay. Data were represented as percentage of cell
viability, where the control group accounts for 100% of viability. B: Cell viability measured by LDH assay in the culture media. Data are presented as a percentage of the OGD value. C:
HCS analysis of mitochondria depolarization as measured using MitoTracker, where cells showing low levels of mitochondrial dye were identiﬁed as cells with depolarized
mitochondrial membranes. D: HCS analysis of nuclear morphology. Condensed and fragmented nuclei are represented as percentage of the total number in the respective cell
populations (neurons and astrocytes). Data are presented as mean ± SEM. Statistical analysis: B, C and neuronal cultures in D, Student's t-test; *P b 0.05; **P b 0.01; ***P b 0.001;
****P b 0.0001; A and mixed cultures in D, One-way ANOVA and Dunnet's multiple comparison post-test, where the control group is glucose+/oxygen+ in the respective cell system;
*P b 0.05; **P b 0.01; ****P b 0.0001.
Fig. 4.Caspase-3 and PARP activation after OGD. A: Representative images of active caspase-3 (red)/Hoechst 33258 (blue) staining (ﬂuorescencemicroscopy), inmixed and pure neuronal
cultures, after OGD and after OGD+MK801. Bar: 20 μm. Arrows indicate example of “cleaved-caspase-3 positive cells”. High magniﬁcation images of single negative- (neuronal culture,
vehicle) and positive-cells (neuronal culture, vehicle +3 hs OGD) are included in the ﬁgure. Bar = 5 μm B: Quantitative analysis of condensed/fragmented nuclei and active caspase-3
positive cells in mixed and pure neuronal cultures. C: PARP activity in mixed and pure neuronal cultures after OGD, OGD + MK801 and OGD + TIQ-A. Data are presented as mean ±
SEM. Statistical analysis: One-way ANOVA and Dunnet's multiple comparison post-test, where the control group is OGD−/MK801- in the respective cell system; *P b 0.05; **P b 0.01;
****P b 0.0001. Abbreviations: OGD, oxygen-glucose deprivation.
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glucose deprivation and glucose reperfusion as important triggers of
neuronal death [36], also involving PARP-1 activation [37]. However, it
should be pointed out that in standard culture conditions cells are ex-
posed to 95% of air corresponding to 20% of oxygen, which is much
higher than physiological in vivo condition (2.5–5.3%) [38]. Actually, a
reduction of the atmospheric oxygen concentration from 21% to 3%
did not modify cell death rate of neural precursors derived from differ-
ent brain regions [39] and is considered a useful tool to promote neural
differentiation [40].
As already indicated by a number of studies, we also conﬁrmed that
mixed culture are less sensitive to OGD, and the astrocytes are resistant
to OGD in experimental conditions similar to those used in this study [2,
41]. However, the OGD experimental conditions differentially affect as-
trocytes. In fact, the activation of caspase-3 and -7 has been described in
astrocytes after 75 min OGD [30] and astrocyte sensitivity to OGD has
been described after 3 days of reoxygenation [43]. Moreover, depending
on the OGD timing [30] and in combination with the mitochondrial
damage [44], the caspase-9 mediated intrinsic apoptosis pathway is
also involved in OGD-induced cell damage, leading to caspase-3 activa-
tion. A lactate-depending mechanism related to the glycogen storage
confers astrocyte resistance to OGD [42,45]. We then evaluated if the
presence of astrocytes in the culture affect neuron vulnerability to
OGD. By using a morphological method in order to distinguish different
cell population in themixed culture, we found the same vulnerability of
neurons compared to the pure neuronal cultures. It iswell described the
neuroprotective effect of astrocytes inmixed cultures against glutamate
excitotoxicity [46]. However, when the injury involve a mitochondrial
damage (i.e. during OGD exposure) astrocytes increased the vulnerabil-
ity of neurons in the co-culture [47]. The neuroprotective effect depends
on the OGD timing [45] and is not visible in biochemical assays, thus
suggesting that morphological HCS methods should be preferred for
studying potential neuroprotective agents in astrocytes-neurons
mixed cultures.
Moreover, we conﬁrmed the activation of caspase-3 in both “pure”
and “mixed” cultures after OGD exposure and 24 hr reperfusion,
which is strongly reduced by the glutamate receptor inhibitor MK801.
By usingmorphological viability assay, it is possible to study theOGD re-
sponse of neuronal cultures from the early stages (mitochondrial dam-
age) to the late apoptosis marker (condensed nuclei) throughout the
intermediate steps of the intrinsic apoptosis pathway (caspase-3 activa-
tion), leading to more descriptive data than biochemical viability assays
(MTT and LDH assays).Moreoverwe described the use of the cell-based
High Content Screening in the study of OGD-induced cell death in pure
and neuronal cultures, as already reported by our group [48], show dif-
ferent sensitivity compared to biochemical and conventional microsco-
py methods. The possibility to standardize methods in order to better
dissect the mechanisms underlying cell death during hypoxia/ischemia
can push forward the researches in the ﬁeld.
We then investigated the effect of PARP-inhibitor TIQ-A [49] and the
pan-caspase inhibitor ZVAD-fmk [50] on OGD in pure and mixed cul-
tures, alone or in combination. We observed that the TIQ-A and ZVAD-
fmk co-administration exerts a partial neuroprotective effect in pure
neuronal cultures, while the effect observed in the mixed culture is
very modest and can be appreciated only when using morphological
methods.
A neuroprotective effect of TIQ-A in fetalmice cortical neurons treat-
ed with Ara-C but plated on a conﬂuent astrocyte layer has been de-
scribed [44,51]. However, the cell composition of the culture was not
indicated in these studies. In contrast to these data, we saw no effects
by TIQ-A on OGD induced cell death, using both biochemical and mor-
phological assays, in pure neuronal and mixed cultures. Moreover,
upon OGD, we found an increase in PARP enzymatic activity in the
Fig. 5. Effect of Caspases and PARP inhibition in OGD treated cultures. A: Representative images of mixed and neuronal cultures (ﬂuorescencemicroscopy), after OGD and OGD+TIQ-A+
ZVAD-fmk. Neurons are labelled by anti-β-III-tubulin (green); astrocytes are labelled by anti-GFAP (red). Bar= 50 µm. B: Cell viability measured by MTT assay. Data were represented as
percentage of cell viability, where the control group represents 100% of viability (horizontal dotted line). C: Quantitative analysis of condensed/fragmented nuclei in mixed and pure
neuronal cultures. Data are presented as mean ± SEM. Statistical analysis: B, One-way ANOVA and Dunnet's multiple comparison post-test, where the control group is the OGD,
***P b 0.001. C, Student's t-test, *P b 0.05; **P b 0.01. Abbreviations: GFAP, Glial ﬁbrillary acidic protein; OGD, oxygen-glucose deprivation.
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pure but not in the mixed neuronal culture, thus suggesting that the
presence of astrocytes dampens PARP activation.
Also, published data on caspase inhibition effectiveness in relation to
neuroprotection after OGD are contradictory, pointing to either protec-
tion [50] or total inefﬁciency in blocking the death process [52] depend-
ing on the in vitro model utilized. In our experimental conditions,
caspase inhibition, as well as PARP inhibition, do not counteract OGD-
induced cell death in either pure or mixed cultures. Nevertheless, our
data support a combinatorial approach to prevent neuronal death
upon OGD, being the combination of z-VAD and TIQ-A neuroprotective.
Our ﬁndings are in line with results reported by Yap and colleagues on
the combination of PARP inhibitor 3-AB and caspase inhibitor ZVAD-
fmk in theMCAOmodel as they observed an additive effect in the reduc-
tion of the infarcted area after the combination treatment with the two
inhibitors [53]. In fact, mounting evidence indicates that a hybrid phe-
notype of cell death between apoptosis and necrosis, called necroptosis,
can be observed in neuronal cells after ischemia induction [26,54].
In this scenario, in which multiple cellular and molecular mecha-
nisms activated upon OGD could possibly lead to either neuron death
or neuron recovery, the astrocyte/neuron interplay has a major role
[55] and this should be reﬂected in the type of the cell system utilized
for testing or developing neuroprotective strategies. The choice of a
proper well-standardized in vitro culture system coupled with HCS
can indeed improve the translational power of the OGD model.
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amyloid-β accumulation and astrocytes
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ABSTRACT
Microvascular dysfunction is considered an integral part of Alzheimer
disease (AD) pathogenesis, but the possible relationship between
amyloid pathology, microvascular dysfunction and cell death is still
unclear. In order to investigate the influence of intraneuronal amyloid-
β (Aβ) accumulation on vulnerability to hypoxia, we isolated primary
cortical neurons from Tg2576 (carrying the amyloid precursor protein
APPSwe mutation) and wild-type fetal mice. We first demonstrated
that neurons isolated from Tg2576 newborn mice show an increase in
VEGFa mRNA expression and a decrease in the expression of the
two VEGF receptors, Flt1 and Kdr, compared with wild-type cells.
Moreover, APPSwe primary neurons displayed higher spontaneous
and glutamate-induced cell death. We then deprived the cultures of
oxygen and glucose (OGD) as an in vitro model of hypoxia. After
OGD, APPSwe neurons display higher levels of cell death in terms
of percentage of pyknotic/fragmented nuclei and mitochondrial
depolarization, accompanied by an increase in the intraneuronal Aβ
content. To explore the influence of intraneuronal Aβ peptide
accumulation, we used the γ-secretase inhibitor LY450139, which
showed that the reduction of the intracellular amyloid fully protects
APPSwe neurons from OGD-induced degeneration. Conditioned
medium from OGD-exposed APPSwe or wild-type astrocytes
protected APPswe neurons but not wild-type neurons, during OGD.
In conclusion, the presence of themutated human APP gene, leading
to the intracellular accumulation of APP and Aβ fragments, worsens
OGD toxicity. Protection of APPSwe neurons can be obtained either
using a γ-secretase inhibitor or astrocyte conditioned medium.
KEY WORDS: Alzheimer’s disease, Primary neurons, Intraneuronal
amyloid, Oxygen glucose deprivation, Glutamate, Neurovascular
coupling
INTRODUCTION
Brain function is strictly dependent on an appropriate blood support
and tissue perfusion, to ensure nutrient and oxygen delivery and to
remove metabolic waste products (Zlokovic, 2011). The fine
regulation of the blood support to the neurons is performed by the
cerebrovascular unit (CVU) which provides the functional coupling
between energy demand and vasodilation (Nelson et al., 2016). This
histological structure includes neurons, vascular cells (endothelial
cells, pericytes and vascular smooth muscle cells), glial cells
(astrocytes, microglia, and oligodendrocytes) and extracellular
matrix protein, which plays a part in blood–brain barrier (BBB)
regulation. Notably, the paracrine mechanism, including vascular
endothelial growth factor (VEGF) and related receptors, participates
in the cross-talk among different cell types in both normal and
ischemic conditions (Redzic et al., 2015). To highlight the
importance of the glial component, namely astrocytes, the CVU is
also termed ‘gliovascular unit’. In the CVU, astrocytes define
functional domains and contact the microvessels with endfeet
plastered on the vessel wall (Nedergaard et al., 2003). This physical
contact is also used to guarantee the lactate/glucose dynamic in the
CVU (Barros et al., 2007).
The contribution of vascular dysfunctions to Alzheimer’s disease
(AD) pathogenesis is now receiving increasing attention, especially in
late-onset forms of the disease (Kapasi and Schneider, 2016). Recent
imaging studies in preclinical and early AD have indicated that an
impairment of the CVU leading to a reduction of the cerebral blood
flow is an early event in AD (Garwood et al., 2016; van de Haar et al.,
2016). However, the relative contribution of the different cell types
and molecular mechanisms in CVU dysfunction, and its impact on
neuron vulnerability is not clear. In fact, on one hand, neurons
progressively accumulate amyloid peptide in the cytoplasm, leading
to an increase of the intrinsic vulnerability (Baker-Nigh et al., 2015).
On the other hand, astrocytes are subject to a number of cellular and
molecular regulations related to the pathological microenvironment,
including their activation as a consequence of AD neuroinflammation
and amyloid plaques. It is not clear whether this results in
neuroprotection, in further damage or in a biphasic effect,
depending on the stage of the disease (Garwood et al., 2016).
In vitro models are useful to understand the relative contribution
of intrinsic neuronal vulnerability due to β-amyloid (Aβ) peptide
accumulation (Baldassarro et al., 2014) and astrocyte support
associated with brain hypoperfusion. In particular, oxygen and
glucose deprivation (OGD) is an in vitro model that mimics
fundamental aspects of hypoperfusion (and ischemic) damage, i.e.
low oxygen pressure and low nutrient levels (Goldberg and Choi,
1993). This model has been widely used to explore cellular and
molecular mechanisms in experimental set-ups mimicking ischemic
lesions and trauma (Cimarosti and Henley, 2008; Baldassarro et al.,
2016). However, to the best of our knowledge, no studies have been
published in which OGD is applied to in vitro cell systems
appropriate for AD, i.e. which accumulate Aβ peptides (Baldassarro
et al., 2014). Thus, the aim of the study was to establish a possibleReceived 28 September 2016; Accepted 17 February 2017
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link between intraneuronal accumulation of Aβ and the
vulnerability to a mild hypoxic/ischemic injury, using an in vitro
model. First, we established an in vitro system of primary neurons
and astrocytes derived from transgenic Tg2576 mice and wild-type
controls. Tg2576 is a mouse model carrying a single human
amyloid precursor protein mutation (APPswe) (Hsiao et al., 1996),
and was chosen because of its predictive validity in
pharmacological and non-pharmacological research targeting AD
(Bilkei-Gorzo, 2014). These cell systems were then used to explore
the contribution of intraneuronal Aβ accumulation and astrocyte-
conditioned culture medium to neuron viability during OGD.
RESULTS
Cell system characterization and experimental design
Primary neurons were derived from the telencephalon of single
pups, immediately characterized for the genotype. In this way, in
each culture well, 100% of either wild-type (Wt) or APPswe
neurons was seeded. Neurons were allowed to mature in vitro for
8 days, then characterized for cell composition by
immunocytochemistry for neural (β-III-tubulin) and astroglial
(GFAP) proteins (Fig. 1A). Both Wt and APPswe pure neuronal
cultures contained a very low percentage of astrocytes (Wt, 3±2%;
Tg2576, 2±3%), and no differences in cell composition between the
genotypes were found. APPswe neurons were also characterized for
amyloid peptide intracellular deposition using the 6E10 antibody.
This antibody reacts with full-length amyloid precursor protein
(APP) and the soluble form (sAPPα), as well as with the processed
Aβ peptides. It is reactive to human-specific amino acid residues 1-
6, within the amino acids 3-8 of Aβ. All neurons derived from
Tg2576 mice show high intensity staining, whereas Wt neurons are
negative (Fig. 1B). We also investigated the expression level of
VEGFa and related receptors, a regulatory factor with a key role in
angiogenesis, vascular development, and neuronal survival after
ischemia (Takahashi and Shibuya, 2005). Notably, VEGFA mRNA
expression level in APPswe is twice that of Wt (P=0.0274), while
type 1 (FLT1) and type 2 (KDR) VEGF receptors are strongly down-
regulated (FLT-1, P=0.0092; KDR, P=0.001; Fig. 1C).
APPswe neurons are more vulnerable than Wt neurons
We then challenged Wt and APPswe neurons under conventional
experimental conditions to mimic in vitro hypoxic/ischemic brain
conditions. In particular, glutamate excitotoxicity was established
by 10 min exposure to 42 µM glutamate [EC50 at 7 days in vitro
(DIV); Ha et al., 2009] followed by 24 h withdrawal; OGD was
applied for 3 h, followed by 24 h reperfusion (Goldberg and Choi,
1993; Baldassarro et al., 2016) (Fig. 2A). Cell viability was
established by the contemporaneous analysis of the mitochondrial
membrane potential by MitoTracker and nuclear morphology by
Hoechst 33258, using cell-based high-content screening as an
analytical method. MitoTracker is a mitochondrial-selective
fluorescent label that allows mitochondria depolarization, an early
event in neurodegeneration, to be recognized in neurons (Lipton,
1999). OGD-induced cell death is characterized by mitochondria
depolarization and cells showing depolarized mitochondria can be
identified as poorly MitoTracker-labelled cells (Wappler et al.,
2013; Wilson et al., 2014). Vulnerability of Wt and APPswe
neurons to glutamate excitotoxicity is shown in Fig. 2B. APPswe
neurons showed a higher cell death compared to Wt, both in the
absence and in the presence of glutamate (Fig. 2D; treatment: F1,15,
P<0.0001; genotype: F1,15, P<0.0001). OGD resulted in cell death,
as evaluated by mitochondrial function (Fig. 2C; OGD: F1,33,
P<0.0001; genotype: F1,33, P<0.0001) and nuclear fragmentation in
both Wt and APPswe neurons (Fig. 2D; OGD: F1,17, P=0.0005;
genotype: F1,17, P<0.0001). OGD produced stronger neuron
degeneration in APPswe than in Wt neurons (mitochondria,
P<0.0001; nuclei, P=0.0237). Representative images of
MitoTracker-positive neurons in normoxia and under OGD are
presented in Fig. 2E,F,I,J. Morphological criteria for automatically
distinguishing normal versus pathological nuclei (pyknotic and
fragmented) and representative images of Hoechst 33258-stained
nuclei after normoxia or OGD exposure are presented in Fig. 2G,H,
K,L.
Intraneuronal amyloid increases neural vulnerability during
OGD
In order to establish if intraneuronal accumulation of Aβ peptides
contributes to the increased vulnerability of APPswe neurons
compared to Wt we used the γ-secretase inhibitor LY450139. This
drug reduces both soluble Aβ and amyloid plaque burden in
transgenic mice, lowering Aβ40 and Aβ42 production and secretion
by the γ-secretase enzyme complex (Abramowski et al., 2008).
Neuronal cultures were treated with the γ-secretase inhibitor
LY450139, starting from 48 h after seeding and for the entire
duration of the experiment (Fig. 3A). LY450139 (10 µM) inhibits
the generation of Aβ peptides in vivo and in vitro, as also described
for primary neurons transfected with APPswe (Elvang et al., 2009;
Jämsä et al., 2011). This treatment also produces a substantial
decrease of cytoplasmic 6E10-immunostaining in APPswe neurons
(Fig. 3B,C), which proves the effectiveness of the γ-secretase
inhibition, resulting in a reduction in the intracellular levels of APP/
Aβ (Sivilia et al., 2013). Cells treated with LY450139 were then
Fig. 1. Culture characterization. (A) Representative images of double-
stained cells showing β-III-tubulin-positive neurons and GFAP-positive
astrocytes. Scale bar: 50 µm. (B) Representative images of 6E10-stained cells
showing intracellular accumulation of the human APP protein/β-amyloid
fragments. Scale bar: 10 µm. Nuclei are stained blue with Hoechst 33258.
(C) mRNA expression level of VEGF and VEGF receptors FLT-1 and KDR
(VEGFA, Wt n=15, APPswe n=11; FLT1, Wt n=13, APPswe n=11; KDR, Wt
n=13, APPswe n=9). Bars represent mean+s.e.m. Statistical analysis:
Student’s t-test between genotypes (*P<0.05; **P<0.01; ***P<0.001).
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exposed to OGD and analysed for mitochondrial function (Fig. 3D)
and nuclear morphology (Fig. 3E). LY450139 did not modify cell
viability either in Wt or APPswe neurons, but it did abolish the
mitochondria dysfunction induced by OGD in APPswe neurons
(Fig. 3D; normoxia versus OGD, P=0.0028; OGD versus OGD
+LY450139, P=0.0389) and afford partial protection against
nuclear pyknosis (Fig. 3E; normoxia versus OGD, P=0.0268).
Astrocyte-conditioned medium after OGD protects APPswe
neurons from OGD
In order to investigate the possible contribution of the paracrine
properties of Wt and APPswe astrocytes in neuronal vulnerability
after OGD, we prepared conditioned medium from astrocytes
(ACM). The astrocytes were derived from Wt and APPswe mice.
Cultures showing 98±2% of GFAP-positive cells and 6E10-
immunoreactivity in APPswe GFAP-positive astrocytes are
presented in Fig. 4B. We applied to astrocytes the same OGD
protocol as used for neurons (3 h OGD and 24 h reperfusion). The
culture medium was collected both after the OGD and reperfusion
phases and used to treat primary neurons in the two phases of the
experiment. Neuron viability after reperfusion was then established
as mitochondria function (Fig. 4C) and nuclear morphology
(Fig. 4D). ACM, whether from Wt or APPswe astrocytes, is not
effective in protecting Wt and APPswe neurons from OGD.
Conversely, ACM derived from both Wt and APPswe astrocytes
fully protects APPswe neurons from OGD as measured by
Fig. 2. Vulnerability ofWt andAPPswe
neurons to culture condition,
glutamate excitotoxicity and OGD.
(A) Experimental design. Primary
neurons isolated from Wt and Tg2576
mice were exposed at 7 DIV to the
challenge stimulus (42 µM glutamate or
3 h OGD). Cells were then exposed to
the original culture medium for 24 h.
(B) Cell viability analysis of Wt and
APPswe neurons exposed to vehicle
and glutamate, as established by
nuclear morphology (Wt vehicle, n=4;Wt
glutamate, n=5; APPswe vehicle, n=5;
APPswe glutamate, n=5). (C,D) Cell
viability analysis of Wt and APPswe
neurons exposed to normoxia and OGD,
as established by mitochondrial function
(C; Wt normoxia, n=10; Wt OGD, n=10;
APPswe normoxia, n=8; APPswe OGD,
n=9) and nuclear morphology (D; Wt
normoxia, n=6; Wt OGD, n=5; APPswe
normoxia, n=5; APPswe OGD, n=5).
(E-L) Representative images of
MitoTracker-stained cells (E,F,I,J) and
Hoechst-stained nuclei (G,H,K,L)
isolated from Wt (E,I,G,K) and
APPswe (F,J,H,L) mice and exposed to
normoxia (E-H) or OGD (I-L). Scale bar:
50 µm (E,F,I,J) and 80 µm (G,H,K,L). G
and K include high-magnification images
of a normal nucleus (G) or pyknotic/
fragmented nuclei (K); scale bar: 10 µm.
Bars represent mean±s.e.m. Statistical
analysis: Two-way ANOVA, followed by
Sidak’s multiple comparison test.
Asterisks represent differences between
vehicle- and glutamate-treated groups
(B; ****P<0.0001) or between normoxia-
and OGD-exposed groups (C,D;
*P<0.05; **P<0.01; ***P<0.001); letters
represent differences between
genotypes (a, P<0.05; c, P<0.001;
d, P<0.0001).
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mitochondrial function (Fig. 4D; OGD versus ACM-Wt, P=0.113;
OGD versus ACM-hAPP, P<0.0001) and number of pyknotic
nuclei (Fig. 4D; OGD versus ACM-Wt, P=0.0011; OGD versus
ACM-hAPP, P=0.0022). No statistical differences between Wt and
APPswe ACM in protecting APPswe neurons were detected
(Fig. 4C; one-way ANOVA followed by Tukey’s post hoc Wt
versus APPswe ACM, P=0.1039).
DISCUSSION
Neurovascular abnormalities and aberrant glucose metabolism
could be early events in the pathogenic cascade of AD and the
underlying biological mechanisms are still obscure (Lourenço et al.,
2015). In particular, there is a lack of studies aimed at examine the
inter-related role of intracellular APP/Aβ peptide accumulation and
neurovascular coupling during AD development and/or progression
(Sagare et al., 2012). The aim of this study was to provide a novel
in vitro system to dissect the relative contribution of neurons and
astrocytes to cell vulnerability during hypoxic conditions in
Alzheimer’s disease. We thus derived primary cortical neurons
and astrocytes from neonatal Tg2576 mice and Wt littermates. The
experimental set-up included cells derived from single pups, which
were split into different wells (technical replicates), with the single
animal taken as the unit for statistical analysis (biological
replicates). The experiments were analysed using a high-content
approach, thus avoiding bias and providing a quite robust platform.
Cell-based high-throughput technology combining cellular imaging
with high-throughput data analysis (Radio andMundy, 2008) has in
fact been successfully applied to drug screening (O’Brien, 2014)
and was also used to set up standard procedures according to the
European Centre for the Validation of Alternative Methods
(ECVAM) Good Cellular Culture Practice guidelines (Coecke
et al., 2005). We first demonstrated that primary neurons derived
from mice carrying the APPswe mutation, thus accumulating APP
and amyloid peptides, are more vulnerable than neurons derived
from Wt mice to conventional culture conditions, glutamate and
OGD. We then demonstrated that the reduction in the concentration
of amyloid peptides obtained by blocking γ-secretase enzyme
synthesis results in a protection of APPswe neurons from OGD-
induced degeneration. Finally, we showed that conditioned medium
obtained from either Wt or APPswe astrocytes exposed to OGD is
neuroprotective for APPswe, but not for Wt neurons.
The intracellular concentration of Aβ42, the most toxic Aβ variant,
in pyramidal (CA1) human neurons has been estimated to be much
higher in sporadic AD patients than in control subjects (Umeda et al.,
2011). This is due to an early dysfunction of APP processing which
occurs before extracellular plaque deposition (LaFerla et al., 2007;
Gouras et al., 2010). Tg2576 mice also exhibit a high level of
intraneuronal Aβ peptides at the pre-plaque stage (Balducci et al.,
2011; Beggiato et al., 2014) and several working hypotheses have
endeavoured to clarify the possible relationship between this event
and cell vulnerability and death (Bramham, 2008; Crews and
Masliah, 2010; Pensalfini et al., 2014). For example, intraneuronal
Aβ perturbs local protein synthesis and cytoskeleton dynamics
(Bramham, 2008) and is causally related to the activation of the
protein kinases responsible for intracellular tau hyperphosphorylation
and caspase-3 activation (Takahashi et al., 2002; Eimer and Vassar,
Fig. 3. Effect of γ-secretase inhibition on the vulnerability of primary neurons to OGD. (A) Experimental design. Primary neurons isolated from Wt and
Tg2576 mice were treated with LY450139 from 2 DIV to the end of the experiment. At 7 DIV, cells were exposed to 3 h of OGD and 24 h of reperfusion in the
previous culture medium. (B) Representative images of 6E10 immunostaining of APPswe neurons, showing the intracellular accumulation of human APP protein/
Aβ fragments. Scale bar: 50 µm. (C) Quantification of 6E10 in Tg2576 cells exposed to normoxia and treated or not with LY450139 (APPswe vehicle, n=5;
APPswe LY450139, n=5). (D,E) Cell viability analysis ofWt and APPswe neurons exposed to normoxia andOGD, treated or not with LY450139, as established by
mitochondrial function (E; Wt normoxia, n=10; Wt normoxia, LY450139, n=6; Wt OGD, n=10; Wt OGD LY450139, n=4; APPswe normoxia, n=7; APPswe
normoxia LY450139, n=6; APPswe OGD, n=8; APPswe OGD LY450139, n=4) and nuclear morphology (F; Wt normoxia, n=6; Wt normoxia LY450139, n=4; Wt
OGD, n=5; Wt OGD LY450139, n=4; APPswe normoxia, n=5; APPswe normoxia LY450139, n=4; APPswe OGD, n=5; APPswe OGD LY450139, n=5). Bars
represent mean±s.e.m. Statistical analysis: one-way ANOVA followed by Tukey’s multiple comparisons test inside the same genotype. Asterisks represent
differences between LY450139- and vehicle-treated groups (*P<0.05; ***P<0.001; ****P<0.0001).
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2013). In this study, we described how APPswe neurons are more
vulnerable not only to OGD but also to glutamate excitotoxicity, that
is the main driver for OGD-induced cell death (Goldberg and Choi,
1993), proving that the presence of the mutation influences the
response of neurons to this stimulus. Treatment of the cultures with
the γ-secretase inhibitor LY450139 results in neuroprotection, thus
suggesting that intraneuronal Aβ accumulation could be responsible
for the increased vulnerability to OGD observed in APPswe
compared with Wt neurons. Actually, APPswe cells died in greater
numbers in standard culture conditions, thus, the higher cell death
under glutamate and OGD exposure could be an additive effect.
However, the γ-secretase inhibition does not affect Wt viability nor
the spontaneous cell death of APPswe neurons, strongly linking the
inhibition of Aβ production to the protective effect.
In view of the key role of astrocytes in the CVU, we then
performed experiments to dissect the possible interaction between
astrocytes and neurons in our experimental systems, focusing on
astrocyte-derived paracrine factors. Astrocytes are considered to be
inherently neuroprotective in ischemic stroke and similar conditions
(Zhao and Rempe, 2010), because of the role of astrocytes in
supporting neuron energy homeostasis (Brown and Ransom, 2007).
In vitro, co-cultures of neurons and astrocytes are more resistant to
oxidative stress than pure neural cultures (Mattson and Rychlik,
1990). We have shown that conditioned medium obtained during
OGD either fromWt or APPSwe astrocytes is also neuroprotective in
APPSwe but not inWt neurons. After 3 h OGD and 24 h reperfusion,
the percentage of low-MitoTracker-stained cells in Wt is around 30%
and in APPSwe is around 53%, while the percentage of pyknotic
nuclei is 22% and 35%, respectively. After 3 h OGD and 24 h
reperfusion, the percentage of low-MitoTracker-stained cells in Wt is
29.61±2.15% and in APPSwe is 54.92±4.76%, while the percentage
of pyknotic nuclei is 22.16±1.18% and 28.28±1.81%, respectively.
Thus, the OGD conditions used in this study can be considered ‘mild’
(Yu et al., 2012; Baldassarro et al., 2016). The ACM is not effective
Fig. 4. Effect of astrocyte conditioned medium on the vulnerability of primary neurons to OGD. (A) Experimental design. Primary astrocytes isolated from
Wt and Tg2576micewere exposed to 3 hOGD, and conditionedmedium collected.Wt and APPswe primary neurons were then exposed toWt and APPsweACM
during normoxia or OGD and reperfusion. (B) 6E10 immunostaining of APPswe astrocytes, showing the intracellular accumulation of human APP protein/Aβ
fragments in GFAP-positive cells. Scale bar: 50 µm. (C,D) Cell viability analysis of Wt and APPswe neurons exposed to normoxia and OGD, treated or not with
ACM, as established by mitochondrial function (C; Wt OGD, n=10; Wt OGD ACM-Wt, n=5; Wt OGD ACM-APPswe, n=6; APPswe OGD, n=9; APPswe OGD
ACM-Wt, n=5; APPswe OGD ACM-APPswe, n=6) and nuclear morphology (D; Wt OGD, n=5; Wt OGD ACM-Wt, n=5; Wt OGD ACM-APPswe, n=4; APPswe
OGD, n=5; APPswe OGD ACM-Wt, n=5; APPswe OGD ACM-APPswe, n=5). The yellow horizontal bars represent normoxia values (the height of the bar
represent the range of themean value±s.e.m.). Bars represent mean+s.e.m. Statistical analysis: one-way ANOVA followed by Dunnett’s multiple comparison test
inside the same genotype. Asterisks represent differences between ACM-treated groups and groups exposed to OGD only (*P<0.05; **P<0.01; ****P<0.0001).
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when used with Wt neurons, while it reduces the viability indices to
Wt values when used with APPSwe neurons.
The reason for the selective effect of both ACM in APPSwe
neurons only is not clear. In view of the role of astrocytes in CVU,
the altered vascular endothelial growth factor (VEGFa) signalling
observed in APPSwe- compared with Wt-derived cells could play a
role. VEGFa and its receptors are in fact expressed in adult brain by
neurons and astrocytes (Licht and Keshet, 2013; Mackenzie and
Ruhrberg, 2012) and its expression is modulated by pathological
conditions (Calzà et al., 2001) in humans (Boer et al., 2008) and in
AD (Tarkowski et al., 2004). Here, we showed that APPSwe-
derived neurons actually showed also a decreased expression of the
relative receptors KDR and FLT-1. Moreover, the gene expression
analysis of neurospheres derived from pre-plaque Tg2576 mice and
analysed for clustering indicated that all upregulated genes in
Tg2576 centred on VEGF (Baldassarro et al., 2013). It may thus be
postulated that a different production of or sensitivity to paracrine
factors occurs in APPSwe compared with Wt neurons. Several
paracrine mechanisms between cells in the CVU playing a major
role in neuron viability have been described in vivo and in in vitro
systems, including growth factors (Lin et al., 2006; Li et al., 2014).
Notably, VEGF seems to have a two-fold effect on neuron viability,
which also depends on amyloid dosage (Sanchez et al., 2013; Dal
Prà et al., 2014; Wood et al., 2015). Moreover, other potential
cellular players for in vivo OGD neuroprotection, including
endothelial cells and pericytes should be considered.
In conclusion, in this study we present an in vitro system aimed to
dissect the contribution of the different cell types of the CVU to
hypoxia and OGD. Primary neurons and astrocytes derived from
transgenic animals carrying gene mutations of interest for AD are a
promising tool for investigating co-morbidities and cofactors such
as Aβ deposition and vascular dysfunction leading to hypoxia.
Finally, the use of cell-based high-content analysis is recommended
in order to improve in vitro data robustness.
MATERIALS AND METHODS
Primary neuronal cultures
All animal protocols described herein were carried out according to the
European Community Council Directives (86/609/EEC), and comply with
the guidelines published in theNIHGuide for the Care andUse of Laboratory
Animals. Cortical neurons from single neonatal (within 24 h frombirth)Wt or
Tg2576 (Taconic, Hudson, NY, USA) mice were prepared according to
standard protocols (Fernández et al., 2005; Del Vecchio et al., 2009). Briefly,
brains were removed and cortical tissue dissected, freed from the meninges,
and minced into small pieces. Cells were dispersed in Kreb’s buffer (0.12 M
NaCl, 4.8 mM KCl, 1.2 mM KH2PO3, 25.4 mM NaHCO3, 14.2 mM
glucose, 0.01 mg/ml Phenol Red, 1.5 mM MgSO4) containing BSA 0.3%
and 0.025% trypsin (Sigma-Aldrich) for 15 min at 37°C, followed by
mechanical trituration with a Pasteur pipette in Kreb’s buffer containing
0.004%deoxyribonuclease I (DNaseI, Sigma-Aldrich), and 0.052% soybean
trypsin inhibitor (SBTI; Sigma-Aldrich). After centrifugation (500 g, 5 min),
cells were resuspended inNeurobasal culturemedium supplementedwith 2%
B27 (Invitrogen), 2 mM glutamine (Sigma-Aldrich), 100 U/ml penicillin,
and 100 μg/ml streptomycin (pen/strep; Invitrogen) and plated onto Cultrex
2D substrate (0.25 mg/ml; Trevingen, Gaithersburg,MD,USA) coated plates
or coverslips. Cells were maintained in a humidified incubator at 37°C with
5% CO2. To obtain neuronal culture (99% neurons) cells were treated after
24 h with 10 μM cytosine arabinofuranoside (Sigma-Aldrich) and at 4 DIV,
half of the medium was changed. Neurons isolated from Tg2576 mice are
denoted as APPswe primary neurons.
Primary astrocyte cultures
Primary astrocytes were isolated from single 7-day-old Wt or Tg2576 mice
using the same protocol as the primary neuronal cultures (Jones et al., 2011),
except that cells were plated and maintained in DMEM with 15% fetal
bovine serum (FBS), non-essential amino acid mixture (Sigma-Aldrich),
pen/strep (Invitrogen) and 2 mM Glutamine (Invitrogen). Cultures were
seeded in culture-treated flasks at a density of 125,000 cells/cm2
and maintained at 37°C 5% CO2. Cells were detached with trypsin
(10 min, 37°C) and replated twice before use. For the OGD exposure,
astrocytes were seeded in flat-bottom 96-well plates and exposed to OGD
2 weeks after plating. Astrocytes isolated from Tg2576 mice are denoted as
APPswe primary astrocytes.
Genotyping
Mouse tails were used for genotyping analysis. The mouse genomic DNA
was extracted using the GenElute Mammalian Genomic DNAMiniPrep Kit
(Sigma-Aldrich) according to the manufacturer’s instructions and eluted in
100 µl of elution solution. DNA concentration was determined using a
spectrophotometer and Tg2576 mice were identified by the presence of the
mutated human APP gene (FW: 5′-GATGAGGATGGTGATGAGGTA-3′
REV: 5′-ACTGGCTGCTGTTGTAGG-3′) using the Real Time PCR
technique and the SYBR Green qPCR master mix (Bio-Rad) and 0.4 µM
forward and reverse primers. The amount of DNA used for each sample was
10 ng and PCR amplification conditions were: 60°C for 30 s.
Glutamate excitotoxicity
At 7 DIV, Wt and APPswe primary neurons were treated with 42 µM
glutamate. Briefly, medium was removed and cells were exposed to Krebs
buffer, with or without glutamate, for 10 min. After glutamate treatment,
Krebs buffer was replaced with medium (Fernandez et al., 2005).
Oxygen and glucose deprivation and treatment
OGD was performed on primary cortical neurons and primary astrocytes
cultures using an air-tight hypoxia chamber (Billups-Rothenberg, Del Mar,
CA, USA) saturated with 95% N2, 5% CO2 (Goldberg and Choi, 1993).
Glucose deprivation was achieved using a glucose-free Neurobasal medium,
supplemented with B27, glutamine and penicillin/streptomycin as above.
Oxygen was removed by flushing the hypoxia chamber with N2-CO2
mixture for 6-8 min at 25 l/min. The flushing was repeated after half
the incubation time. The OGD condition was maintained for 3 h, after
which plates were re-oxygenated for 24 h in the old medium in a cell
incubator.
Wt and APPswe astrocyte media, both from the OGD and after
reperfusion phases were collected, and used as astrocyte-conditioned
medium (ACM) on neurons. In one set of experiments, Wt and APPswe
primary cortical neurons were exposed to Wt and APPswe ACM both in the
OGD and the reperfusion phases. In another set of experiments, primary
cortical neurons were treated from 2 DIV to the end of the experiment
(8 DIV) with 10 µM LY450139.
MitoTracker staining
Cells were stained with MitoTracker Orange (Thermo Scientific, Waltham,
MA, USA) following the manufacturer’s instructions. Briefly, cells were
treated for 30 min at 37°C with 150 nMMitoTracker. After twowashes with
PBS, cells were fixed and used in the immunocytochemistry procedure.
Immunocytochemistry
At 8 DIV, cells werewashed with ice-cold PBS and fixed in a solution of 4%
paraformaldehyde for 20 min at room temperature (RT) and washed twice
with PBS. Cells were then treated with 0.1 M PBS, 0.3% Triton X-100
containing 1% BSA and 1% normal blocking serum prepared from the
species in which the secondary antibody was raised for 1 h at RT.
The following primary anti-sera were used: anti-6E10 (mouse; Covance,
SIG-39320, batch no. D11AF00145; 1:1000), anti-β-III-tubulin (mouse;
R&D Systems, MAB-1195, batch. no. HGQ0113121; 1:1000), anti-GFAP
(rabbit; Dako, Z0334, batch no. 20005461; 1:1000) overnight at 4°C. Cells
were washed with PBS and incubated with goat Alexa 488-conjugated anti-
mouse, goat Alexa 568-conjugated anti-rabbit, goat Alexa 658-conjugated
anti-mouse (Invitrogen) secondary antibodies for 30 min at 37°C. Cells
were washed twice in PBS and incubated with the nuclear dye Hoechst
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33258 (1 µg/ml) for 20 min at RT, washed with PBS and mounted with
0.1% para-phenylendiamine solution.
Cell-based high-content screening
For HCS analysis cells were grown in 96 flat-bottomwell HCS plates (Nunc,
Roskilde, Denmark). Analysis of condensed nuclei, cell number and lineage/
differentiation markers were performed with Cell Insight CX5 High Content
Screening (HCS; Thermo Scientific), using the Compartmental Analysis
BioApplication. Based on nuclear staining, the software is able to recognise
nuclei and calculate the percentage of high intensity/small sized condensed
nuclei.Moreover, based on nuclei identification, the software is able to detect
the presence of the marker-specific stain in the cell body, calculating the
percentage of immunoreactive cells and fluorescence intensity. For the
MitoTracker analysis, the software is able to recognize every single cell by its
nuclear staining and quantifies the fluorescence intensity inside the cell body.
The operator can select a fluorescence threshold that allows the software to
discriminate between ‘high-intensity staining’ and ‘low-intensity staining’.
Using the same parameters and the same threshold it is possible to perform an
automatic, statistically robust and objective analysis. This technique avoids
also the bias of the analysis of randomly chosen fields, because the analysis is
performed in all cells. From 60,000 to 80,000 cells/well were analysed.
RNA isolation and reverse transcription
Total RNA isolation was performed with the RNeasy Micro kit (Qiagen)
following the manufacturer’s instructions. Total RNAwas eluted in RNase-
free water and concentration estimated through absorbance values at 260,
280 and 320 (Nanodrop 2000 spectrophotometer, Thermo Scientific). First-
strand cDNAs were obtained using the iScript cDNA Synthesis Kit (Bio-
Rad), incubating at 42°C for 30 min. An RNA sample with no reverse
transcriptase enzyme in the reaction mix was processed as a no-reverse
transcription control sample.
Semi-quantitative real-time PCR
Semi-quantitative real-time PCR was performed using the CFX96 real-time
PCR system (Bio-Rad). The reactions were performed in a final volume of
20 µl consisting of 1× SYBR Green qPCR master mix (Bio-Rad) and
0.4 µM forward and reverse primers. In order to avoid possible
contamination of genomic DNA in isolated RNA, the sample with no
reverse transcriptase enzyme was processed in parallel with the others and
tested by real-time PCR for every pair of primers used. All primers used
were designed using Primer Blast software (NCBI) and synthesized by
IDT (Coralville). The following primer sequences were used: VEGFA
(FW: 5′-AAGAGAAGGAAGAGGAGAG-3′; REV: 5′-ACCCAAGAG-
AGCAGAAAG-3′); FLT1 (FW: 5′-CGTGCAAGGAACCTCAGACA-3′;
5′-ATCATAGGGCAGCCGTTCAC-3′); KDR (FW: 5′-ATGTCCTTGGC-
TGTGCAAGA-3′; REV: 3′-CCTTCATTGGCCCGCTTAAC); GAPDH
(FW: 5′-GGCAAGTTCAATGGCACAGTCAAG-3′; REV: 5′-ACATAC-
TCAGCACCAGCATCACC-3′) was used as a housekeeping gene to
normalize the amount of reverse-transcribed RNA used for PCR. Thermal
profile of PCR reactions consisted first of a denaturation step (95°C, 2 min)
and 40 cycles of amplification (95°C for 15 s and 60°C for 60 s). At the end
of the amplification cycles, the melting curve of amplified products was
performed according to the following temperature/time scheme: heating
from 55°C to 95°C with a temperature increase of 0.5°C/s.
Primer efficiency values for all primers were 95-102%. The 2(−ΔΔCT)
method was used for the calculation of gene expression.
Statistical analysis
The number of wells per animal varied according to the cell isolation yield.
For mRNA analysis, each value derived from a single animal. For HCS
analysis, individual data were obtained from the mean value of the wells
obtained from a single animal culture. Exclusion criteria in data analysis
were pre-established for each assay as follows. mRNA analysis: samples in
which curves not fitting the melting temperature or in which a double peak
was observed were excluded from the analysis; HCS analysis: wells in
which the software was unable to automatically identify the nuclei were
excluded from the analysis. The final number of data per group is reported in
the figure legends.
Data are reported as mean±s.e.m. Prism software (GraphPad) was used
for statistical analyses and graph generation. Student’s t-test, two-way
ANOVA and Sidak’s multiple comparison or one-way ANOVA and
Dunnett’s or Tukey’s multiple comparison post hoc were used to analyse
data, as specified in the figure legends. Results were considered significant
when the probability of their occurrence as a result of chance alone was less
than 5% (P<0.05).
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Tarkowski, E., Issa, R., Sjögren, M., Wallin, A., Tarkowski, A. and Kumar, P.
(2004). Increased intrathecal levels of the angiogenic factors VEGFand TGF-beta
in Alzheimer’s disease and vascular dementia. Neurobiol. Aging. 23, 237-243.
Umeda, T., Tomiyama, T., Sakama, N., Tanaka, S., Lambert, M. P., Klein, W. L.
and Mori, H. (2011). Intraneuronal amyloid β oligomers cause cell death via
endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial
dysfunction in vivo. J. Neurosci. Res. 89, 1031-1042.
van de Haar, H. J., Jansen, J. F. A., van Osch, M. J. P., van Buchem, M. A.,
Muller, M., Wong, S. M., Hofman, P. A. M., Burgmans, S., Verhey, F. R. J. and
Backes, W. H. (2016). Neurovascular unit impairment in early Alzheimer’s
disease measured with magnetic resonance imaging. Neurobiol. Aging 45,
190-196.
Wappler, E. A., Institoris, A., Dutta, S., Katakam, P. V. G. and Busija, D. W.
(2013). Mitochondrial dynamics associated with oxygen- glucose deprivation in
rat primary neuronal cultures. PLoS ONE 8, e63206.
Wilson, M. S., Graham, J. R. and Ball, A. J. (2014). Multiparametric High Content
Analysis for assessment of neurotoxicity in differentiated neuronal cell lines and
human embryonic stem cell-derived neurons. Neurotoxicology 42, 33-48.
Wood, L. B., Winslow, A. R., Proctor, E. A., McGuone, D., Mordes, D. A., Frosch,
M. P., Hyman, B. T., Lauffenburger, D. A. and Haigis, K. M. (2015).
Identification of neurotoxic cytokines by profiling Alzheimer’s disease tissues
and neuron culture viability screening. Sci. Rep. 5, 16622.
Yu, Z., Xu, J., Liu, N., Wang, Y., Li, X., Pallast, S., van Leyen, K. and Wang, X.
(2012). Mitochondrial distribution of neuroglobin and its response to oxygen-
glucose deprivation in primary-cultured mouse cortical neurons. Neuroscience
218, 235-242.
Zhao, Y. and Rempe, D. A. (2010). Targeting astrocytes for stroke therapy.
Neurotherapeutics 7, 439-451.
Zlokovic, B. V. (2011). Neurovascular pathways to neurodegeneration in
Alzheimer’s disease and other disorders. Nat. Rev. Neurosci. 12, 723-738.
678
RESEARCH ARTICLE Disease Models & Mechanisms (2017) 10, 671-678 doi:10.1242/dmm.028001
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
	   151	  
4.7 Foetal and adult oligodendrocyte precursor cells are differentially vulnerable to 
inflammation and oxygen-glucose deprivation (Baldassarro et al., unpublished – B). 
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Foetal and adult oligodendrocyte precursor cells are differentially vulnerable to 
inflammation and oxygen-glucose deprivation. 
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Abstract 
 
Acute traumatic or vascular lesions of the central nervous system are characterized by an 
extensive myelin loss, when occurring in the adult life, or impaired myelination, when 
occurring during early postnatal stage. Hypoxia and inflammation characterize both 
conditions, severely affecting the myelin repair or myelin development, respectively. Both 
processes are dependent on oligodendrocyte precursor cells (OPCs) and its capability to 
differentiate into mature, myelinating oligodendrocyte (OL). 
In this study we investigated the response of OPC derived from neural stem cells (NSCs) 
isolated from foetal and adult brains to in inflammatory and hypoxic insults, focusing on OPC 
survival and differentiation. OPCs were exposed to a cytokine cocktail, to mimic 
inflammation, or to oxygen-glucose deprivation (OGD), to mimic hypoxic condition. After 
exposure to inflammatory cytokines, the differentiation of both foetal and adult OPCs is 
completely abolished. On the contrary, when exposed to OGD, only foetal- and not adult-
brain derived OPC degenerate. Moreover, foetal OGD-induced cell death is characterized by a 
delayed onset.  
These results indicate than the biological response of OPC to inflammation and demyelination 
are different in foetal and adult cells. The understanding of the underlying molecular 
mechanism will strongly contribute to differentiate myelination enhancing and 
neuroprotective therapies for neonatal and adult CNS lesions. 
 
  
Keywords 
oligodendrocyte precursor cells, inflammation, hypoxia/ischemia, oxygen-glucose deprivation 
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1. Introduction 
 
The myelin loss is a major pathological event in traumatic and vascular lesions of the central 
nervous system (CNS), and it is also considered a major cause of neurodegeneration and 
chronic disabilities (Verden and Macklin, 2016). The underlying pathogenic mechanisms 
include the myelin breakdown by oxidative stress products and oligodendrocyte (OL) cell 
death. Moreover, also oligodendrocyte precursor cells (OPC), the cell responsible for myelin 
development during early postnatal age and of myelin repair during the adult life, undergoes 
to extensive degeneration (Alizadeh et al., 2015) and impaired differentiation into mature OL 
(van Tilborg et al., 2017).  
During the adult life, myelin damages can be efficiently and correctly repaired and functions 
restored (Crawford et al., 2013) thanks to OPCs, which proliferate, migrate to the 
unmyelinated axons and differentiate in mature oligodendrocytes (OLs) after lesion (Trotter et 
al., 2010). Since OPCs are the cells responsible for both developmental myelination and 
myelin repair during the adult life, it has been suggested that remyelination in adulthood is 
resembling the developmental myelination mechanism (Franklin & Hinks 1999). However, 
morphological differences between the two processes lead to the view that these two 
mechanisms are differentially regulated (Miron, 2011) Moreover, we also demonstrated that 
PARP expression and activity, such as the effect to PARP inhibition exposure is substantially 
different in OPC derived from foetal or adult brain, impacting on cell survival and 
differentiation (Baldassarro et al., 2017). 
Two main pathological mechanisms are involved in myelin injury and demyelination, both in 
foetal (e.g. neonatal hypoxia/ischemia) and adult lesions (e.g. multiple sclerosis, MS; spinal 
cord and brain trauma, stroke), i.e. inflammation and hypoxia/ischemia (HI; Calzà et al., 
2017). 
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Inflammation has a dual role on myelin and OPC pathobiology, being a promoter of myelin 
repair in some conditions, and a severe inhibitor in other conditions (Tognatta and Miller, 
2016). In fact, depending on the severity of the inflammation, an overproduction of 
cytokines/chemokines may lead to excessive inflammation and OL cell death (Patel and 
Klein, 2011). This has been considered for many years the cause of remyelination failure in 
several conditions, usually characterized by the establishment of severe (and chronic) 
inflammatory microenvironment. More recently, the role of OPC differentiation block has 
been indicated as preeminent event to explay remyelination failure in multiple sclerosis 
(Irvine and Blakemore, 2008) and spinal cord injury (Mekhail et al., 2012), and stroke both in 
experimental animals and humans. In particular, in lesion models of 
inflammatory/demyelinating diseases local OPCs in the white matter proliferate and part of 
them differentiates into astrocytes, while the remaining cells are mainly blocked in a 
progenitor phenotype (Sozmen et al., 2016). 
HI also occurs in acute injuries, like trauma and stroke. In these conditions, most of the white 
matter infarcts are believed to be secondary to vascular occlusion and endothelial cell 
dysfunction (El Waly et al., 2014). Three hours after HI, OLs show swelling and 
vacuolization, followed by retraction and cell death in 24 hours (Pantoni et al., 2006; McIver 
et al., 2010). Oxygen deprivation is the major cause of neonatal encephalopathy, a common 
cause of neonatal brain injury that affects 1 to 3 per 1000 live births in developed countries 
and up to 26 per 1000 live births in the developing world. The pattern of injury depends on 
the brain developmental time, and on the severity of the insult (Rocha-Ferreira and Hristoya, 
2016). In particular, since myelination occurs from late embryonic gestation throughout post-
natal life and continues until adult life (Fancy et al., 2011), a myelination impairment is a 
typical event when HI occurs at neonatal stages (Rocha-Ferreira and Hristoya, 2016). At this 
age, late OPC are highly susceptible to HI, and the activation of the Cdk2 pathway induces 
OPCs proliferation, delayed/impaired maturation of OLs and apoptosis (Back et al., 2002; 
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Jablonska et al., 2012). HI also induces an inflammatory response that has the positive role to 
remove damaged cells, debris and lipids, followed by a switch from pro- to anti-inflammatory 
profile that stimulates repair processes (Rocha-Ferreira et al., 2016). Several cell types are 
involved in this complex event, which is quite different in neonatal and adult life. After HI in 
adult CNS, leukocytes are activated within hours and migrate into the brain/spinal cord 
injured site, where cytokines are produced in large amounts. On the contrary, HI in new-borns 
induces an immediate (minutes) innate immune response. Age differences in HI-response 
mechanisms also include the cross-talk between excitotoxic, oxidative and inflammatory 
injury, determining the so-called “windows of susceptibility” during late foetal and early 
postnatal brain (Liu et al., 2013). 
Thus, on spite of the fact that OPCs are the cells responsible for both myelin formation during 
development and myelin repair during the adulthood, and in spite of the fact that most OPCs 
that populate adult CNS are generated during prenatal stages (REF), the response of this cells 
to lesion including their capability to evolve into myelinating OL is quite different (Calzà et 
al., 2017). 
In the present study we then analysed in vitro response of foetal and adult OPCs to stimuli 
responsible for myelin loss in vivo. In order to follow all developmental stages of OPC, we 
derived these cells from neural stem cells (NSCs) obtained from foetal forebrain and adult 
subventricular zone. We then exposed these cell systems to experimental conditions 
mimicking in vitro inflammation (cytokine cocktail composed by TGF-b1, TNF-a, IL-1b, IL-
6, IL-17 and IFN-c) and HI model (oxygen-glucose deprivation, OGD), to investigate survival 
and differentiation. Results from this study could have important implication in the 
development of myelin enhancing therapies and neuroprotection strategies. 
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2. Materials and methods  
 
2.1 Cell preparation and cultures 
All animal protocols described herein were carried out according to the European Community 
Council Directives (86/609/EEC), and comply with the guidelines published in the NIH Guide 
for the Care and Use of Laboratory Animals. 
Foetal and adult NSCs were isolated from E.13-14 foetal forebrain or 2.5 month old adult sub-
ventricular zone (SVZ), following the Ahlenius and Kokaia protocol (Ahlenius and Kokaia, 
2010). Oligodendrocyte differentiation was performed following the Chen protocol (Chen et 
al., 2007) with some modifications. Tissues were enzymatically dissociated using trypsin 
(SIGMA), hyaluronidase (SIGMA) and DNase (SIGMA), than mechanically dissociated by 
piepetting. The solution was filtered, centrifuged and the resulting pellet was washed twice in 
HBSS. After 7 minutes centrifugation at 400 × g, the cellular pellet was resuspended in 
serum-free medium (DMEM/F12 GlutaMAX 1 x; 8 mmol/L HEPES; 100 U/100 µg 
Penicillin/Streptomycin; 0.1 x B27; 1 x N-2; 20 ng/mL bFGF; 20 ng/mL EGF) and, after cell 
count, cells were plated in suspension at a density of 10 cells/µl in a final volume of 3 mL in 
low-attachment 6-well plates (NUNC). Half medium was changed every three days, 
centrifuging the cell suspension at 300 × g for 5 minutes and gently resuspending the cellular 
pellet in fresh medium. Neurospheres were allowed to proliferate until they attained a 
diameter of about 100µm. 
To obtain oligospheres, primary neurospheres were centrifuged at 300 x g for 5 minutes. The 
pellet was mechanically dissociated by pipetting and cells were counted and plated again at a 
density of 10 cells/µl in a final volume of 3 mL of OPCs medium (DMEM/F12 GlutaMAX 1 
x; 8 mmol/L HEPES; 100 U/100 µg Penicillin/Streptomycin; 0.1 × B27; 1 × N-2; 20 ng/mL 
bFGF; 20 ng/mL PDGF) in low-attachment 6-well plates (NUNC). Oligospheres were 
centrifuged and the pellet was mechanically dissociated to obtain a single cell suspension. 
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After cell count, cells were plated at a density of 3000 cells/cm2 on poly-D,L-ornithine 
(50µg/ml)/laminin (5µg/ml) coating, in OPC medium. 
In order to induce oligodendrocyte differentiation and maturation, after 3 DIVs OPC  medium 
was replaced with the oligodendrocyte differentiation medium (DMEM/F12 GlutaMAX 1 x; 8 
mmol/L HEPES; 100 U/100 µg Penicillin/Streptomycin; 0.1 x B27; 1 x N-2; 50 nM T3; 10 
ng/ml CNTF; 1x N-acetyl-L-cysteine -NAC-). 
 
2.2 Cytokines exposure 
After the primary neurospheres splitting, foetal and adult cultures were divided in two groups: 
one treated with a mix of six different cytokines (TGF-b1, TNF-a, IL-1b, IL-6, IL-17 and 
IFN-c; 20 ng/mL each) and the other treated with vehicle (0.04% of the cytokines solvent: 
10% glycerol/100 nM glycine/25 nM Tris, pH 7.3). After oligospheres expansion, medium 
was changed with the standard one, without cytokines, in both groups. 
 
2.3 Oxygen-glucose deprivation 
OGD was performed using an air-tight hypoxia chamber (Billups-Rothenberg Inc., Del Mar., 
CA) saturated with 95% N2- 5% CO2 (Goldberg and Choi, 1993). Glucose deprivation was 
achieved using a glucose-free complete medium. Oxygen was removed by flushing the 
hypoxia chamber with N2-CO2 mixture for 6-8 min at 25 l/min. The flushing was repeated 
after half the incubation time. The OGD condition was maintained for 3 h, after which plates 
were re-oxygenated for 24 h in the old medium in a cell incubator. 
 
2.4 Immunocytochemistry  
Indirect immunofluorescence was used to identify OPCs (NG2-positive cells), mature 
(CNPase-positive cells) and myelinating (MBP-positive cells) oligodendrocytes, neurons (β-
III-tubulin-positive cells), astrocytes (GFAP-positive cells) and deyodinases 3 expressing 
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cells (D3). The following primary antisera were used: mouse anti-β-III-tubulin (R&D system, 
Trento, Italy) 1:3000; rabbit anti-GFAP (Glial Fibrillary Acidic Protein, Dako) 1:1000; rabbit 
anti-NG2 (chondroitin sulphate proteoglycan, neural/glial antigen 2, Millipore, Merck S.p.a., 
Milan, Italy) 1:350; mouse anti-CNPase (2', 3'-cyclic nucleotide 3'-phosphodiesterase, 
Millipore) 1:500; rabbit anti-MBP (Myelin Basic Protein, Dako) 1:500; goat anti-D3 
(deyodinase type 3, Santa Cruz Biotechnology) 1:100. Donkey Alexa 488-conjugated anti 
mouse IgG. donkey Alexa 568-conjugated anti-rabbit IgG, 1:500 (Invitrogen) and 
DyLight488-conjugated affinity-pure donkey anti-Goat IgG (Jackson Immunoresearch) 1:100 
were used as secondary antisera. After immunofluorescence staining, cells were incubated 
with the nuclear dye Hoechst 33258 (1 µg/mL in PBS, 0.3% Triton-X 100) for 20 min at RT. 
Cells were finally washed in PBS and mounted in glycerol and PBS (3:1, v/v) containing 
0.1% paraphenylendiamine. 
 
2.5 Fluorescence microscopy 
Fluorescence microscopy was used to quantify the percentage od D3-expressing cells in 
foetal cultures 24 hours after OGD exposure. 
Images were captured using a Nikon Eclipse E600 microscope equipped with digital CCD 
camera Q Imaging Retiga-2000RV (Q Imaging, Surrey, BC, Canada). Measurements were 
performed using Nis-Elements AR 3.2 software. 
Five random filed per glass (duplicate for group) were analysed. D3-positive cell 
percentage was calculated on the total number of cells per field, identified by the nuclear 
saining. 
 
2.6 High Content Screening 
For HCS analysis cells were grown in 96 flat-bottom well HCS plates (NUNC). Analysis of 
condensed nuclei, cell number and lineage/differentiation markers were performed with Cell 
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Insight™ CX5 High Content Screening (HCS; Thermo Scientific), using the Compartmental 
analysis BioApplication. Based on nuclear staining, the software is able to recognise nuclei 
and calculate the percentage of high intensity/small sized condensed nuclei. Moreover, based 
on the nuclei identification, the software is able to detect the presence of the marker-specific 
stain in the cell body, calculating the percentage of the immunoreactive cells. 
Lineage/differentiation markers analysis was performed only on cells showing intact nuclei, 
excluding condensed nuclei from the percentage calculation. 
 
2.7 Statistical Analysis 
Experiments were performed in triplicate for cell number and viability and in duplicate for 
cell markers analysis. Data are reported as mean ± SEM. Prism software (GraphPad) was used 
for statistical analyses and graph generation. Student’s t test or two-way ANOVA (for the 
time course of OGD vulnerability of foetal OPCs) were used to analyse data. Results were 
considered significant when the probability of their occurrence as a result of chance alone was 
less than 5% (P < 0.05). 
 
3. Results 
 
3.1 The cells systems. 
OPCs were obtained driving NSCs differentiation by specific factors. After neurospheres 
splitting, PDGF was substituted to EGF in the culture medium, starting the OPCs 
differentiation, obtaining oligospheres in suspensions. In order to obtain OPCs cultures, 
oligospheres were sedded as single cell suspension and, after 3 days, bFGF/PDGF medium 
was substituted by T3 containing medium, allowing the OLs maturation for 12 DIVs (Figure 
1A).  
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NSCs-derived cultures are mixed cultures composed by OPCs, OLs and astrocytes, with a 
small percentage of neurons (Baldassarro et al., 2017). Lineage progression from NG2-
positive OPC (DIV0) through CNPase- mature OL as far as myelinating CNPase/MBP-
positive OL is illustrated in Fig. 1B-D (representative images). The culture composition 
changes during the 12 DIV differentiation period, starting from DIV0, where the majority of 
cells are NG2 positive (NG2-positive cells 80%; CNPase-positive cells 5%), passing thorough 
DIV 6, where CNPase cells are growing in number (NG2-positive cells 60%; CNPase-
positive cells 30%), reaching the end of the differentiation with CNPase/MBP positive cells 
representing the majority of cells (CNPase-positive cells; 70% in foetal and 45% in adult 
cultures; MBP-positive cells, 40% in foetal and 30% in adult cultures).  Both cultures show 
around 40% of GFAP-positive cells at 12 DIVs, and a small percentage (6-8%) of beta-III-
tubulin positive cells (neurons). 
 
3.2 Inflammatory cytokines block foetal and adult OPCs differentiation. 
In this experiment, NSCs-derived OPCs were exposed at the inflammatory cytokines mix 
during the oligospheres phase, during replication and in absence of differentiating stimuli. 
The cytokine mix was composed by TGF-b1, TNF-a, IL-1b, IL-6, IL-17 and IFN-c. This 
cocktail was choose from in vivo experiments, detected in EAE model, the animal model of 
MS, and we already demonstrated that, when used in these experimental conditions, block 
adult OPCs differentiation (Fernandez et al., 2016). Three days after the OPCs cell seeding, 
cells were triggered to differentiation into OPCs by T3 (Fig 2A). Cells were analysed at the 
end of the differentiation phase for cell number, cell death and positivity for markers 
expressed at different maturation stages (12 DIV, black arrow in Fig 2A) by HCS technology. 
Both foetal and adult OPCs cultures treated with the cytokine mix show an increase in the 
total cell number at the end of the differentiation phase compared to the vehicle-treated cells 
(Student’s t test: foetal, p < 0.0001; adult, p = 0.0009; Fig 2B). Cytokines treatment during the 
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proliferation phase do not induce cell death in both foetal and adult cultures. However, in the 
oppiste way, cytokines-treated foetal cells show a lower percentage of dead cells compared to 
vehicle-treated cells (p = 0.0007; Fig 2C). 
At the end of the differentiation period, cytokines-treated cells show a different cell 
composition compared to vehicle-treated cells. As already described (Fernandez et al., 2016), 
in adult cultures, cytokine treatment of OPCs determines an increase in the percentage of 
NG2-positive cells (Student’s t test, p = 0.0025), which is not observed in the foetal cultures 
(Student’s t test, p = 0.5076). However, in both foetal and adult cultures, OPCs differentiation 
is drastically reduced in the cytokines- compared to the vehicle-treated, as indicated by the 
percentage of mature (CNPase-positive cells) and myelinating (MBP-positive cells) OLs 
(Student’s t test: CNPase, foetal, p < 0.0001, adult, p = 0.0273; MBP, foetal p < 0.0001, adult, 
p = 0.0036). Moreover, also differentiation into astrocyte is decreased by cytokines exposure 
in both foetal and adult cultures, compared to vehicle-treated cells (Student’s t test: foetal, p = 
0.0030; adult p = 0.0001; Fig 2 D-L).  
 
3.3. Foetal but not adult OPCs are vulnerable to OGD-induced cell death 
We then tested foetal and adult OCDs vulnerability to OGD, the most widely used in vitro 
model for HI. The OGD model was previously set up and characterized in primary pure 
neuronal and mixed neurons/astrocytes cultures (Baldassarro et al., 2018), demonstrating that 
3 hours of OGD followed by 24 hours of reoxygenation/reperfusion is able to induce neuronal 
cell death. 
OGD was thus tested in the NSCs-derived OPCs, during the proliferation of seeded OPCs, 24 
hours before the T3-mediated differentiation induction (Figure 3 A). OGD induces a reduction 
in cell number after the differentiation phase in foetal (p < 0.0001), and an increase in adult 
cultures (p < 0.0001; Fig 3 B). The cell number reduction in foetal cultures is associated to a 
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drastic increase of cell death (p < 0.0001), effect not observed in adult cultures (p = 0.1247; 
Fig 3 C). 
In order to investigate the foetal OPC vulnerability according to the phases of the H/I 
pathogenic mechanism, we exposed foetal OPCs to OGD as previously described and we 
analysed the cell number and cell viability, by HCS technology, at three different time points: 
after reoxygenation phase (before adding the T3-induced differentiation stimulus to the 
culture; 0 DIV), and at 6 and 12 DIVs after T3 exposure. Results were analysed by two-ways 
ANOVA, considering the culture time (0, 6 and 12 DIVs) and condition (OGD and 
normoxia). As showed in the previous experiments, both cell number and cell death are 
affected by OGD (two-ways ANOVA for cell number; culture condition, p < 0.0001, F(2,60) 
= 33.48; time, p < 0.0001, F(1,30) = 57.35; interaction, p < 0.0001, F(2, 60) = 106.4; two-
ways ANOVA for cell death, culture condition, p < 0.0001, F(1,30) = 118.4; time, p < 0.0001, 
F(2,60) = 114.6; interaction, p < 0.0001, F (2, 60) = 110.2). However, cell death is a late 
responce, with an effect observed only at 12 DIVs (Sydak post-hoc: normoxia vs. OGD; cell 
number, p < 0.0001; cell death, p < 0.0001; Fig 3 D-E). 
As already indicated, the OPC preparation derived from NSC also contains astrocytes, and 
few neurons. In order to establish the cell population affected by OGD, we used Cell 
Insight™ CX5 HCS. The software identify nuclear size and morphology (normal nucleus for 
living cells; condensed nuclei for dead cells), and the associated cytoplasm immunostaining 
for astrocytes (GFAP), neurons (b-III-tubulin), OPC (NG2), mature OL (CNPase) and 
myelinating OL (MBP), thus allowing the identification of degenerating cell type. The final 
percentage of astrocyte and neurons in the differentiated cultures are not affected by OGD 
(Student’s t test: foetal, GFAP, p = 0.3137, foetal beta-III-tubulin, p = 0.2998; adult, GFAP, p 
= 0.1530, beta-III-tubulin, p = 0.9914). On the contrary, OGD exposure causes a decrease in 
the number of NG2-, CNPase- and MBP-positive cells in foetal- (Student’s t test: NG2, p = 
0.0158; CNPase, p < 0.0001; MBP, p = 0.0002) cultures while adult-derived cultures 
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(Student’s t test: CNPase, p = 0.6283; MBP, p =0.3606) do not show differences in the mature 
and myelinating OLs. However, adult cultures exposed to OGD show an increase in the 
number of NG2-positive cells, compared to normoxia-exposed cultures (p = 0.0025; Figure 4 
A). 
With regard to the lineage composition of dead cells, foetal-derived cultures show an increase 
in cell death in NG2, CNPase and MBP-positive cells (NG2, p = 0.0002; CNPase, p = 0.0028; 
MBP, p = 0.0095), without affecting astrocytes and the small percentage of neurons 
(Student’s t test: GFAP, p = 0.0880; beta-III-tubulin, p = 0.1272). Adult-derived cultures, as 
expected by the analysis of the whole culture, do not show cell death in any population 
(Student’s t test: NG2, p = 0.4690; CNPase, p = 0.2321; MBP, p = 0.3568; GFAP, p = 0.8302; 
beta-III-tubulin, p = 0.4015; Figure 4 B-J). 
Moreover, after the reoxygenation phase (0 DIV, Figure 5 A), foetal-derived cultures show an 
increase in D3-positive cells (p = 0.0009; Fig 5 B-D).      
 
4. Discussion 
 
The most investigated example of the role of inflammation in remyelination failure is multiple 
sclerosis (MS), the most diffuse inflammatory/demyelinating disease in humans (Goodin, 
2014). In the acute focal phase of the disease, remyelination is efficient (Rodgers et al., 2013), 
however this process progressively fails (Boyd et al., 2013; Lassmann et al., 2012), and the 
most accredited hypothesis for remyelination failure is the block of OPCs differentiation and 
maturation into myelinating OL (Kuhlmann et al., 2008; Miller and Mi, 2007). The block of 
this process leads to an inefficient myelin repair (Zhang et al., 2015). 
Numerous in vitro and in vivo studies have indicated that inflammatory cytokines are involved 
in OPCs differentiation block, affecting cell cycle exit and the expression of genes encoding 
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for proteins regulating and determining remyelination (Chew et al., 2005; Falahati et al., 
2013; Kang et al., 2013; Su et al., 2011; Tanner et al.,  2011; Fernandez et al., 2016).  
 
Less data are instead available on the mechanism of OPC differentiation block in neonatal 
age. Here we showed that both foetal and adult NSCs-derived OPCs are vulnerable to 
cytokines exposure, that leads to a differentiation block, thus confirming the differentiation 
block observed in adult NSCs-derived OPCs alredy described  (Fernandez et al., 2016).  
 
A different vulnerability to OGD is instead observed in foetal and adult OPCs. Adult OPCs 
are not vulnerable to 3 hours of OGD followed by 24 hours of reoxygenation/reperfusion, 
before the T3-mediated differentiation induction, in terms of cell viability and differentiation 
process, while foetal cultures are highly susceptible, leading to an increase in cell death and a 
reduction in cell number. Moreover, we showed that the OGD-cell death induction, is a slow 
process and selective for OPCs/OLs.   
 
The impaired OLs maturation in OGD seems to be maturation stage-dependent, where 
PreOLs (late OPCs) are the most susceptible cells, followed by early OPCs and mature OLs, 
which implies that death of PreOLs causes subsequent failure of myelination (Back et al., 
2002). In vitro experiments demonstrated that oxygen-glucose deprivation (OGD) in primary 
OPCs, induces intracellular Ca2+ overload, mitochondrial damage and ROS generation (via 
ERK1/2 pathway), resulting in PreOLs death (Cai et al., 2016). Calcium overload leads also 
to lipases, endonucleases and proteases activation, leading to the cytoskeleton disaggregation 
(Rocha-Ferreira et al., 2016). 
 
A complex dysregulation of the TH tissue signalling is present in acute phase of EAE 
(experimental allergic encephalomyelitis), the rodents and primate animal model of MS 
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(Dell’Acqua et al., 2012; D’Intino et al., 2011; Fernandez et al., 2016), which correlates with 
the rise of inflammatory cytokines released by peripheral cells and resident microglia (Borjini 
et al., 2016). 
This pathological characteristic of severe demyelinating disease, was causally linked to an 
increase in D3-positive cells and D3 expression both in vivo and in vitro, causing the 
inactivation of T3 and subsequent differentiation block. The hypothesis has been confirmed 
by in vitro studies in our lab, where we demonstrated that the inhibition of D3 restores the 
OPC differentiation during exposure to the inflammatory cytokine cocktail (Fernandez et al., 
2016). 
An increase in D3 activity and mRNA expression level has been described in other 
neurological conditions characterized by inflammation and demyelination, e.g., ischemia-
induced hypoxic brain damage (Jo et al., 2012) and nerve lesion (Li et al., 2001). 
In the present study we demonstrated that foetal cells show an up-regulation of D3 enzyme 24 
hours after the OGD-exposure, pointing the focus of the future studies on the implication of 
THs metabolism dysregulation OGD-mediated.  
 
Another possible mechanism refers to glutamate excitotoxicity. It is well described that HI-
induced cell death is linked to glutamate receptors overactivation and consequent 
excitotoxicity. Glutamate receptors expression and functions are also dynamics throughout the 
OPCs differentiation process, while little is known about differences in their expression and 
function between foetal and adult primary or NSCs-derived OPCs.  
In particular, for many years, AMPA/kainite, but not NMDA receptors, have been considered 
the mediator of glutamate excitotoxicity in glial cells (Tekkök and Goldberg, 2001) and, in 
particular, the HI-induced cell death glutamate-mediated in pre OLs (Deng et al., 2003). 
However, more recently it has been demonstrated that NMDA receptors play a role during 
development myelination (Káradóttir et al., 2007) and are partners in the OL myelinating 
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processes. A different expression of these receptors during the differentiation process, could 
also explain the different sensitivity to glutamate in different stages. In particular OPCs show 
higher expression of AMPA/kainite receptor, mGluR while, postmitotic OLs have higher 
NMDA receptor expression (Butts et al., 2008). 
We previously demonstrated that adult OPCs show a more mature phenotype in early stages 
of differentiation, while achieving a less yield of maturation compared to foetal (Baldassarro 
et al., unpublished). Future studies will clarify the role of glutamate exitotoxicity in OGD-
induced cell death in foetal OPCs, and consequent different role of glutamate receptors in 
adult-derived cells. 
 
The understanding of differences in response of foetal and adult OPCs to demyelination 
stimuli, and their origin, will contribute to the development of myelination promoting 
therapies in foetal/neonatal and adult pathologies. 
 
Acknowledgements 
 
This work was supported by the IRET Foundation, Ozzano Emilia, Italy (no-profit 
organization), in the frame of the “Step-by-step” POR-FESR 2016-2020 Emilia Romagna 
Region project. 
 
 
	   168	  
References 
 
Alhenius H and Kokaia Z. Isolation and generation of neurosphere cultures from embryonic 
and adult mouse brain. Methods Mol Biol, 2010; 633: 241-252. 
Alizadeh A, Dyck SM and Karimi-Abdolrezaee S. Myelin damage and repair in pathologic 
CNS: challenges and prospects. Front Mol Neurosci, 2015. 8: 35. 
Baldassarro VA, Marchesini A, Giardino L and Calzà L. PARP activity and inhibition in fetal 
and adult oligodendrocyte prectursor cells: Effect on cell survival and differentiation. 
Stem Cell Res, 2017. 22: 54-60. 
Baldassarro VA, Marchesini A, Facchinetti F, Villetti G, Calzà L and Giardino L. Cell death 
in pure-neuronal and neuron-astrocyte mixed primary culture subjected to oxygen-
glucose deprivation: The contribution of poly(ADP-ribose) polymerases and caspases. 
Microchem J, 2018. 136: 215-222. 
Baldassarro VA, Krezel W, Giardino L and Calzà L. Nuclear receptors and foetal vs. adult 
oligodendrocyte precursor cells differentiation. unpublished 
Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, Arvin KL and Holtzman 
DM. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J 
Neurosci, 2002. 22: 455-463. 
Borjini N, Fernández M, Giardino L and Calzà L. Cytokine and chemokine alterations in 
tissue, CSF, and plasma in early presymptomatic phase of experimental allergic 
encephalomyelitis (EAE), in a rat model of multiple sclerosis. J Neuroinflammation, 
2016. 13: 291. 
Boyd A, Zhang H and Williams A. Insufficient OPC migration into demyeli- nated lesions is 
a cause of poor remyelination in MS and mouse models. Acta Neuropathol, 2013. 125: 
841–859. 
	   169	  
Butts BD, Houde C and Mehmet H. Maturation-dependent sensitivity of oligodendrocyte 
lineage cells to apoptosis: implications for normal development and disease. Cell Death 
Diff, 2008. 15: 1178-1186   
Cai Q, Ma T, Li C, Tian Y and Li H. Catalpol Protects Pre-Myelinating Oligodendrocytes  
against Ischemia-induced Oxidative Injury through ERK1/2 Signaling Pathway. Int J 
Biol Sci, 2016. 12: 1415-1426. 
Calzà L, Baldassarro VA, Fernandez M, Giuliani A, Lorenzini L and Giardino L. Thyroid 
hormone and the white matter of the central nervous system: from development to 
repair. Vit and Horm, 2017. In press. 
Chen Y, Balasubramaniyan V, Peng J, Hurlock EC, Tallquist M, Li J and Lu QR. Isolation 
and culture of rat and mouse oligodendrocyte precursor cells. Nat Proc, 2007; 2: 1044-
1051. 
Chew LJ, King WC, Kennedy A andGallo V. Interferon-gamma inhibits cell cycle exit in 
differentiating oligodendrocyte progenitor cells. Glia, 2005. 52: 127–143.  
Crawford AH, Chambers C and Franklin RJ. Remyelination: The true regeneration of the 
central nervous system. Journal of Comparative Pathology, 2013. 149: 242–254.  
Dell'Acqua ML, Lorenzini L, D'Intino G, Sivilia S, Pasqualetti P, Panetta V, Paradisi M, 
Filippi MM, Baiguera C, Pizzi M, Giardino L, Rossini PM and Calzà L. Functional and 
molecular evidence of myelin- and neuroprotection by thyroid hormone administration 
in experimental allergic encephalomyelitis. Neuropathology and Applied Neurobiology, 
2012; 38: 454–470. 
Deng W, Yue Q, Rosenberg PA, Volpe JJ and Jensen FE. Oligodendrocyte excitotoxicity 
determined by local glutamate accumulation and mitochondrial function. J Neurochem, 
2006. 98: 213-222.  
	   170	  
D'Intino G, Lorenzini L, Fernandez M, Taglioni A, Perretta G, Del Vecchio G, Villoslada P, 
Giardino L and Calzà L. T3 administration ameliorates the demyelination/remyelination 
ratio in a non-human primate model of multiple sclerosis by correcting tissue 
hypothyroidism. Journal of Neuroendocrinology, 2011; 23: 778–790.  
El Waly B, Macchi M, Cayre M and Durbec P. Oligodendrogenesis in the normal and 
pathological central nervous system. Front. Neurosci, 2014. 8: 145 
Falahati S, Breu M, Waickman AT, Phillips AW, Arauz EJ, Snyder S, Porambo M, Goeral K, 
Comi AM, Wilson MA, Johnston MV and Fatemi A. Ischemia- induced 
neuroinflammation is associated with disrupted development of oli- godendrocyte 
progenitors in a model of periventricular leukomalacia. Dev Neurosci, 2013. 35: 182–
196. 
Fernández M, Baldassarro VA, Sivilia S, Giardino L and Calzà L. Inflammation severely 
alters thyroid hormone signaling in the central nervous system during experimental 
allergic encephalomyelitis in rat: Direct impact on OPCs differentiation failure. Glia, 
2016. 64: 1573-1589. 
Franklin RJM and Hinks GL. 1999. Understanding CNS remyelination: Clues from 
developmental and regeneration biology. J Neurosci Res 58:207–213. 
Goldberg MP and Choi DW. Combined oxygen and glucose deprivation in cortical cell 
culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J 
Neurosci, 1993; 13: 3510-3524.  
Goodin DS. The epidemiology of multiple sclerosis: Insights to disease pathogenesis. Handb 
Clin Neurol, 2014. 122: 231–266. 
Irvine KA and Blackmore WF. Remyelination protects axons from demyelination-associated 
axon degeneration. Brain, 2008. 131: 1464-1477. 
	   171	  
Jablonska B, Scafidi J, Aguirre A, Vaccarino F, Nguyen V, Borok E, Horvath TL, Rowitch 
DH and Gallo V. Oligodendrocyte regulation after Neuonatal Hypoxia requires FoxO1-
mediated p27kip1 expression. J Neurosci, 2013. 32: 14775-14793. 
Jo S, Kalloò I, Bardóczi Z, Arrojo e Drigo R, Zeo ̈ld A, Liposits Z, Oliva A, Lemmon VP, 
Bixby JL, Gereben B and Bianco AC. Neuronal hypoxia induces Hsp40-mediated 
nuclear import of type 3 deiodinase as an adaptive mechanism to reduce cellular 
metabolism. J Neurosci, 2012. 32: 8491-8500. 
Kang Z, Wang C, Zepp J, Wu L, Sun K, Zhao J, Chandrasekharan U, DiCorleto PE, Trapp 
BD, Ransohoff RM and Li X. Act1 mediates IL-17-induced EAE pathogenesis 
selectively in NG21 glial cells. Nat Neurosci, 2013; 16: 1401–1408. 
Káradóttir R and Attwell D. Neurotransmitter receptors in the life and death of 
oligodendrocytes. Neuroscience, 2007. 145: 1426-1438. 
Kuhlmann T, Miron V, Cui Q, Wegner C, Antel J and Bruck W. Differentiation block of 
oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple 
sclerosis, Brain, 2008. 131: 1749–1758. 
Lassmann H, van Horssen J and Mahad D. Progressive multiple sclerosis: Pathology and 
pathogenesis. Nat Rev Neurol, 2012. 8: 647–656. 
Li WW, Le Goascogne C, Ramaugé M, Schumacher M, Pierre M and Courtin F. Induction of 
type 3 iodothyronine deiodinase by nerve injury in the rat peripheral nervous system. 
Endocrinol, 2001. 142: 5190–5197. 
Liu C, Li Y, Yu J, Feng L, Hou S, Liu Y, Guo M, Xie Y, Meng J, Zhang H, Xiao B, Ma C. 
Targeting the shift from M1 to M2 macrophages in experi- mental autoimmune 
encephalomyelitis mice treated with fasudil. PLoS One, 2013. 8: e54841–54854. 
	   172	  
McIver SR, Muccigrosso M, Gonzales ER, Lee JM, Roberts MS, Sands MS and Goldberg 
MP. Oligodendrocyte degeneration and recovery after focal cere- bral ischemia. 
Neuroscience, 2010.  169: 1364–1375. 
Mekhail M, Almazan G and Tabrizian M. Oligodendrocyte-protection and remyelination 
post-spinal cord injuries: A review. Progress in Neurobiology, 2012. 96, 322–339. 
Miller RH and Mi  S. Dissecting demyelination. Nat Neursci, 2007. 10: 1351-1354. 
Miron VE, Kuhlmann T and Antel JP. CElls of the oligodendrocglial lineage, myelination, 
and remyelination. Biochimica et Biophysica Acta, 2011. 1812: 184-193. 
Pantoni L, Sarti C, Alafuzoff I, Jellinger K, Munoz DG, Ogata J and Palumbo V. Postmortem 
examination of vascular lesions in cognitive impair- ment: a survey among 
neuropathological services. Stroke, 2006. 37: 1005–1009. 
Patel JR and Klein RS. Mediators of oligodendrocyte differentiation during remyelination. 
FEBS Lett, 2011; 585: 3730-3737. 
Rocha-Ferreira E and Hristova M. Plasticity in the neonatal brain following hypoxic-ischemic 
injury. Neural Plast, 2016. 2016: 4901014.  
Rodgers JM, Robinson AP and Miller SD. Strategies for protecting oligo- dendrocytes and 
enhancing remyelination in multiple sclerosis. Discov Med, 2013. 16: 55-63.  
Sozmen EG, Rosenzweig S, Llorente IL, DiTullio DJ, Machnicki M, Vinters HV, Havton LA, 
Giger Rj, Hinman JD and Carmichael ST. Nogo receptor blockade overcomes 
remyelination failure after white matter stroke and stimulates functional recovery in 
aged mice. Proceedings of the National Academy of Sciences of the United States of 
America, 2016. 113: E8453–E8462.  
Su Z, Yuan Y, Chen J, Zhu Y, Qiu Y, Zhu F, Huang A and He C. Reactive astrocytes inhibit 
the survival and differentiation of oligodendrocyte precursor cells by secreted TNF-a. J 
Neurotrauma, 2011. 28: 1089–1100. 
	   173	  
Tanner DC, Cherry JD and Mayer-Pro€schel M. Oligodendrocyte progenitors reversibly exit 
the cell cycle and give rise to astrocytes in response to interferon-c. J Neurosci, 2011. 
31: 6235–6246. 
Tekkök SB and Goldberg MP. AMPA/Kainate Receptor Activation Mediates Hypoxic 
Oligodendrocyte Death and Axonal Injury in Cerebral White Matter. J Neurosci, 2001. 
21: 4237-4248. 
Tognatta R and Miller RH. Contribution of the oligodendrocyte lineage to CNS repair and 
neurodegenerative pathologies. Neuropharmacology, 2016; 110: 539-547. 
Trotter J, Karram K and Nishiyama A. NG2 cells: Properties, progeny and origin. Brain Res 
Rev, 2010. 63: 72–82. 
van Tilborg E, de Theije CGM, van Hal M, Wagenaar N, de Vries LS, Benders MJ, Rowitc 
DH and Nijboer CH. Originand dynamics of oligodendrocytes in the developing brain: 
Implications for perinatal white matter injury. Glia, 2018. 66: 221-238. 
Verden D and Macklin WB. Neuroprotection by central nervous system remyelination: 
Molecular, cellular, and functional considerations. J Neurosci Res, 2016. 94: 1411-
1420. 
Zhang Y, Luo X, Wu D and Xu Y. ROR nuclear receptors: structures, related diseases and 
drug discovery. Acta Pharmacologica Sinica, 2015. 36: 71-87.  
 
	   174	  
Legend to the figures. 
 
Figure 1. Experimental design 
 
(A) After NSCs isolation and neurospheres expansion, in presence of bFGF and EGF, 
oligospheres were generated by spheroids disgregation and bFGF/PDGF exposure. 
Oligospherese were than dissociated and single cell cultures were seeded in the same medium. 
After 3 DIVs, medium was changed and cells were exposed to T3, in order to differentiate, for 
12 DIVs. 
(B-D) Representative images of culture progress from OPCs (NG2-positive cells, 0 DIV, B), 
through mature OLs (CNPase-positive cells, 6 DIV, C) to mature/myelinating OLs 
(CNPase/MBP-positive cells, 12 DIV, D). 
 Abbreviations: CNPase, 2’,3’-cyclic nucleotide 3’-phosphodiesterase; MBP, myelin basic 
protein; NG2, chondroitin sulphate proteoglycan, neural/glial antigen 2. 
 
Figure 2. Cytokines exposure effect on viability and differentiation in foetal and adul NSCs-
derived OPCs.  
 
(A) Experimental design. Cells were exposed to cytokine mix during the oligospheres 
proliferation phase. Three days after cell seeding, differentiation was induced by T3 exposure. 
Cells were analysed at the end of the differentiation phase (black arrow, 12 DIV). 
(B) Graph shows the cell number at the end of the differentiation phase (12 DIV), in foetal 
and adult cultures, exposed to vehicle or cytokine mix. Bars represent the total cell number 
per well. 
(C) Graph shows the cell death at the end of the differentiation phase (12 DIV), in foetal and 
adult cultures, exposed to vehicle or cytokine mix. Bars represent the percentage of cells 
showing condensed nuclei, on the total number of cells per well. 
(D) Graph shows the percentage of lineage specific positive cells at the end of the 
differentiation phase (12 DIV) in foetal and adult cultures, exposed to vehicle or cytokines 
mix. The percentage of OPCs (NG2-positive cells), mature OLs (CNPase-positive cells), 
myelinating OLs (MBP-positive cells) and astrocytes (GFAP-positive cells), was calculated 
on the total cell number, showing a normal nuclear morphology, per well. 
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(E-L) Images show CNPase-positive (E, F, I, J) and MBP-positive (G, H, K, L) detected in 
foetal (E, I, G, K) and adult (F, J, H, L) cultures exposed to vehicle (E-H) or cytokines mix (I-
L). White bar in image L: 50 µm. 
Bars represent mean value + SEM. Statistical analysis: Student’s t test; * p < 0.05, ** p < 
0.01, *** p < 0.001, **** p < 0.0001. 
Abbreviations: CNPase, 2’,3’-cyclic nucleotide 3’-phosphodiesterase; GFAP, Glial fibrillary 
acidic protein; MBP, myelin basic protein; NG2, chondroitin sulphate proteoglycan, 
neural/glial antigen 2. 
 
Figure 3. OGD effect on viability of foetal and adul NSCs-derived OPCs and effect on D3 
expression. 
 
(A) Experimental design. Cells were exposed to 3 hours OGD, followed by 24 hours of 
reoxygeneation, one day before the T3-mediated differentiation induction.  
(B) Graph shows the cell number at the end of the differentiation phase (12 DIV), in foetal 
and adult cultures, exposed to normoxia or OGD. Bars represent the total cell number per 
well. 
(C) Graph shows the cell death measured at the end of the differentiation phase (12 DIV), in 
foetal and adult cultures, exposed to normoxia or OGD. Bars represent the percentage of cells 
showing condensed nuclei, on the total number of cells per well. 
(D) Graph shows the cell number at 0, 6 and 12 DIV in foetal cultures, exposed to normoxia 
or OGD. Bars represent the total cell number per well. 
(E) Graph shows the cell death measured at 0, 6 and 12 DIV in foetal cultures, exposed to 
normoxia or OGD. Bars represent the percentage of cells showing condensed nuclei, on the 
total number of cells per well. 
Bars represent mean value + SEM. Statistical analysis: Student’s t test (B, C, F) and two-way 
ANOVA, followed by Tukey’s post-hoc (D, E); *** p < 0.001, **** p < 0.0001. 
Abbreviations: OGD, oxygen-glucose deprivation. 
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Figure 4. OGD effect on differentiation and lineage-specific cell death induction in foetal and 
adult NSCs-derived OPCs. 
  
(A) Graph shows the percentage of lineage specific positive cells at the end of the 
differentiation phase (12 DIV) in foetal and adult cultures, exposed to normoxia or OGD. The 
percentage of OPCs (NG2-positive cells), mature OLs (CNPase-positive cells), myelinating 
OLs (MBP-positive cells), astrocytes (GFAP-positive cells) and neurons (beta-III-tubulin), 
was calculated on the total cell, showing a normal nuclear morphology, number per well. 
(B) Graph show the percentage of lineage specific positive cells showing also a condensed 
nuclei, at the end of the differentiation phase (12 DIV) in foetal and adult cultures, exposed to 
normoxia or OGD. The percentage of OPCs (NG2-positive cells), mature OLs (CNPase-
positive cells), myelinating OLs (MBP-positive cells), astrocytes (GFAP-positive cells) and 
neurons (beta-III-tubulin), was calculated on the total cell, showing a normal nuclear 
morphology, number per well. 
(C-J) Images show NG2-positive (C, D, G, H) and CNPase/MBP-positive (E, F, I, J) detected 
in foetal (C, G, E, I) and adult (D, H, F, J) cultures exposed to normoxia (C-F) or OGD (G-J). 
White bar in image J: 50 µm. 
Bars represent mean value + SEM. Statistical analysis: Student’s t test; ** p < 0.01, *** p < 
0.001, **** p < 0.0001. 
Abbreviations: CNPase, 2’,3’-cyclic nucleotide 3’-phosphodiesterase; GFAP, Glial fibrillary 
acidic protein; MBP, myelin basic protein; NG2, chondroitin sulphate proteoglycan, 
neural/glial antigen 2. 
 
Figure 5. OGD effect on D3 expression. 
 
(A) Experimental design. Cells were exposed to 3 hours OGD, followed by 24 hours of 
reoxygeneation, one day before the T3-mediated differentiation induction. D3 gene 
expression was analysed in both normoxia and OGD exposed foetal cultures at 0 DIV, after 
the reoxygenation phase. 
(B-D) Graph shows the percentage of D3-positive cells before the T3-mediated differentiation 
induction (0 DIV) in foetal cultures, exposed to normoxia or OGD (B). Images show D3-
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positive cells detected in foetal cultures exposed to normoxia (C) or OGD (D). White bar in 
image H: 50µm. 
Bars represent mean value + SEM. Statistical analysis: Student’s t test *** p < 0.001. 
Abbreviations: D3, deyodinases 3; OGD, oxygen-glucose deprivation. 
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4.8 Inflammation severely alters thyroid hormone signaling in the central nervous system 
during experimental allergic encephalomyelitis in rat: Direct impact on OPCs 
differentiation failure (Fernandez et al., 2016). 
 
 
RESEARCH ARTICLE
Inflammation Severely Alters Thyroid
Hormone Signaling in the Central Nervous
System During Experimental Allergic
Encephalomyelitis in Rat: Direct Impact on
OPCs Differentiation Failure
Mercedes Fernandez,1 Vito A. Baldassarro,1,2 Sandra Sivilia,3
Luciana Giardino,3,4 and Laura Calza1,2,4
Differentiation of oligodendrocyte precursor cells (OPCs) into myelinating oligodendrocytes is severely impaired by inflamma-
tory cytokines and this could lead to remyelination failure in inflammatory/demyelinating diseases. Due to the role of thyroid
hormone in the maturation of OPCs and developmental myelination, in this study we investigated (i) the possible occurrence
of dysregulation of thyroid hormone signaling in the CNS tissue during experimental neuroinflammation; (ii) the possible
impact of inflammatory cytokines on thyroid hormone signaling and OPCs differentiation in vitro. The disease model is the
experimental allergic encephalomyelitis in female Dark-Agouti rats, whereas in vitro experiments were carried out in OPCs
derived from neural stem cells. The main results are the following: (i) a strong upregulation of cytokine mRNA expression level
was found in the spinal cord during experimental allergic encephalomyelitis; (ii) thyroid hormone signaling in the spinal cord
(thyroid hormone receptors; deiodinase; thyroid hormone membrane transporter) is substantially downregulated, due to the
upregulation of the thyroid hormone inactivating enzyme deiodinase 3 and the downregulation of thyroid hormone receptors,
as investigated at mRNA expression level; (iii) when exposed to inflammatory cytokines, deiodinase 3 is upregulated in OPCs
as well, and OPCs differentiation is blocked; (iv) deiodinase 3 inhibition by iopanoic acid recovers OPCs differentiation in the
presence on inflammatory cytokines. These data suggest that cellular hypothyroidism occurs during experimental allergic
encephalomyelitis, possibly impacting on thyroid hormone-dependent cellular processes, including maturation of OPCs into
myelinating oligodendrocytes.
GLIA 2016;64:1573–1589
Key words: remyelination, inflammatory cytokines, rat, deiodinases, iopanoic acid
Introduction
Multiple sclerosis (MS) is the most diffuse inflammatory/demyelinating disease in humans (Goodin, 2014). The
focal phase of MS is characterized by inflammation and acute
damage of the myelin sheath and axons. At this stage, myelin
repair may be robust and efficient, early lesions correctly
repaired and function restored (Rodgers et al., 2013). This
process is ensured by the presence of oligodendrocyte precur-
sor cells (OPCs) (Trotter et al., 2010) that proliferate and
differentiate into mature, myelinating oligodendrocytes (OL)
(Boulanger and Messier, 2014). However, for unknown rea-
sons this process progressively fails in MS (Boyd et al., 2013;
Lassmann et al., 2012). Currently, a blockade of OPCs matu-
ration is regarded as a pre-eminent cause of remyelination
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failure in MS (Kuhlmann et al., 2008; Miller and Mi, 2007),
suggesting the hypothesis that remyelination depends on suc-
cessful OPCs differentiation (Zhang et al., 2015a).
The reasons for OPCs differentiation block in MS are
unknown. In vitro and in vivo studies have indicated that
inflammatory cytokines impair OPCs differentiation, inhibit-
ing cell cycle exit and the expression of myelin-related genes
(Chew et al., 2005; Falahati et al., 2013; Kang et al., 2013;
Su et al., 2011; Tanner et al., 2011). However, the intracellu-
lar machinery supporting the cytokine-induced OPCs differ-
entiation block has been not identified.
Thyroid hormone (TH) is one of the best characterized
differentiating agents of OPCs, inducing cell-cycle arrest and
transcription of premyelinating genes (Billon et al., 2002;
Casaccia-Bonnefil and Liu, 2003; Dugas et al., 2012). The
circulating prohormone thyroxine (T4) secreted by the thy-
roid gland is converted into the active form (triiodothyronine,
T3) by astrocytes in the CNS through the enzyme deiodinase
2 (D2) (Bianco et al., 2002; Calza et al., 2015; Morte and
Bernal, 2014). TH tissue homeostasis is then guaranteed by
deiodinase 3 (D3), which inactivates T4 to reverse-T3 (rT3)
and T3 to 3,5-diiodo-l-thyronine (T2). Therefore, a local TH
metabolism also supported by TH membrane transporters
(Bernal et al., 2015; Lee et al., 2015) guarantees the appro-
priate intracellular content of TH in the CNS and the TH-
dependent genomic (via nuclear receptor, TRs) and nonge-
nomic effects (Dentice et al., 2013). Direct action of T3 has
been found in purified OPCs, where T3 induces cell cycle
exit and terminal differentiation into myelinating oligoden-
drocytes (Raff, 2006), also regulating the expression of myelin
protein-encoding genes (Strait et al., 1997).
Inflammatory cytokines impair OPCs differentiation
(Kuhlmann et al., 2008), alter TH tissue metabolism and
intracellular T3 availability (de Vries et al., 2015). These data
supported the attempt to use TH to overcome OPCs differ-
entiation block during experimental inflammatory-
demyelinating diseases. Our previous work showed that a
short in vivo TH administration during experimental allergic
encephalomyelitis (EAE) promotes OPCs maturation, protects
myelin sheaths and axons, and ultimately improves functional
and clinical outcome in rat and non-human primates Calli-
thrix Jacchus (Calza et al., 2002, 2015; Dell’Acqua et al.,
2012; D’Intino et al., 2011; Fernandez et al., 2004a,b). TH
supplementation also restores oligodendroglial lineage and
OL maturation from neural stem/progenitor cells (NSCs)
derived from inflamed animal brains (Fernandez et al., 2009).
These results have been confirmed by other labs in the cupri-
zone demyelination model in mouse (Harsan et al., 2008)
and rat (Castelo-Branco et al., 2014; Franco et al., 2008; Sil-
vestroff et al., 2012). Contrasting results have been obtained
by TH treatment in perinatal inflammation-induced white
matter injury, either positive (perinatal hypoxa-ischemia,
Hung et al., 2013; intraventricular hemorrhage, Vose et al.,
2013), or no effects (white matter injury induced by
interleukin-1b, Schang et al., 2014). The substantial differ-
ences in adult vs. neonatal models, make quite difficult to
compare these data sets, also considering the delicate balance
between maternal-derived TH and the perinatal development
of fetal thyroid function (Moog et al., 2015).
To establish whether a dysregulation of TH cellular sig-
naling induced by inflammation is causally linked to differen-
tiation failure of OPCs, two sets of experiments were
performed. It was first investigated whether the increase in
inflammatory cytokines that occurs in the CNS of the animal
model of MS is linked to a dysregulation of the molecular
mediators of TH action. Then, the hypothesis that intracellu-
lar hypothyroidism induced by inflammatory cytokines is
responsible for OPCs differentiation failure was tested in vitro
in OPCs derived from adult NSCs, by using the deiodinase
inhibitor iopanoic acid (IOP) as pharmacological tool.
Materials and Methods
Animals, EAE Induction, and Disease follow-up
Dark-Agouti (DA, Harlan, Italy) female rats, 150–175 g body
weight, were used. For EAE induction rats were immunized using
0.15 g/mL guinea pig spinal cord in complete Freund’s adjuvant
(CFA, Sigma, St. Louis, MO), 50% v/v, to which 5 mg/mL of heat-
inactivated Mycobacterium (Difco H37Ra) was added. Two control
groups were included: intact, un-injected animals, and adjuvant-
injected animals (complete Freund’s adjuvant 1 heat-inactivated
Mycobacterium). Rats were regularly weighed and examined for clin-
ical signs of EAE by two independent observers and scored as fol-
lows: 15 loss of tail tone, 25mono or bilateral weakness of hind
legs or middle ataxia, 35 ataxia or paralysis, 45 severe hind leg
paralysis, 55 severe hind leg paralysis and urinary incontinence.
During the acute phase, animals were fed with humid pellets on the
cage floor. Experimental groups intended for molecular biology and
proteomic studies were the followings: control n5 10; EAE-acute
[11 days post immunization (DPI)] n5 9; Adjuvant-acute (11 DPI)
n5 8; EAE-relapsing-remitting (RR, 18 DPI) n5 7; Adjuvant-RR
(18 DPI) n5 8. Additional control (n5 5) and EAE-acute animals
(n5 5) were used for immunohistochemistry (IHC) experiments.
At the time of sacrifice, CSF and blood were collected. Then
thoracic and lumbar tracts of the spinal cord (TSC, LSC) were dis-
sected, immediately snap frozen and stored at 2808C till used. TSC
was used for microdissection, LSC was used for molecular biology
studies. Plasma samples and CSF were stored at 2808C till used.
All animal protocols described herein were carried out accord-
ing to the European Community Council Directives (86/609/EEC),
approved by the intramural ethical committee for animal experimen-
tation of Bologna University and Ministry of Health (no. 158/2013-
B), and comply with the guidelines published in the NIH Guide for
the Care and Use of Laboratory Animals.
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Inmunohistochemistry
Lumbar spinal cord tissues were frozen after fixation in 4% parafor-
maldehyde and picric acid saturated aqueous solution in 0.1 M
S€orensen buffer pH 7, and 14 lm thick coronal sections (Microm
HN550, Bio-Optica, Milan, Italy) were processed for inmunohisto-
chemistry and myelin staining. Sections were incubated with the pri-
mary antibodies diluted in PBS-0.3% Triton X-100 overnight at
48C. Primary antibodies and dilutions used were: mouse anti OX42
(AbD Serotec, Raleigh, NC), 1:250; mouse anti NG2 (membrane-
spanning chondroitin sulphate proteoglycan, Millipore, Merck S.p.a.,
Milan, Italy), 1:100; mouse anti CNPase (20,30-cyclic nucleotide 30-
phosphodiesterase, Millipore) 1:250; rabbit anti MBP (Myelin Basic
Protein, Dako) 1:100; rabbit anti GFAP (Glial Fibrillary Acidic Pro-
tein, Dako) 1:500; mouse anti NeuN (Neuron-Specific Nuclear Pro-
tein, Millipore) 1:250; goat anti D3 (Deiodinase type 3, Santa Cruz
Biotechnology), 1:50. After rinsing in PBS, the sections were incu-
bated at 378C for 30 min with the secondary antisera: DyLight488-
conjugated affinity-pure goat anti-mouse IgG (ThermoScientific),
DyLight488-conjugated affinity-pure donkey anti-goat IgG (Jackson
Immunoresearch), Rhodamine RedTM-X-conjugated affinity-pure
donkey anti-mouse IgG (Jackson Immunoresearch) and Rhodamine
RedTM-X-conjugated affinity-pure donkey anti-rabbit IgG (Jackson
Immunoresearch) diluted in PBS-0.3% Triton X-100. For nuclear
staining, sections were incubated for 20 min in PBS-0.2% Triton X-
100 containing 1 lg/mL Hoechst 33258 (InvitrogenTM). Sections
were then rinsed in PBS and mounted in phenylenediamine solution
(0.1% 1,4-phenylenediamine, 50% glycerine, carbonate/bicarbonate
buffer pH 8.6, Sigma). Control slices incubated with only secondary
antibodies were processed in parallel. FluoroMyelinTM Fluorescence
Myelin staining (Molecular Probes, Eugene, OR) was also per-
formed, following manufacturer’s specifications. Images were cap-
tured using a Nikon Eclipse E600 microscope equipped with digital
CCD camera Q Imaging Retiga-2000RV (Q Imaging, Surrey, BC,
Canada). Measurements were performed using Nis-Elements AR 3.2
software. The NG2 immunoreactive area was calculated as area frac-
tion (percentage of NG2 immunoreactive area). The mean intensity
of D3 in NeuN positive neurons was calculated in a region of inter-
est (ROI). Confocal microscopy was used to study the co-presence
of neuronal marker (NeuN), astrocytic marker (GFAP) microglial
marker (OX42) and oligodendrocytic markers (NG2 and CNPase)
with D3. Sections were scanned with a Nikon Ti-E fluorescence
microscope coupled to an A1R confocal system (Nikon). A diode
laser system with 405 wavelength output, air-cooled Argon-Ion laser
system with 488 wavelength output and Yellow diode-pumped solid
state laser system with 561 wavelength output were used. Images
were acquired with 203 and oil immersion 603 with an optical res-
olution of 0.18 micron, using Nis-Elements AR 3.2 software. All the
z-stacks were collected in compliance with optical section separation
(z-interval) values suggested by Nis-Elements AR 3.2 software. Then,
the 603 z-stacks were elaborated by using IMARIS software 8.0.1
(Bitplane, Zurich, Switzerland) (Fig. 6E). An isosurface of the cell
body of a single cell was created using the cell marker fluorescence
channel (NG2, CNPase or GFAP) of the raw image (cell identifica-
tion and surface extraction, Fig. 6). The voxels corresponding to the
D3- (red) and cell markers (green) immunostaining inside the object
delimitated by the surface was then isolated (masked channels), and
the voxels in both green and red channels were visualized in 3D
projection.
RNA Isolation and Retrotranscription
Half of the lumbar spinal cord was used for the isolation of RNA by
RNeasy Mini kit (Qiagen, Milan, Italy). Total RNA was eluted in
RNase free water. The RNA obtained was subjected to DNase treat-
ment (1 U/lL) in 13 DNase buffer in the presence of RNase (4 U/
lL, Fermentas, Life Sciences, Italy), incubating at 378C for 30 min.
First strand cDNAs were obtained using the enzyme M-Moloney
murine leukemia virus (M-MuLV) reverse transcriptase (20 U/lL)
(Fermentas) in the presence of 13 first strand buffer, 2 mM of each
d(NTP) (Fermentas), 5 lM p(dN)6 random primers (Roche, Molec-
ular Biochemicals) and 25 ng/lL oligo(dT)18 (Fermentas), incubat-
ing at 428C for 60 min. An RNA sample with no reverse
transcriptase enzyme in the RT reaction mix was processed as a no
RT control sample. The cDNA obtained was stored at 2208C till
used for PCR.
Semiquantitative Real-Time PCR
Semiquantitative real-time PCR was performed using the
Mx3005PTM real-time PCR system (Stratagene, CA). The reactions
were performed in a final volume of 25 lL consisting of 13 SYBR
Green qPCR master mix (Fermentas) and 0.4 lM forward and
reverse primers. In order to avoid possible contamination of genomic
DNA in isolated RNA, the sample with no reverse transcriptase
enzyme (no RT sample) was processed in parallel with the others
and tested by real-time PCR for every pair of primers used. All pri-
mers used were designed using Beacon Designer software (BD 5.1,
Premier Biosoft International, Palo Alto, CA) or Primer BLAST and
synthesized by IDT (Coralville, IA). The primer sequences, National
Center for Biotechnology Information (NCBI) genbank reference
sequence accession number and size of amplified products are set
out included in Table 1. GAPDH was used as housekeeping gene to
normalize the amount of retrotranscribed RNA used for PCR. Ther-
mal profile of PCR reactions consisted first of an activation step of
master mix Taq polymerase (958C, 10 min), then two steps of: (1)
denaturation (958C, 10 min); (2) annealing/extension (40 cycles of:
958C for 15 s, 608C for 30–60 s); at the end of amplification cycles
the melting curve of amplified products was performed according to
the following temperature/time scheme: heating from 558C to 958C
with a temperature increase of 0.58C/s.
The efficiency of the primers used for real-time PCR reactions
was calculated by amplifying control cDNA serial dilution in the
presence of each pair of primers, under the conditions described
above. Standard curve slope and primer efficiency were calculated
with the MxPro QPCR software 3.1 (Stratagene, CA), obtaining
efficiency values for all primers used in the range of 95–102%; the
2(2DDCT) method for the calculation of gene expression relative to a
given group was taken as “reference” having a value of 1 (User Bul-
letin #5, Guide to Performing Relative Quantitation of Gene Expres-
sion Using Real-Time Quantitative PCR Applied Biosystems).
The specificity of real-time PCR reactions was evidenced by
both melting curves which yielded a single peak at the corresponding
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melting temperature (Tm) and electrophoresis in agarose gel (2,5%)
of random amplified products which showed a single band of the
expected size for each pair of primers used (results not shown).
Cytokines and TH Assay in CSF and Plasma
xMAP technology and Luminex platform (Luminex 200TM Luminex
Corporation, Austin, TX) provided with Luminex xPONENT 3.1
(Luminex) and Milliplex Analyst 3.5.5 softwares (Millipore Corpora-
tion, Billerica, MA) were used to quantify cytokines/chemokines
(TGFb1, IL-1b, MCP-1, TNF-a and RANTES) in the CSF and
T3, T4, and TSH in plasma. The Milliplex MAP kit (Millipore) for
TGFb1; the rat cytokine/chemokine magnetic bead panel kit
(RECYTMAG-65K, Millipore) for IL-1b, MCP-1, TNF-a, and
RANTES; the Milliplex MAP kit Rat-THY-30K (Millipore Corpora-
tion) were used.
CSF samples were centrifuged at 4,000g for 10 min at 48C
before being processed. In brief, 25 lL CSF samples were incubated
with specific monoclonal antibodies-conjugated bead population
overnight at 48C. Washed beads were then incubated with the detec-
tion antibody solution at RT for 30 min, then with the streptavi-
din–phycoerythrin conjugated solution. After washing, beads were
resuspended in the sheath fluid, shacked for 10 min and then read.
For TH assays, plasma samples were centrifuged at 4,000g for
10 min at 48C. In brief, plasma samples were incubated with specific
TABLE 1: Primer Sequences Description
Gene NCBI ACC. N. Primer sequences Size (bp)
TRa1 NM_001017960 F: 50-gcaaacacaacattccgc-30
R: 50-tcctgatcctcaaagacctc-30
108
TRa2 NM_031134 F: 50-gcaaacacaacattccgc-30
R: 50-caccaaactgctgctcaa-30
160
TRb NM_012672 F: 50-gcaaacacaacattccgc-30
R: 50-caccaaactgctgctcaa-30
198
MTC8 NM_147216 F: 50-caatggtgtggtgtctgc-30
R: 50-cggtaggtgagtgagagc-3
150
D-2 U53505 F: 50-ctcctcacggtagacttg-30
R: 50-gttccagacacagcgtag-30
189
D-3 NM_017210 F: 50-gcatccgcaagcatttcc-30
R: 50-ggcatctcctcaccttcac-30
85
GAPDH NM_17701 F: 50-ggcaagttcaatggcacagtcaag-30
R: 50-acatactcagcaccagcatcacc-30
125
Klf9 NM_057211.1 F: 50-agtggcttcgaaggggaaac-30
R: 50-tccgagcgcgagaactttt-30
174
INF-c NM_138880.02 F: 50-agcatcgccaagttcgaggtga-30
R: 30-agcaccgactccttttccgct-50
124
IL-1b NM_031512 F: 50-tcgttgcttgtctctccttg-30
R: 30-tcgttgcttgtctctccttg-50
118
TNF-a NM_012675.3 F: 50-tcgtgcctcagcctcttctcatt-30
R: 30-ggctacgggcttgtcactc-50
186
TGF-b NM_021578 F: 50-caattcctggcgttaccttg-30
R: 30-agccctgtattccgtctcct-50
122
TREM-2 NM_001106884 F: 50-acacccttgctggaactgtc-30
R: 30-gaaacctgactggaggtgct-50
233
CD40 NM_134360 F: 50-atgccaaccgtgcgactc-30
R: 30-taacctgaagcccttgattgag-50
101
Detailed information about gene, NCBI (National Center for Biotechnology Information) genbank accession number, forward (F) and
reverse (R) sequences and size of PCR product (base pair, bp) has been included.
Abbreviations: TR, thyroid receptor; MCT8, monocarboxylate transporter 8; D2, deiodinase type 2; D3, deiodinase type 3; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase, KLF9, kruppel-like factor 9; IL-1b, interleikin 1 beta; TNF-a, tumor necrosis factor alpha;
TGF-b, trasforming growth factor beta; TREM2, triggering receptor expressed on myeloid cells 2; CD40, TNF receptor superfamily
member 5.
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monoclonal antibodies-conjugated beads (anti-T3/anti-T4/anti-TSH)
and HRP-conjugated solution overnight at 48C. Washed beads were
incubated with the detection antibody solution (20–258C, 30 min)
and then with the streptavidin–phycoerythrin conjugated solution
(20–258C, 30 min). The samples MFI (mean fluorescence intensity)
for each analyte was interpolated in the corresponding standard
curve to obtain the pg/mL values (Milliplex Analyst 3.5.5 software).
Reverse T3 ELISA kit was used for quantification of plasma levels of
rT3 (Uscn, Life Science), following the manufacturer’s instructions.
Laser Capture Microdissection and Gene Expression
Analysis
Laser capture microdissection (LCM) was performed in TSC using a
NIKON Eclipse TE 2000-S and SLmCUT laser microdissection sys-
tem (MMI Molecular Machines & Industries AG, Glattbrugg, Swit-
zerland). The whole procedure was carried out in an RNase-free
environment. Solutions were prepared in diethyl pyrocarbonate
(DEPC, Sigma)-treated water and working surfaces were decontami-
nated with RNase decontamination solution (RNaseZap, Sigma).
The laser microdissection-isolation caps and membrane slides (metal
frame coated with 1.5 lm thick PEN membrane) used were nuclease
and nucleic acid free (MMI). Stored tissue at 2808C was equilibrat-
ed to 2208C for at least 5 h, then embedded in optimum cutting
temperature (OCT) compound and sectioned (20 lm thickness) on
a cryostat (Microm). Sections were fixed in EtOH decreasing con-
centration scale, then stained in toluidine RNase-treated, dehydrated
in EtOH increasing concentration scale, air-dried and immediately
processed for LCM. Inflammatory infiltrates from each EAE-RR ani-
mal, corresponding to a total area of 2 3 106 lm2, were cut and
captured in a separate cap. In the case of control animals, a similar
area was captured.
RNA isolation was performed with the RNeasy Micro kit
(Qiagen), following the manufacturer’s instructions. The RNA
obtained, quantified with the Nanodrop 2000 spectrophotometer,
was around 800 ng from each captured animal area. Retrotranscrip-
tion was performed with the Maxima Reverse Transcriptase enzyme
(Thermo Scientific) following the manufacturer’s instructions. Semi-
quantitative real-time PCR of cDNA obtained from laser capture
microdissected RNA was performed as described above. D3 gene
expression was studied; GAPDH was used as housekeeping gene.
Thermal profile of PCR reactions consisted of two first steps of: (1)
denaturation (958C, 10 min); (2) annealing/extension, 40 cycles of:
958C for 15 s, 578C for 30 s. The amount of cDNA used for D3
and GAPDH PCR reactions was 10 ng.
Cell Culture and Treatment
Adult NSCs were isolated following the Ahlenius and Kokaia proto-
col (Ahlenius and Kokaia, 2010) and oligodendrocyte differentiation
was performed following the Chen protocol (Chen et al., 2007) with
some modifications, as described in Fig. 3A. Brains from five month
old rats were collected in a 50 mL tube containing ice-cold HBSS
(Life Technologies, Milan, Italy).
The subventricular zone (SVZ) was isolated from 1 mm thick
coronal slices and triturated in cold HBSS. The HBSS was then
removed and the tissues enzymatically dissociated (13 HBSS;
5.4 mg/mL D-glucose (Sigma); 15 mmol/L HEPES (Life Technolo-
gies); 1.33 mg/mL Trypsin (Sigma); 0.7 mg/mL hyaluronidase (Sig-
ma); 80 U/mL DNase (Sigma). After 15 min incubation at 378C
tissues were pipetted several times to favor dissociation and incubat-
ed again at 378C for 10 min. The solution was filtered through a 70
mm filter and then centrifuged at 400g for 5 min. The resulting pel-
let was washed twice, first with a sucrose-HBSS solution (0.3 g/mL
sucrose in 0.53 HBSS), 500 3 g 10 min), then with a solution
consisting of BSA (40 mg/mL) and HEPES (0.02 mol/L) in EBSS.
After 7 min centrifugation at 400g, the cellular pellet was resus-
pended in serum-free medium (DMEM/F12 GlutaMAX 13;
8 mmol/L HEPES; 100 U/100 lg penicillin/streptomycin; 0.13
B27; 13 N-2; 20 ng/mL bFGF; 20 ng/mL EGF) and, after cell
count, cells were plated at a density of 10 cells/mL in a final volume
of 3 mL in low-attachment 6-well plates (NUNC). Medium was
changed every three days, centrifuging the cell suspension at 300g
for 5 min and gently resuspending the cellular pellet in fresh medi-
um. Neurospheres were allowed to proliferate until they attained a
diameter of about 100 mm.
To obtain oligospheres, primary neurospheres were centrifuged
at 300g for 5 min. The pellet was mechanically dissociated by pipet-
ting and cells were counted and plated again at a density of 10 cells/
mL in a final volume of 3 mL of OPCs medium (DMEM/F12 Glu-
taMAX 13; 8 mmol/L HEPES; 100 U/100 lg Penicillin/Strepto-
mycin; 0.13 B27; 13 N-2; 20 ng/mL bFGF; 20 ng/mL PDGF) in
low-attachment 6-well plates (NUNC).
At this step, cells were divided into two groups: one treated with
a mix of six different cytokines (TGF-b1, TNF-a, IL-1b, IL-6, IL-17
and IFN-c; 20 ng/mL each) and the other treated with vehicle (0.04%
of the cytokines solvent: 10% glycerol/100 nM glycine/25 nM Tris,
pH 7.3). Images of oligospheres were taken at 3, 5 and 7 DIV.
Oligospheres were centrifuged at 300g for 5 min and the pellet
was mechanically dissociated to obtain a single cell suspension. After
cell count, cells were plated at a density of 3,000 cells/cm2 on poly-
D,L-ornithine (50 mg/mL)/laminin (5 mg/mL) coating, in OPCs
medium, containing 20 ng/mL bFGF and 20 ng/mL PDGF.
After 3 DIV, OPCs medium was replaced with the oligodendro-
cyte differentiation medium [DMEM/F12 GlutaMAX 13; 8 mmol/L
HEPES; 100 U/100 lg penicillin/streptomycin; 0.13 B27; 13 N-2;
50 nM T3; 10 ng/mL CNTF; 13 N-acetyl-L-cysteine (NAC)].
The cytokine treated group was then divided into two sub-
groups: one treated with vehicle and the other treated with IOP (10
mM). Another vehicle-exposed experimental group was treated with
the cytokine mix during the differentiation phase, while the control
group was treated with vehicle. Oligodendrocyte differentiating fac-
tors (T3, CNTF and NAC) were refreshed every two days.
Population Doubling
Oligosphere images were analyzed using Image Proplus software
(Media Cybernetics, Bethesda, MD). Counting procedure was per-
formed as already described (Baldassarro et al., 2013) calculating the
cell number based on spheres and single cell area. Population dou-
bling was calculated using the following formula: PD5 log10(N/
N0) 3 3.33, where PD is the Population Doubling, N and N0 are
the final and initial number of cells, respectively.
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Immunocytochemistry
At 12 DIV after the differentiation induction, cells were fixed (cold
4% paraformaldehyde, 20 min), washed (two PBS washes, 10 min
each) and incubated overnight at 48C with primary antibodies diluted
in PBS/0,3% Triton X-100. Primary antibodies and dilutions used
were: mouse anti beta-III-tubulin (R&D system, Trento, Italy) 1:3000;
rabbit anti PDGFaR (platelet derived growth factor alpha receptor,
Santa Cruz Biotechnology) 1:300; mouse anti NG2 (membrane-span-
ning chondroitin sulphate proteoglycan, Millipore), 1:300; mouse anti
CNPase (20,30-cyclic nucleotide 30-phosphodiesterase, Millipore)
1:500; rabbit anti MBP (Myelin Basic Protein, Dako) 1:500; rabbit
anti GFAP (Glial Fibrillary Acidic Protein, Dako) 1:1,000; goat anti
D3 (Deiodinase type 3, Santa Cruz Biotechnology), 1:100.
Cells were washed twice using PBS and incubation of second-
ary antibodies was performed at 378C for 30 minutes. Secondary
antisera and dilutions used were: Alexa488-coniugated affinity-pure
Donkey anti-Mouse IgG (Life Technologies, Eugene, OR) 1:500,
Alexa568-conjugated affinity-pure Donkey anti-Mouse IgG (Molecu-
lar Probe, Eugene, OR) 1:500, DyLight488-conjugated affinity-pure
Donkey anti-Goat IgG (Jackson Immunoresearch) 1:100, Alexa568-
conjugated affinity-pure Donkey anti-Rabbit IgG (Life Technologies)
1: 500, and RRX-conjugated Donkey anti-rabbit IgG (Jackson
Immunoresearch) 1:500, all diluted in PBS/0.3% Triton X-100.
After two washes with PBS, cells were incubated with Hoechst
33258 (1 mg/mL in PBS/0.2% Triton X-100) for 30 min at RT.
After the last two washes in PBS, cells were mounted with phenyle-
nediamine solution (0.1% 1,4-phenylenediamine; Sigma, 50% glyc-
erine; Sigma, carbonate/bicarbonate buffer pH 8.6). Controls were
always performed on secondary antibodies.
Each antibody staining was performed in duplicate and at least
five random fields per glass were analyzed using NIS-Elements
Microscope Imaging Software (Nikon, Shinjuku, Tokyo, Japan).
Hoechst staining was used to identify the total cell number
and condensed nuclei, while the different markers were used to iden-
tify specific lineage (beta-III-tubulin for neurons, GFAP for astro-
cytes, NG2 for OPCs, CNPase for mature oligodendrocytes and
MBP for myelinating oligodendrocytes). The lineage analysis was
performed on cells presenting intact, non-condensed nucleus.
Statistical Analysis
GraphPad Software (San Diego, CA) was used for statistics and
graph preparation. Data are expressed as mean1 SEM. Student’s t
test and one-way analysis of variance (ANOVA) followed by post hoc
tests were used for statistical analyses. Results were considered signifi-
cant when the probability of their occurrence by chance alone was
less than 5%. Details on the tests are reported in results and figure
captions.
Results
Inflammatory Cytokines Expression Level
During EAE
In the first set of experiments, the expression profile and con-
tent of inflammatory cytokines and tissue expression of TH
molecular mediators in the acute and RR phase of EAE were
investigated. EAE clinical progression was monitored by the
neurological disability score and body weight (Fig. 1A,B).
Neurological deficit appeared on 9–10 DPI, with a rapid
increase in disability which in most rats reached the highest
clinical score on 11–13 DPI (acute phase), followed by a
short remission and a second relapse phase (RR) with a simi-
lar disability score observed in the acute phase. Body weight
dropped drastically in the acute phase without recovery dur-
ing RR (Fig. 1B, group effect P< 0.0001). Adjuvant injected
animals, developed arthritis and also ceased body weight
increase (group effect P< 0.0001).
Histopathology (inflammation and demyelination) was
evaluated at the two investigated times (acute: 11DPI; RR:
18DPI) in the fasciculus gracilis, in the dorsal horn of the
spinal cord (Fig. 1C), as this is the most affected CNS struc-
ture in rodent models of EAE (Robinson et al., 2014). As
expected, microglial reaction starts in the acute phase, when
OX42-IR cells retract elongation, taking on a rounder mor-
phology (see Fig. 1C, control compared with EAE 11DPI)
and converge around blood vessels (see arrows around the sul-
cal branches of the posterior spinal artery). Demyelination
signs appear in the acute phase, as revealed by the slight
decrease in fluoromyelin staining intensity in the peripheral,
submeningeal part of the dorsal funiculus (Fig. 1C,
EAE11DPI, see stars), appearing very extensive at 18DPI, in
the areas characterized by microglia concentration (asterisks).
The expression of genes that encode for cytokines/che-
mokines involved in neuroinflammation processes was studied
in the LSC by real-time PCR (Fig. 1D). The pattern of
mRNA expression was similar for all investigated genes. The
cytokine IL-1b mRNA was strongly upregulated in EAE-
acute animals (around 150-fold vs the control group) and in
EAE-RR animals (around 30-fold vs the control group; CNT
vs EAE-acute, P< 0.0001; CNT vs EAE-RR, P< 0.0001).
The expression of TNF-a mRNA increased significantly in
the EAE group of animals in the two investigated phases of
the disease, around eightfold versus the control group (CNT
vs EAE-acute, P< 0.0001; CNT vs EAE-RR, P< 0.0001).
The INF-c mRNA was also strongly upregulated in EAE-
acute (around 500-fold vs control), and in EAE-RR animals
(around 200-fold vs control; CNT vs EAE-acute, P5 0.0001;
CNT vs EAE-RR, P5 0.0006). CD40 mRNA increased
around 20-fold versus the control group in EAE acute and
RR (CNT vs EAE-acute, P< 0.0001; CNT vs EAE-RR,
P< 0.0001). TGF-b mRNA expression was upregulated in
EAE-acute and EAE-RR (around eightfold vs the control
group; CNT vs EAE-acute, P< 0.0001; CNT vs EAE-RR,
P< 0.0001). Finally, TREM2 mRNA was significantly
increased in EAE-RR group of animals, (around 4.5-fold vs
controls; CNT vs EAE-RR, P5 0.0025). It should be noted
that the overexpression of INF-c mRNA in EAE-acute
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FIGURE 1: EAE clinical course, histopathology and cytokine expression. Neurological disability score (A) and animals’ body weight (B).
The red arrows indicate the days of sacrifice at 11 and 18 DPI. Statistical analysis: two-way ANOVA, ****P<0.0001. (C) Spinal cord histo-
pathology. Micrographs illustrate OX42-IR microglia and fluoromyelin staining in control, EAE acute phase (11DPI) and remission-
relapsing phase (18 DPI). Arrows indicate microglia accumulation around vessels; asterisks indicate microglial reaction and associated
demyelination. Scale bar 50 lm. (D) Cytokine mRNA expression level in the LSC (control: N510; EAE-acute: n59; Adjuvant-acute:
n58; EAE-relapsing-remitting: n57; adjuvant-RR: n58). Results obtained after analysis through the 2(2DDCT) method. Statistical analysis:
one-way ANOVA and Dunnett’s post hoc test, **P<0.01; ***P<0.001. E: Cytokine/Chemokine levels in the CSF. Results are presented
as individual values (pg/mL) and the mean6SEM is also shown. Statistical analysis: one-way ANOVA and Dunnett’s post hoc test,
*P<0.05; **P<0.01; ***P<0.001; ****P<0.0001. Abbreviations: ADJ, adjuvant; DPI, days post immunization; dh, dorsal horn; EAE,
experimental allergic encephalomyelitis; CD40, cluster of differentiation 40; gr, fasciculus gracilis; INF-c, interferon c; IL-1b, interleukin
1b; MCP-1, monocyte chemotactic protein-1; TGF-b, transforming growth factor b; TNF-a, tumor necrosis factor-a; TREM2, triggering
receptor expressed on myeloid cells 2; RANTES, regulated on activation, normal T cell expressed and secreted; RR, relapsing-remitting.
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animals is the highest EAE-induced upregulation observed
compared with the other cytokines/chemokines investigated.
IL-1b, TNF-a, TGF-b, MCP-1, and RANTES in CSF
samples (Fig. 1E) was then simultaneously quantified. IL-1b
protein was significantly increased in EAE-acute group com-
pared with control animals (P5 0.0004). This increase was
not observed in the EAE-RR experimental group. TNF-a was
also increased in EAE-acute animals compared with controls
(P5 0.0256). Moreover, the level of this cytokine was signifi-
cantly higher in ADJ-RR compared with the control group of
animals (P5 0.0002). MCP-1 chemokine also increased in
EAE animals and this difference was significant in the group
of EAE-acute animals (CNT vs EAE-acute, P< 0.0001),
whereas RANTES chemokine was increased in the EAE-RR
group of animals (CNT vs EAE-acute, P5 0.0265 CNT vs
EAE-RR, P5 0.0310). The level of TGF-b was increased in
EAE animals, as it was significantly higher in the acute phase
of the disease (CNT vs EAE-acute, P5 0.0294).
The Expression of TH-Signaling Genes Is Altered
in the Nervous Tissue During EAE
We first investigated the impact of the extensive inflammation
described above on the expression of genes encoding for the
TH transporter MCT8, the different genes encoding for the
nuclear receptors (TRa1, TRa2, TRb) and the activating
(D2) and inactivating (D3) enzymes by real-time PCR (Fig.
2A). There is a significant decrease in the expression of
MTC8 in the EAE-RR group (CNT vs EAE-RR, one-way
ANOVA P5 0.0265). The MTC8 mRNA level is also lower
in adjuvant-RR animals (P< 0.0001). The expression level of
mRNA encoding for TR subtypes a1, a2 and b is decreased
in EAE animals compared with the control group in both
investigated phases of the disease. Statistical analysis per-
formed through one-way ANOVA and Dunnett’s multiple
comparisons test gave the following P values: TRa1, CNT vs
EAE-acute, P5 0.0022; CNT vs EAE-RR, P5 0.0067;
TRa2, CNT vs EAE-acute, P5 0.0253; CNT vs EAE-RR,
P5 0.0161; TRb, CNT vs EAE-acute, P5 0.0164; CNT vs
EAE-RR, P5 0.0008). The mRNA of TRb was also downre-
gulated in the adjuvant-RR group (P5 0.0207). D2 mRNA
did not show any significant difference in EAE animals com-
pared with controls. In contrast, D2 mRNA level in
adjuvant-RR group was lower than in control animals
(P5 0.0037). The expression of D3 was instead subjected to
a strong upregulation in EAE animals in the acute phase
(around 30 times) and to a more moderate upregulation in
the EAE-RR group (around 10 times) compared with con-
trols (P< 0.0001).
In an attempt to correlate the observed changes in TH
signaling with EAE histopathology (inflammation and demye-
lination), the mRNA expression in microdissected samples of
the spinal cord was analyzed. The focus was laid on the gene
and the time showing the most extensive regulation, i.e., D3
in the acute phase, and an SC area with extensive inflamma-
tion and cellular infiltrates. Micrographs in Fig. 2B show rep-
resentative images of toluidine stained sections of the spinal
cord in control and acute-EAE animals. Extensive cellular
infiltrates enriched by peripheral cells were observed in the
white matter and around vessels penetrating the grey matter
(arrows). As in the whole LSC tissue, an upregulation of D3
mRNA (Student’s t test, P5 0.0003) was found in TSC
microdissected areas of acute-EAE compared with control
animals.
Finally, TH levels were quantified in plasma (Fig. 2C).
The working dynamic ranges of the standard curves were:
10,000–13.77 pg/mL for T3 and TSH; 200,000–274.33 pg/
mL for T4. T3 plasmatic levels do not differ significantly
across the experimental groups studied. T4 and TSH are sig-
nificantly decreased in acute-EAE compared with control ani-
mals (Student’s t test, P5 0.0332 and P5 0.0004,
respectively). No changes in rT3 plasma levels were observed
(results not shown).
In Vitro Exposure to Inflammatory Cytokines
Impairs OPCs Differentiation
In order to answer the question of whether the inflammatory
cytokines upregulated during EAE impair OPCs differentia-
tion, in vitro studies deriving OPCs from oligospheres under
T3 exposure were performed (Chen et al., 2007). This cell
system (OPCs-enriched) was preferred to primary OPCs iso-
lation, because T3 stimulation is necessary for NSC specifica-
tion in the oligodendrocyte lineage and for OL differentiation
and maturation (Castelo-Branco et al., 2014). The schedule
of the experiment is presented in Fig. 3A. After 12 days dif-
ferentiation, 17.26 2.2% OPCs (NG2-positive cells) were
obtained, while mature OL ranged from 40.06 3.8%
(CNPase) to 22.36 1.9% (MBP). The morphology of the
cells was consistent with the respective differentiation phase
(Fig. 3E,F, vehicle). In all groups, GFAP-positive astrocytes
account for 29.96 3.7% of the cell population, while
6.26 4.1% of the cells are beta-III-tubulin positive (data not
shown, average values6 standard deviation from three inde-
pendent experiments).
Inflammatory cytokines have different roles on OPCs
biology, on the proliferation and differentiation phases,
respectively. We then used two exposure schemes to investi-
gate the effect of cytokines on OPCs, i.e. (i) exposure during
the proliferation phase of OPCs in vitro generation and (ii)
exposure during OL in vitro differentiation (see Fig. 3A). The
cytokines mix was composed of TGF-b1, TNF-a, IL1-b, IL-
6, IL-17, and IFN-c, as derived in Results section (Fig.
1D,E). The exposure to the cytokines mix during oligosphere
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generation increased the proliferation index (Fig. 3B) after 5
(P5 0.0176) and 7 (P5 0.0062) DIVs compared with the
vehicle group, resulting in a higher number of cells at 12
DIV after seeding (Fig. 3C, P< 0.0001). The percentage of
condensed nuclei was not different in cytokines- and vehicle-
exposed cells. Conversely, the exposure to cytokines during
the differentiation phase provoked a decrease in the number
of cells at 12DIV compared with vehicle cells (P5 0.0111;
Fig. 3C), and an increase in the percentage of condensed
nuclei (P5 0.0002) (Fig. 3D), thus indicating a toxic effect
of cytokines in differentiating OPCs.
Next, the effect of cytokine exposure on OPCs differen-
tiation and OL maturation was analyzed, labeling antigens
expressed at different stages of OL maturation. Representative
micrographs at 12DIV are shown in Fig. 3E and the quantifi-
cation results in Fig. 3F. Cytokine exposure during prolifera-
tion or differentiation results in an increase of NG2-IR cells
(P5 0.0015 and P5 0.0022, respectively). The percentage of
mature, myelinating OL, as normalized according to the cell
survival in the different conditions dramatically decreases
when cytokines are present in the culture medium during
proliferation (CNPase, P5 0.0002; MBP, P5 0.0030), while
FIGURE 2: Thyroid hormone signaling related genes and proteins in EAE. (A) Thyroid hormone system molecules mRNA expression level
in the LSC (control: N510; EAE-acute: n59; adjuvant-acute: n58; EAE-relapsing-remitting: n57; adjuvant-RR: n58). Results are
obtained after analysis by the 2(2DDCT) method. Statistical analysis: one-way ANOVA and Dunnett’s post hoc test, *P<0.05; ***P<0.01;
***P<0.001; ****P<0.0001. B: Expression analysis of D3 mRNA in microdissected areas of the spinal cord in EAE vs control animals.
Micrographs show the toluidine blue staining of a coronal section of thoracic spinal cord in control and EAE rats, where cellular infil-
trates included in the microdissected areas are illustrated (arrows). Results are obtained after analysis by the 2(2DDCT) method. Statistical
analysis: Student’s t test, ***P<0.001. Bars: 250 lm; 100 lm. C: T3, T4 and TSH levels in plasma in control and acute EAE. Statistical
analysis: Student’s t test, §P<0.05 and §§§P<0.001. Abbreviations: D2, D3, deiodinase enzyme type 2, and 3; dh, dorsal horn; EAE,
experimental allergic encephalomyelitis; MCT8, monocarboxylate transporter 8; TH, thyroid hormone; TR, thyroid hormone receptor;
TSH, thyroid stimulating hormone; vh, ventral horn.
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FIGURE 3: Effect of OPC-enriched cultures cytokine exposure on OPCs proliferation and differentiation. (A) Design of the in vitro experi-
ments. (B) Proliferation index during oligosphere proliferation. Total number of cells (C) and percentage of condensed nuclei (D) after
cell seeding at 12 DIVs of differentiation. (E) Representative images of NG2-, CNPase-, MBP- and GFAP-IR cells from the three experi-
mental groups at 12 DIV. (F) lineage marker analysis of the different groups. Two biological replicates and at least 10 fields per group
were analyzed. Statistical analysis: one-way ANOVA followed by Tukey posttest, *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001.
Abbreviations: bFGF, basic fibroblast growth factor; CNTF, ciliary neurotrophic factor; CNPase, 20,30-cyclic nucleotide 30-
phosphodiesterase.; EGF, epidermal growth factor; GFAP, glial fibrillary acid protein; NAC, N-acetyl-L-cysteine; NG2 chondroitin sul-
phate proteoglycan, neural/glial antigen 2; NSC, neural stem cells; MBP, myelin basic protein; OPCs, oligodendrocyte precursor cells;
PDGF, platelet derived growth factor.
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no changes are observed when cytokines are present in the
differentiation phase only. Notably, GFAP-positive cells follow
the same profile as mature OL, and are drastically decreased
after cytokine exposure during proliferation (P5 0.0013).
An Appropriate Intracellular Content of TH Is
Required to Overcome the Block of OPCs
Differentiation Induced by Inflammation
In view of the results from in vivo experiments, which indi-
cated that the T3 inactivating enzyme D3 is strongly upregu-
lated in acute EAE, and in order to determinate whether
cellular hypothyroidism due to inflammatory cytokines causes
the OPCs differentiation block, we first focused in the study
of D3 in the cell system exposed to the cytokines mix. After
12 DIVs of differentiation, less than 10% of cells express a
detectable level of D3 in the control OPCs-enriched culture.
The exposure to cytokines during the proliferation phase leads
to an increase of over 35% in D3-IR cells (P5 0.0001) (Fig.
4A,B). Moreover, in order to identify the cell type expressing
D3, cultures were double stained for D3 and cell markers for
astrocytes (GFAP) or early OPCs (PDGFaR). As showed in
Fig. 4C,D, the majority of cells expressing D3 are PDGFaR-
positive (89.06 4.0%), while the remaining cells are astro-
cytes. Thus, it could be hypothesized that the increase in D3
protein in the cell system may lower T3 availability, leading
to a cellular hypothyroidism in OPCs. This could determine
the impairment of OPCs cell cycle exit, as is suggested by the
high number of NG2-positive cells corresponding to prolifer-
ating OPCs, and the low number of CNPase- and MBP-
positive cells corresponding to mature OL.
To test this hypothesis, the nonspecific deiodinase enzyme
inhibitor IOP was introduced into the cell system. IOP has
been used to study rodent and human deiodinase biochemical
properties (St Germain et al., 2009). IOP was used with the
intent to inhibit D3 and restore T3 intracellular content in an
environment characterized by the presence of T3, inflammatory
cytokines, OPCs and astrocytes (Fig. 5A). IOP was added to
the culture in the differentiation phase, 24 h before adding T3
(Fig. 5B). IOP exposure partially restored the maturation of OL
from OPCs (Fig. 5C). More specifically, the following percen-
tages of cells along the maturation lineage of OPCs were
obtained (Fig. 5D): (i) in the presence of T3, alone: NG2
17.1%, CNPase 40%, MBP 22.3%; (ii) in the presence of
FIGURE 4: Effect of OPC-enriched cultures cytokine exposure on D3 expression and effect of deiodinase inhibition on OL differentiation.
(A) Representative images of D3-positive cells in the vehicle- and cytokine-exposed groups. (B) Percentage of D3-positive cells in the
vehicle- and cytokine-exposed groups. (C) Representative images of double staining GFAP/D3 and PDGFaR/D3. (D) Percentage of D3
positive cells that are also positive for PDGFaR or GFAP. Grey bar: PDGFaR/D3; black bar: NG2/D3. Statistical analysis: Student’s t test,
***P<0.001. Bar: 50 lm. Abbreviations: D3, deiodinase-3; GFAP, glial fibrillary acidic protein; NG2 chondroitin sulphate proteoglycan,
neural/glial antigen 2; OPCs, oligodendrocyte precursor cells; PDGFaR, platelet derived growth factor a receptor; T3 thriiodothironin.
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T31 cytokines (vs T3 alone): NG2 46.9% (P< 0.0001);
CNPase 4.9% (P< 0.0001); MBP 0.7% (P< 0.0001); (iii) in
the presence of T31 cytokines1 IOP (vs T31 cytokines):
NG2 20.7% (P< 0.0001), CNPase 22.3% (P5 0.0008), MBP
13.1% (P< 0.0001). The morphology of the cells is consistent
with lineage progression.
FIGURE 5: Effect of deiodinase inhibition on OL differentiation in cytokines exposed OPC-enriched cultures. (A) Pathway of TH tissue
metabolism, and effect of IOP. (B) Protocol of OPCs proliferation and differentiation, cytokine exposure and IOP treatments. (C) Cell
morphology and lineage analysis after D3 inhibition induced by IOP treatment. (D) Graph shows the cell lineage analysis. (E) mRNA
expression relative quantification of the Klf9 gene, normalized to the T3-vehicle group. Two biological replicates and at least 10 fields
per group were analyzed. Statistical analysis: A: Student’s t test, ***P<0.001. (D and E) One-way ANOVA and by Tukey’s post hoc test.
Asterisks represent differences between treated groups and T3-only exposed group (**P<0.01; ***P<0.001; ****P<0.0001), while let-
ters represent differences between cytokine-only exposed group and cytokines1 IOP treated group (c5P<0.001; d5P<0.0001). Bar:
20 lm. Abbreviations: bFGF, basic fibroblast growth factor; CNTF, ciliary neurotrophic factor; CNPase, 20,30-cyclic nucleotide 30-
phosphodiesterase; D3, deiodinase-3; EGF, epidermal growth factor; IOP, iopanoic acid; NAC, N-acetyl-L-cysteine; NG2 chondroitin sul-
phate proteoglycan, neural/glial antigen 2; NSC, neural stem cells; MBP, myelin basic protein; OPC, oligodendrocyte precursor cells;
PDGF, platelet derived growth factor.
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Since both astrocytes and OPCs are present in the cell
system, and the correction of cellular hypothyroidism operat-
ed by IOP could thus be either direct in OPCs, or indirect
through astrocytes, the expression level of the transcription
factor, Kruppel-like factor 9 (Klf9), was ultimately studied;
this is a key gene in driving OPCs differentiation in vitro
(Dugas et al., 2012), which is strongly induced by T3. Since
cytokine exposure induces a huge decrease in Klf9 mRNA
(P< 0.0001), the treatment with IOP successively re-
established the expression of this transcription factor
(P< 0.012) (Fig. 5E).
D3 Is Expressed in CNS Cells During EAE
In order to determine whether the in vitro data could some-
how mimic the in vivo condition, double labeling experi-
ments were performed in fixed LSC tissue from control- and
acute EAE-animals (Figs. 1 and 6, supporting results). As
expected, the TH-inactivating enzyme D3 in control animals
is expressed in neurons (see Fig. 1F, supporting results), while
it is not observed in astrocytes, microglial cells, OPCs or OL.
While no changes were observed in D3 staining intensity in
neurons (Fig. 1H, supporting results, motoneurons in the
ventral horn of the LSC), an upregulation was observed in
the white matter in acute EAE (Fig. 6A,C, sampled in the
dorsal funiculus of the LSC), where also an upregulation of
the NG2 immunoreactive area was observed (Fig. 6B,D). In
particular, D3 appears in OPCs, OL and astrocytes. High-
power confocal analysis exploring the co-localization of D3
with cell markers is reported in Fig. 6E, along with the step-
by-step image analysis procedure used to examine the multi-
ple z-plane scanning and its lateral projections. The co-
distribution of red and green channels, corresponding to the
D3-IR in NG2-, CNPase- and GFAP-IR cells, is quite evi-
dent, whereas it is not observed in OX42-IR cells (Fig. 1G,
supporting results). At this time, and according to well estab-
lished results, an activation of microglia (OX42-IR cells, Fig.
1C, supporting results) and a downregulation of MBP-IR
(Fig. 1E, supporting results) is observed in the dorsal horn of
the spinal cord, along with an initial astrogliosis (Fig. 1D,
supporting results).
Discussion
The role of T3 in oligodendrogenesis and developmental
myelination has been known for more than twenty years in
rodents and humans (Bernal, 2005). T3 induces more OLs to
be generated from stem and neural stem cells (Fernandez
FIGURE 6: D3 immunostaining in different cell types in the lumbar spinal cord. Representative images of D3 (A) and NG2 (B) staining in
the ventral spinal cord in control and EAE-acute animals. High magnification of stained cells are included in the EAE images. (C) D3 stain-
ing intensity in control and EAE spinal cord. (D) NG2-IR percentage area in control and EAE spinal cord. (E) 3D visualization and images
elaboration of NG2, CNPase and GFAP-positive cells double stained for D3. Images were elaborated by using IMARIS software, extract-
ing the single cell volume (grey surface) from the whole image. Co-distribution of D3 was visualized in 3D elaborated images (see text
for image analysis procedure). Bars: A–B, 50 mm; E, 5 mm. Abbreviations: A.U. arbitrary units; D3, deiodinase-3; GFAP, glial fibrillary acid
protein; NG2 chondroitin sulphate proteoglycan, neural/glial antigen 2; CNPase, 20,30-cyclic nucleotide 30-phosphodiesterase.
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et al., 2004a; Kang et al., 2007; Whittemore et al., 1999)
driving cell cycle exit and terminal differentiation into myeli-
nating OL (Casaccia-Bonnefil and Liu, 2003; Raff, 2006)
and regulates the expression of genes encoding for myelin
proteins (Baxi et al., 2014; Strait et al., 1997). The critical
role of intracellular T3 in appropriate myelination was further
confirmed by the discovery of the mutation of MCT8 in the
Allan-Herndon-Dudley syndrome (Schwartz et al., 2005),
leading to severe hypomyelination and TH metabolism
impairment in the brain (Lopez-Espındola et al., 2014). Last-
ly, TH is recommended in OPCs differentiation protocols
(Chen et al., 2007).
According to the so-called “recapitulation hypothesis”,
remyelination after myelin damage follows some myelination
steps and mechanisms occurring during development (Frank-
lin and Hinks, 1999). However, a number of myelination
inhibitory factors are present in the adult diseased microenvi-
ronment (Fancy et al., 2011). Herein it is suggested that
altered TH tissue metabolism induced by inflammatory cyto-
kines could be one of these factors, thus extending to the
CNS the evidence described in peripheral tissues, and indicat-
ing that cytokines affect a variety of genes involved in TH
metabolism, including D2 and D3 (Boelen et al., 2011; de
Vries et al., 2015).
By means of in vivo experiments, it was first demon-
strated that a complex dysregulation of the TH tissue signal-
ing is present in acute EAE, which correlates with the rise of
inflammatory cytokines released by peripheral cells and resi-
dent microglia (Rodgers and Miller, 2012). The present study
confirms the dramatic rise in mRNA tissue expression level
for several cytokines, some of which (IL-1b, TNF-a, and
TGF-b) also increased in the CSF. Also confirmed was the
upregulation of TREM2, a membrane receptor expressed on
microglial cells during EAE (Piccio et al., 2007), and CD40,
associated with anti-inflammatory M2 microglia (Liu et al.,
2013).
In parallel, a 30-fold upregulation was found in the T3
inactivating enzyme D3 mRNA, while no significant changes
were found in the D2 gene expression. Notably, in microdis-
sected inflammatory infiltrates a modest (threefold) upregula-
tion of D3 mRNA was observed. The expression level of all
TRs isoforms was decreased. In brain tissue, D2 is mainly
localized in astrocytes and D3 in neurons (Courtin et al.,
2005). In EAE, D3 protein is detectable also in astrocytes,
NG2-IR OPCs and CNPase-IR OL. Thus, not only peripher-
al cells infiltrating the spinal cord parenchyma during EAE
(Boelen et al., 2009) but also resident cells express high levels
of the T3-inactivating enzyme. Although the different prepa-
ration of whole and microdissected tissue for mRNA expres-
sion analysis makes hard a direct comparison between these
results, we can argue that D3 regulation in astrocytes, OPCs
and OL is even higher that in peripheral cells infiltrating spi-
nal cord parenchyma.
Notably, an increase in D3 activity and mRNA expres-
sion level has been described in other neurological conditions
characterized by inflammation and demyelination, e.g.,
ischemia-induced hypoxic brain damage (Jo et al., 2012) and
nerve lesion (Li et al., 2001). Finally, a downregulation of all
TRs was also found, including TRa, responsible for oligoden-
droglial lineage induction from NSC (Marziali et al., 2015),
as well as TRb, responsible for OPCs maturation into oligo-
dendrocytes (Baxi et al., 2014).
A decrease was observed in T4 and TSH plasma levels,
possibly indicating that the TH negative feedback in the pitu-
itary and hypothalamus is altered, as already described in
severe systemic inflammation (Docter et al., 1993; de Vries
et al., 2015), and in the non-human primate model of MS
(D’Intino et al., 2011).
The overall scenario emerging from our in vivo data,
namely D3 overexpression and TR downregulation, supports
the hypothesis that inflammation leads to a substantial tissue
hypothyroidism during EAE, and this could impact on cellu-
lar processes requiring an appropriate TH drive, including
OPCs differentiation into myelinating OL. Indeed, extensive
in vitro and in vivo evidence indicates that OPCs maturation
into myelinating oligodendrocytes is a T3-dependent process.
In vitro studies have quite elegantly described the role of T3
and TRs as key components of the molecular machinery trig-
gering OPCs out of the cell cycle toward mature OL (Durand
and Raff, 2000). The absence of all TRs results in the persis-
tence of OPCs proliferation and the absence of differentiation
in adult optic nerves, leading to a default in myelination
(Baas et al., 2002). T3 is also necessary in the signaling cas-
cade that promotes myelin repair, possibly involving the tran-
scription factor Kruppel-like factor 9 (Klf9) (Dugas et al.,
2012).
To directly test if cytokine-induced alteration of intra-
cellular T3 availability is involved in OPCs differentiation
failure during inflammation, in vitro studies were performed
using OPCs derived from NSCs obtained from the SVZ of
adult rats. In this cell system, OPCs, mature OLs and astro-
cytes are present. We described that OPC maturation was
impaired after cytokines exposure during proliferation. Nota-
bly, these effects are maintained also when cytokines are
withdrawn from the medium, suggesting that cells maintain
the “inflammatory priming” initiated by cytokine exposure,
as already suggested in ischemia (Falahati et al., 2013). On
the contrary, cytokines exposure during differentiation is
cytotoxic, but does not abolish OL maturation of the surviv-
ing cells.
This dual effect according to the culture phase could at
least partially explain the contrasting data on the effect of
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inflammatory cytokines on proliferation and differentiation of
NSCs described so far in EAE models. In fact, while several
papers agree on the increased proliferation of NSCs in the
SVZ during acute EAE (Calza et al., 1998, 2002; Picard-Riera
et al., 2002; Pluchino et al., 2008; Tepavcevic et al., 2011) and
MS (Nait-Oumesmar et al., 2007), contrasting results are
reported using different OPC in vitro systems. IFN-c either
inhibits (1-day postnatal rat purified OPCs primary cultures
and adult mice SVZ derived OPCs, Chew et al., 2005; Plu-
chino et al., 2008, respectively) or induces (7-days postnatal O/
2A OPC primary cultures from the corpus callosum, Tanner
et al., 2011) cell cycle exit in OPCs, also abrogating differentia-
tion into OL induced by T3 (Tanner et al., 2011). TNF-a is
cytotoxic and inhibits OPCs differentiation (primary OPCs, Su
et al., 2011). IL-17 prevents OPCs maturation (OPCs-enriched
primary culture from foetal mice NPCs, Kang et al., 2013). IL-
1b, IL-6, TGF-b1, and TNF-a produced as a result of ischemia
shifted OPCs toward the more immature form (1-day postnatal
rat ischemia, Falahati et al., 2013).
Under cytokine exposure, a dramatic rise in the number
of D3-positive cells was observed. Notably, over 80% of
PDGFaR-IR OPCs and less than 20% of GFAP-IR astrocyte
express D3 under cytokine exposure, thus corroborating what
happens in vivo during EAE. In order to contrast the possible
T3 degradation induced by D3, and to maintain an appropri-
ate T3 concentration in the culture medium for OPCs differ-
entiation, the deiodinase inhibitor IOP was introduced into
the cell system. IOP is used as radiocontrast medium and in
the treatment of drug-resistant hyperthyroidism (Allahabadia
et al., 2000). IOP blocks conversion of T4 to T3 by competi-
tively inhibiting D1 and D2, and blocks T3 inactivation by
inhibiting D3 (Huang et al., 2011), thus increasing T3 avail-
ability. In our system, when used in the presence of T3 and
cytokines, it restores the capability to express differentiation
markers (CNPase and MBP), also restoring OL mature mor-
phology. It may thus be concluded that IOP inhibits D3,
thereby restoring an appropriate T3 content in OPCs that
overcome the cytokine-induced OPCs differentiation block.
This mechanism could explain the positive results
observed in in vivo TH supplementation in different demye-
lination models, and also suggests downstream mechanisms.
TH supplementation, possibly by binding TR and TREs,
actually restores the expression on a number of key genes for
OPCs differentiation (Zhang et al., 2015b). Among others:
Olig1/2 (D’Intino et al., 2011; Harsan et al., 2008), which
are key determinants for OPCs maturation (Meijer et al.,
2012; Zhu et al., 2012); sonic hedgehog, the activation of
which is necessary to promote remyelination by fingolimod
in EAE (Zhang et al., 2015a); Klf9, the activation of which is
necessary and sufficient to promote OL differentiation in
vitro (Denver and Williamson, 2009), and remyelination in
vivo (Dugas et al., 2012). Once again, IOP was able to exten-
sively re-establish Klf9 mRNA expression level, which was
almost suppressed by cytokine exposure. Therefore, as the
appropriate balance between intracellular production and deg-
radation of TH is necessary during cellular differentiation
(Dentice et al., 2013), it follows that a hormone replacement
therapy should be considered as supporting therapy to over-
come OPCs differentiation inhibition observed in inflamma-
tory demyelinating diseases (Kremer et al., 2011; Watzlawik
et al., 2010). This conclusion could be also extended to the
cerebral white matter injury in the premature infant, where a
transient hypothyroxinemia is described (Elitt and Rosenberg,
2014; van Tilborg et al., 2015). However, to pursue this aim,
many other aspects need to be thoroughly investigated from
both a neurobiological and a clinical point of view, starting
from the need to avoid potential hyperthyroidism side effects,
and considering the substantially different profile of thyroid
function and tissue signaling in perinatal period and adult life
(Calza et al., 2015; Moog et al., 2015).
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5. CONCLUSIONS AND PERSPECTIVES	  	  The	  different	   nature	   of	   foetal	  OPCs,	   involved	   in	   developmental	  myelination,	   and	   adult	  OPCs,	  involved	  in	  myelin	  dynamics,	  could	  reflect	  a	  different	  response	  of	  the	  two	  cells	  to	  demyelinating	  insults.	  	  We	  demonstrated	  that	  foetal	  and	  adult	  NSCs-­‐derived	  OPCs	  show	  similar	  role	  of	  RXRγ	  in	  T3-­‐mediated	   differentiation	   and	   the	   same	   response	   to	   inflammation-­‐mediated	  differentiation	  block.	  However,	  the	  two	  systems	  show	  different	  response	  to	  T3-­‐mediated	  differentiation	   induction	   in	   physiological	   conditions,	   mediated	   by	   differentially	  expressed	  NRs,	  and	  to	  PARP	  inhibition,	  selectively	  lethal	  for	  foetal	  OPCs.	  Moreover,	  the	  two	  systems	  show	  a	  totally	  different	  response	  to	  OGD-­‐induced	  cell	  death,	  with	  OPCs/OLs	  selective	  vulnerability	  only	  in	  foetal	  cultures.	  Further	   studies	   will	   focus	   on	   the	   role	   of	   RXRγ	   in	   the	   T3-­‐mediated	   differentiation	  induction,	   with	   a	   focus	   on	   TRs/RXRγ	   dimerization	   and	   genes	   target	   identification.	  Moreover	   deiodinases	   and	   glutamate	   involvement	   in	   foetal-­‐selective	  OGD-­‐induced	   cell	  death	  will	  be	  investigated.	  	  The	   understating	   of	   molecular	   machinery	   underlying	   differences	   in	   physiological	  differentiation	  and	  different	  response	  to	  demyelinating	  insults	  in	  foetal	  and	  adult	  OPCs,	  will	  open	  the	  way	  to	  new	  strategies	  focused	  on	  the	  developing	  of	  differential	  therapies	  in	  foetal	  and	  adult	  demyelinating	  diseases.	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